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I. Introduction 
1. Cytochrome P450 enzymes 
1.1. Nature 
Cytochrome P450 (P450 or CYP) enzymes are present in almost all life forms including bacteria, 
lower eukaryotes, plants and animals and have even been found in viruses (Danielson, 2002; Lamb 
et al., 2009). Their active site contains an iron-heme prosthetic group, where the nitrogen atoms of 
the heme provide the first four ligands while a cysteine thiolate forms the fifth ligand of the heme 
iron. This configuration is responsible for the characteristic absorption maximum at 450 nm upon 
binding of carbon monoxide to the ferrous heme iron, and hence the name ‘Cytochrome P450’ or 
the Pigment absorbing at 450 nm (Omura and Sato, 1964). The enzymes can activate molecular 
oxygen (O2) and, generally, insert one atom in the substrate, while the second atom is reduced to 
water according to the general equation: RH + O2 + 2e
- + 2H+               ROH + H2O, where RH is 
the substrate and ROH is the hydroxylated product (Bak et al., 2011). CYPs catalyze a wide array 
of reactions in primary (general) and secondary (specialized) metabolism and play a major role in 
xenobiotic detoxification. Common CYP-catalyzed reactions include C-hydroxylation, 
dealkylation and epoxidation. However, some CYPs have been reported to catalyze more complex, 
less common reactions such as dimerization and coupling as well as ring formation, contraction, 
and expansion (Guengerich, 2001).  
1.2. Nomenclature 
Unlike animals and bacteria, plants are characterized by the presence of large numbers of CYP 
genes representing about 1% of their genomes (Table I-1). Currently, there are about 21,000 
annotated CYPs, more than 7400 being found in the plant kingdom (Nelson, 2009). It is expected 
that the number will further increase as a result of the blooming genome and transcriptome 
sequencing projects supported by the recent developments in next generation sequencing (NGS) 
techniques.  
Table I-1. Examples of CYP gene and pseudogene counts in selected organisms. 
Organism CYP genes count CYP pseudogenes count 
Homo sapiens 57 47 
Mus musculus 103 82 
Arabidopsis thaliana 244 28 
Ricinus communis 214 47 
Glycine max 313 195 
Populus tichocarpa 310 203 
Vitis vinifera 315 201 
Oryza sativa 323 135 
Solanum lycopersicum 366 93 
 
A common nomenclature system based on the level of amino acid sequence identity and 
phylogenetic association has been devised to categorize CYP genes from all organisms. The name 
consists of the root symbol ‘CYP’, representing ‘cytochrome P450’, followed by an Arabic number 
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denoting the family, one or two letters designating the subfamily, and an Arabic numeral 
representing the individual gene within the subfamily (Nelson et al., 1996). For example, 
cinnamate 4-hydroxylase from A. thaliana was given the name CYP73A5 (Mizutani et al., 1997). 
This denotes that this protein belongs to family 73, subfamily A, and is the peptide number 5 within 
this subfamily. As a general rule, CYPs sharing at least 40% amino acids sequence identity are 
grouped within the same family, while those sharing at least 55% identity are grouped within the 
same subfamily (Nelson, 2006). Since CYPs are found in all domains of life, blocks of numbers 
have been reserved for the classification of new CYP families according to their taxonomic 
divisions. The family numbers has now increased from two to four digits to accommodate the 
expanding number of newly discovered CYPs (Table I-2) (Danielson, 2002). 
Table I-2. CYP families ranges for the major taxonomic divisions. 
Taxonomic division CYP families range 
Animals CYP1-49 CYP301-499 CYP3001-4999 
Lower eukaryotes CYP51-69 CYP501-699 CYP5001-6999 
Plants CYP71-99 CYP701-999 CYP7001-9999 
Bacteria CYP101-299 CYP1001-2999  
 
1.3. Structure, conserved domains and substrate recognition 
CYPs have variable substrate specificities and share low primary amino acid sequence identities 
that may be less than 20% between members of different families (Graham and Peterson, 1999). 
However, the increasing number of solved crystal structures show that most CYPs have common 
features. While prokaryotic CYPs are soluble proteins, eukaryotic CYPs are associated with 
microsomal membranes by a hydrophobic N- terminal membrane anchor that is separated from the 
globular part of the protein by a cluster of basic residues and a proline-rich motif (usually PPxP), 
which acts as a hinge between both parts (Figure I-1) (Werck-Reichhart and Feyereisen, 2000).  
The common conserved secondary structures of CYPs include twelve α helices (αA-L) and five 
β sheets (β1-5), which could be identified in all CYP structures and make up the common CYP-
fold (Figure I-2) (Sirim et al., 2010). The heme prosthetic group is the catalytic center of the 
enzymes and is found deeply buried inside all CYP proteins at the bottom of a large, internal 
binding cavity (Figure I-3) (Seifert and Pleiss, 2009). The core part of the protein surrounding the 
heme shows highest structural conservation reflecting a common mechanism of oxygen activation 
and electron or proton transfer. This core region includes: 
 The heme-binding loop which is located just before the L-helix and contains the absolutely 
conserved cysteine in the signature sequence (FxxGxRxCxG). The underlined cysteine serves 
as the proximal fifth ligand to the iron of the heme. 
 The conserved ExxR motif which is located in the K-helix on the heme proximal side. It is 
important for the stabilization of the meander loop and, in turn, the CYP tertiary structure. 
 The I-helix which is located distal to the heme with its central part directly adjacent to the iron. 
It contains the consensus sequence A/GGxD/ETT/S. The underlined conserved threonine plays 
an important role in proton transfer during catalysis. 
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Figure I-1. Primary structure of endoplasmic reticulum-bound CYPs (class II); adapted from Werck-Reichhart and 
Feyereisen (2000). 
 
Figure I-2. A topological illustration of CYPs showing the main structural features, the substrate recognition sites 
(SRSs) being highlighted in yellow; adapted from Werck-Reichhart and Feyereisen (2000) and Sirim et al. (2010). 
 
  
  
  
    
  
  
 
 
Membrane anchor 
Cluster of basic residues 
Cluster of prolines (PPGP) 
 Helix I (distal face of the heme) 
ExxR motif in helix K 
 
Substrate recognition sites (SRSs) 
Membrane 
anchor 
Globular domain 
Hinge 
Hyper-variable region Conserved features 
 
Heme-binding loop including the conserved 
cysteine coordinated to heme iron 
  Introduction 
4 
 
 
Figure I-3. Cartoon illustration of the tertiary structure of CYPs. The heme is colored orange, the substrate recognition 
sites (SRSs 1–6) are marked red, and the I and L helices are shown in green; adapted from Urlacher and Eiben (2006). 
On the other hand, substrate binding and recognition are mediated by variable regions known as 
the substrate-recognition sites (SRSs). The SRSs were first defined by Gotoh (1992) upon 
alignment of the mammalian CYP2 family with the bacterial CYP101A (P450cam), which was 
the first CYP crystal structure with the bound camphor substrate to be solved (Poulos et al., 1987). 
Regions designated to form the SRSs include (Figure I-2, I-3): 
 SRS-1: the region between the B and C-helices (including the Bꞌ-helix). 
 SRS-2: the C-terminal end of the F-helix. 
 SRS-3: part of the F-G loop and N-terminal end of the G-helix. 
 SRS-4: the N-terminal part of the I-helix. 
 SRS-5: the loop between the K helix and strand 4 of β-sheet 1. 
 SRS-6: the turn in β-sheet 4. 
The residues of the first three SRSs surround the substrate-access channel and are thought to be 
responsible for the substrate specificity, while the residues in the latter three SRSs are much closer 
to the heme catalytic center and most likely present in direct contact with the substrate during 
catalysis. Therefore, they play an important role in controlling the regio- and stereoselectivities of 
the CYPs. 
SRS-6 
SRS-5 
Heme 
SRS-4 
SRS-1 
SRS-2 
SRS-3 
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An updated map of the assigned SRSs based on docking of 868 different substrates to mammalian 
CYPs was recently introduced (Zawaira et al., 2011). The Zawaira map differs from the Gotoh 
map in the following aspects:  
 The length of SRS-1 increased from 28 residues to 49 residues. 
 Two additional SRS-1ꞌa and SRS-1ꞌb regions located N-terminally to SRS-1 were 
identified. 
 SRS-2 and SRS-3 were merged into SRS (2, 3) with a total length of 60 residues instead 
of 19 in the Gotoh map.  
 The lengths of SRSs 4, 5, and 6 increased by a few residues.  
Overall, about 33% of the residues on a CYP are assumed to be within the SRSs in the new map 
compared to only 16% in the Gotoh map (Zawaira et al., 2011; Mustafa et al., 2014). 
1.4. Catalytic cycle 
In the resting state, the iron is hexacoordinated by the four nitrogen atoms of the heme with the 
sulphur of the conserved cysteine at the proximal and a water molecule at the distal sides. The iron 
atom exists in the ferric low-spin state (Ogliaro et al., 2002; Lamb and Waterman, 2013).  
The catalytic cycle of CYPs involves the following steps (Figure I-4): 
1. Substrate binding: When the substrate binds to the protein, the distal water molecules is 
removed. Concomitantly, the ferric iron undergoes transition from the low-spin to the 
high- spin state with increasing its redox potential. 
2. First one-electron reduction: The redox partner (for example, the NADPH-dependent 
cytochrome P450 reductase in eukaryotes) transfers an electron to the CYP, resulting in the 
formation of a ferrous pentacoordinated heme. 
3. Dioxygen binding: Molecular oxygen binds to the heme iron resulting in the formation of the 
ferric superoxo species. 
4. Second one-electron reduction: The redox partner supplies a second electron to the CYP 
resulting in the formation of a ferric peroxo species. 
5. Protonation: A ferric hydroperoxo species (also known as Cpd 0) is generated when the 
previously mentioned ferric peroxo species receives a proton from its environment. 
6. Second protonation and heterolytic scission of the O–O bond: A second protonation 
together with heterolytic cleavage of the O–O bond leads to the release of water and the 
generation of the reactive iron(IV)oxo (or ferryl-oxo) π-radical species known as Cpd I (Rittle 
and Green, 2010). 
7. Reaction with the substrate: The highly reactive Cpd I abstracts a hydrogen atom from the 
substrate to form a substrate radical and a ferryl-hydroxo species known as Cpd II. In the 
classical hydroxylation mechanism, oxygen rebound occurs leading to the formation of the 
hydroxylated product while the heme iron returns to the ferric state. 
8. Release of the product: When the hydroxylated product is released, a water molecule 
occupies back the sixth coordinate of the heme and the enzyme returns to its resting state ready 
for another cycle.  
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Binding of the reduced form of the enzyme to carbon monoxide gives rise to the characteristic 
Soret absorption peak at 450 nm due to the properties of the cysteine thiolate group (Figure I-4, 
step 9). Another way for heme activation is the peroxide shunt (Figure I-4, step 10), where the 
interaction with peroxides and hypochlorites as single-oxygen donors can lead to the formation of 
Cpd 0 directly without going through steps 2–5 of the cycle. This phenomenon was recently 
employed to characterize the nature of Cpd I (Rittle and Green, 2010). 
Figure I-4. Catalytic cycle of CYP-catalyzed hydroxylation. RH is the substrate, ROH is the hydroxylated product. 
1.5. CYP redox partners 
As inferred from the catalytic cycle, the vast majority of CYPs require supply with two electrons 
per cycle to accomplish substrate hydroxylation. Those electrons should be delivered from 
NAD(P)H cofactor one at a time by the aid of a redox partner. When CYPs were first discovered 
in human adrenal gland and liver, two main classes of redox partners were identified. In adrenal 
mitochondrial CYPs, adrenodoxin and adrenodoxin reductase were involved (Omura et al., 1966), 
whereas in liver microsomal systems, NADPH dependent oxidoreductase containing FAD and 
FMN was involved (Lu et al., 1969). The first bacterial CYP discovered was camphor hydroxylase 
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(CYP101 or P450cam) and was identified as a soluble protein (Katagiri et al., 1968). It receives 
its electrons from a putidaredoxin/putidaredoxin reductase system analogous to the mitochondrial 
one. Later on, CYP102 (P450BM3) was discovered as a fusion protein consisting of both CYP and 
reductase domains (Narhi and Fulco, 1987; Hannemann et al., 2007). 
The above mentioned systems represent the most abundant types of redox partners involved in 
CYP catalysis. However, other less abundant systems exist in nature as well. Currently, a total of 
10 classes of CYP redox partner systems have been identified, as summarized in (Table I-3). 
Table I-3. Classes of CYPs based on their redox partner systems; adapted from Hannemann et al. (2007). 
Class/source Electron transport chain Localization/remarks 
Class I   
Bacterial NAD(P)H▸[FdR]▸[Fdx]*▸[P450] Cytosolic, soluble 
Mitochondrial NADPH▸[FdR]▸[Fdx]▸[P450] 
FdR: membrane associated, 
Fdx: mitochondrial matrix, 
soluble 
Class II   
Bacterial NADH▸[CPR]▸[P450] Cytosolic, soluble 
Microsomal A NADPH▸[CPR]▸[P450] Membrane anchored, ER 
Microsomal B NADPH▸[CPR]▸[Cytb5]▸[P450] Membrane anchored, ER 
Microsomal C NADH▸[Cytb5Red]▸[Cytb5]▸[P450] Membrane anchored, ER 
Class III   
Bacterial NAD(P)H▸[FdR]▸[Fldx]▸[P450] Cytosolic, soluble 
Class IV   
Bacterial Pyruvat, CoA▸[OFOR]▸[Fdx]▸[P450] Cytosolic, soluble 
Class V   
Bacterial NADH▸[FdR]▸[Fdx–P450] Cytosolic, soluble 
Class VI   
Bacterial NAD(P)H▸[FdR]▸[Fldx–P450] Cytosolic, soluble 
Class VII   
Bacterial NADH▸[PFOR–P450] Cytosolic, soluble 
Class VIII   
Bacteria, fungi NADPH▸[CPR–P450] Cytosolic, soluble 
Class IX   
fungi NADH▸[P450] Cytosolic, soluble 
Class X   
Independent in 
plants/mammals 
 
[P450] 
 
Membrane bound, ER 
 
 
Abbreviated protein components contain the following redox centers: Fdx (iron–sulfur-cluster); FdR, Ferredoxin 
reductase (FAD); CPR, cytochrome P450 reductase (FAD, FMN); Cytb5, Cytochrome b5; Cytb5Red, Cytochrome b5 
reductase; Fldx, Flavodoxin (FMN); OFOR, 2-oxoacid:ferredoxin oxidoreductase (thiamin pyrophosphate, [4Fe–4S] 
cluster); PFOR, phthatate-family oxygenase reductase (FMN, [2Fe–2S] cluster). 
a Fdx containing iron–sulfur-cluster of [2Fe–2S], [3Fe–4S], [4Fe–4S], [3Fe–4S]/[4Fe–4S] type. 
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1.6. Phylogenetic classification of cytochrome P450 enzymes 
Initially, a primitive classification scheme divided plant CYPs into A-type and non-A-type. This 
was based on the fact that in a phylogenetic analysis the A-type CYPs constituted a monophyletic 
tree, while the non-A-type CYPs were more divergent and did not constitute a consistent group. It 
was believed that A-type CYPs are mainly devoted to plant secondary metabolism, such as the 
biosynthesis of flavonoids, alkaloids, cyanogenic glycosides and lignans, while non- A-type CYPs 
were assumed to be mainly involved in primary metabolism, such as sterols and hormones 
biosynthesis and metabolism. However, this belief proved to be incorrect as many non-A-type 
CYPs were found to be involved in plant secondary metabolism (Nelson and Werck-Reichhart, 
2011; Hamberger and Bak, 2013). 
As mentioned in (I.1.2), CYPs have been named into families and subfamilies. However, the 
proximity of designated family numbers does not necessarily reflect a close phylogenetic 
relationship between them. Family numbers are given according to the priority of sequence 
submission to the nomenclature committee. Therefore, to understand the phylogenetic 
relationships between different families, plant CYPs have been classified into clans; each clan is 
given the lowest number of the CYP families included (Table I-4). So far, 11 plant CYP clans 
have been identified, each of them being derived from a single ancestor. Seven clans are 
represented by one family each and are, therefore, termed the single-family clans, while the 
remaining four are represented by several families each and are termed the multi- family clans 
(Table I-4) (Nelson et al., 2004; Bak et al., 2011; Hamberger and Bak, 2013). 
Table I-4. Plant CYP clans and the classification of included families; adapted from (Xu et al., 2015). 
Clan  Count Names of families included 
CYP51 1 CYP51 
 
      
CYP71 26 
CYP71 CYP73 CYP75 CYP76 CYP77 CYP78 CYP79 
CYP80 CYP81 CYP82 CYP83 CYP84 CYP89 CYP92 
CYP93 CYP98 CYP99 CYP701 CYP703 CYP705 CYP706 
CYP712 CYP719 CYP723 CYP726 CYP736 
 
  
CYP72 8 CYP72 CYP709 CYP714 CYP715 CYP721 CYP734 CYP735 
  CYP749 
 
      
CYP74 1 CYP74 
 
      
CYP85 15 CYP85 CYP87 CYP88 CYP90 CYP702 CYP707 CYP708 
  CYP716 CYP718 CYP720 CYP724 CYP725 CYP728 CYP729 
  CYP733 
 
      
CYP86 7 CYP86 CYP94 CYP96 CYP704 CYP730 CYP731 CYP732 
 
CYP97 1 CYP97 
 
      
CYP710 1 CYP710 
 
      
CYP711 1 CYP711 
 
      
CYP727 1 CYP727 
 
      
CYP746 1 CYP746       
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Figure I-5. Phylogenetic analysis of representative members of 127 plant CYP families showing the relationship 
between the different clans. The analysis was performed by neighbor-joining method. Each clan is labeled and its 
branches are shown in a different color than the other clans. Algal sequences are shown with black branches and 
mostly did not fall within the named clans. CYP names are color-coded: magenta, dicots; blue, monocots; cyan, 
gymnosperms; green, Selaginella moellendorffii; red, Physcomitrella patens. Two-letter codes are used for species: 
At, Arabidopsis thaliana; Bs, Berberis stolinifera; Cj, Coptis japonica; Cr, Chlamydomonas reinhardtii; Ct, 
Catharanthus roseus; El, Euphorbia lagascae; Mi, Micromonas pusilla; Ol, Ostreococcus lucimarinus; Os, Oryza 
sativa; Ot, Ostreococcus tauri; Ph, Petunia hybrida; Pi, Pisum sativum; Po, Populus trichocarpa; Pp, Physcomitrella 
patens; Pt, Pinus taeda; Py, Pyrus communis; Sb, Sorghum bicolor; Sm, Selaginella moellendorffii; Tc, Taxus 
cuspidata; Vc, Volvox carteri; Vs, Vicia sativa; Zm, Zea mays; acquired from Nelson and Werck-Reichhart (2011). 
Single- family clans generally encode essential enzymes such as those responsible for the 
production of sterols, lipids, carotenoids and hormones. They occur under purifying selection 
slowing their duplication and neofuctionalization (Nelson and Werck-Reichhart, 2011). On the 
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other hand, multi-family clans went through several steps of gene-duplication and 
neofunctionalization. In the current classification, CYPs formerly classified as A-type exist within 
the CYP71 clan, while the non-A-Type CYPs are distributed in the other 10 clans. Generally, more 
than 50 % of higher plant CYPs exist within the CYP71 clan. In spite of being the youngest clan, 
it underwent several gene duplication events at a quick rate leading to blooms of genes and the 
emergence of species-specific families. Those were subsequently recruited in secondary 
metabolism aiding the plants to evolve and adapt to their environment (Figure I-5) (Nelson and 
Werck-Reichhart, 2011). 
Although it is difficult to predict CYP substrates from sequence data alone, phylogeny may give a 
clue about the metabolic pathways in which a certain CYP is involved. For example, members of 
the CYP85 clan are mainly involved in the metabolism of medium to large isoprenoids such as 
brassinosteroids, whereas members of the CYP72 clan are involved in the biosynthesis of 
cytokinins and in the metabolism of a variety of hydrophobic compounds such as gibberellin and 
brassinosteroids. Finally, CYP71 clan members are mainly recruited in plant specialized 
metabolism (Nelson et al., 2004; Bak et al., 2011; Nelson and Werck-Reichhart, 2011).  
2. The genus Hypericum 
The genus Hypericum comprises about 500 species of herbs, shrubs and less frequently small trees 
(APGIII, 2009; Nurk et al., 2013). It is therefore by far the largest of the nine genera composing 
the family Hypericaceae, representing more than 80 % of its species. The Hypericaceae is 
classified in the clusioid clade of the order Malpighiales (Wurdack and Davis, 2009). The clusioids 
include five families, namely Bonnetiaceae, Clusiaceae, Calophyllaceae, Podostemaceae and 
Hypericaceae. Formerly, Hypericaceae family members were treated as a subfamily 
(Hypericoideae) within the Clusiaceae (Guttiferae). However, after recent phylogenetic analysis 
of the flowering plant order Malpighiales, they were separated and regarded as distinct families 
(Stevens, 2007; Crockett and Robson, 2011). Generally, Hypericum is distributed worldwide with 
the major occurrence in Eurasia and Andean South America. It is mainly present in temperate 
regions as well as highly elevated areas in the tropics (Robson, 2003). 
The name Hypericum originates from the Greek word hyper meaning ‘above’ and eikon meaning 
‘icon or picture’ because, in the Middle Ages, it was believed that Hypericum flowers avert evil 
spirits and therefore were put above pictures or statues of religious figures. Apparently, this 
nomenclature reflects the antidepressant activity of the plant because, at that time, it was believed 
that depression and related conditions are due to evil spirits inhabiting the sick person. As 
Hypericum could alleviate those conditions, people considered it to have ‘the power to ward off 
evil spirits’ in humans and hence used it to protect their religious figures from demons (Nurk, 
2011). Hypericum is also commonly known as St. John’s wort as its yellow flowers bloom around 
St. John’s day on June the 24th (Miller, 1998). 
Various Hypericum species have been used in traditional medicine in many countries around the 
globe. This is attributed to the variety of bioactive secondary metabolites synthesized by members 
of the genus (Table I-5) (Butterweck, 2003; Crockett and Robson, 2011; Zhao et al., 2015). 
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Table I-5. Main classes of secondary metabolites isolated from Hypericum species. 
Class Example Organ 
Naphthodianthrones Hypericin, Pseudohypericin 
 
Aerial parts, in the dark 
glands 
 
Phloroglucinol derivatives Hyperforin, Adhyperforin 
Hyperfirin, Adhyperfirin 
 
Leaves and flowers, in the 
translucent glands 
Benzophenone derivatives Sampsoniones, Cariphenone 
Hypelodins 
 
Mainly in roots 
Xanthones Kielcorin, Mangiferin 
Norathyriol 
 
Mainly in roots 
Flavonoids Rutin, Quercetin 
Quercitrin, Hyperoside 
 
Aerial parts 
Biflavonoids I3,II8-biapigenin 
I3′,II8-biapigenin 
 
Flowers 
Tannins and procyanidins Procyanidin, Catechin 
Epicatechin 
 
Mainly in leaves 
Phenylpropanoids Caffeic acid 
Chlorogenic acid 
 
 
Essential oil α- and β-Pinene 
Myrcene, Limonene 
Flowers and leaves, in the 
translucent glands 
In the course of this work, two Hypericum species have been employed; namely, Hypericum 
perforatum L. and Hypericum calycinum L. 
2.1. Hypericum perforatum L. 
Hypericum perforatum L. (common St. John's wort) is a perennial herb distributed mainly in 
Europe, Asia, North America and northern Africa (Bilia et al., 2002). It is erect, growing up to a 
height of 100 cm. The leaves are small (1–3 cm long), oblong to elliptic with entire margin and 
obtuse apex. They contain abundant translucent glands filled with colorless essential oil. The 
glands span the entire mesophyll which gives the leaves perforated appearance when held against 
light (Figure I-6), and hence the name perforatum. The calyx is composed of five sepals, the 
corolla of five yellow petals, both petals and sepals as well as the leaves are marked with black 
dots towards their rims. Those dots are known as the dark nodules, filled with reddish brown 
hypericin pigment that exudates upon rubbing, staining the fingers red (Bilia et al., 2002). 
H. perforatum is the most famous and thoroughly investigated member of the family Hypericaceae 
(Nahrstedt and Butterweck, 2010). It has been frequently used in traditional medicine because of 
its wound-healing, anti-inflammatory, diuretic and sedative properties (Di Carlo et al., 2001; Bilia 
et al., 2002; Butterweck, 2003). The plant is also under intensive investigation for its antiviral, 
antibacterial and antitumoral effects (Kubin et al., 2005; Medina et al., 2006). The alcoholic extract 
of the dried flowers or the entire aerial parts is widely prescribed for the treatment of mild to 
moderate depression (Kasper et al., 2010). H. perforatum total sales exceeded 5.5 million dollars 
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in the United States alone, making it the 26th of the top-selling herbal dietary supplements in the 
country in 2013 (Lindstrom et al., 2014). 
 
 
Figure I-6. H. perforatum flowers and a leaf held against light showing white and black dots. 
Various clinical trials concerning its antidepressant activity have shown that St. John’s wort extract 
is comparable to standard synthetic antidepressants but with fewer side-effects (Di Carlo et al., 
2001; Bilia et al., 2002; Schulz, 2006; Linde et al., 2008). Those side effects include 
photosensitivity when administrated at high doses which is caused by hypericin, pseudohypericin 
and to lesser extent by hyperforin (Onoue et al., 2011). In addition, St. John’s wort extract induces 
the P450 metabolizing enzymes CYP3A4, CYP2C9 and CYP1A2, leading to pharmacokinetic 
interactions with drugs metabolized by those enzymes including HIV protease inhibitors, 
immunosuppressants and coumarin-type anticoagulants (Wang et al., 2001; Henderson et al., 
2002). 
The mechanism of the antidepressant action of St. John’s wort extract is proposed to involve non-
selective inhibition of the uptake of neurotransmitters (dopamine, norepinephrine and serotonin) 
from the synaptic cleft between neurons (Neary and Bu, 1999). Recently, TRPC6 has been detected 
as hyperforin target (Leuner et al., 2007). Another suggested mechanism was binding to gamma 
aminobutyric acid (GABA) receptors (Müller et al., 1997). St. John's wort has also been proven to 
have an inhibitory activity on both monoamine oxidase (MAO) and catechol-O-methyltransferase 
(COMT) enzymes, leading to an increased level of norepinephrine in the brain (Thiede and Walper, 
1994).  
The various classes of active constituents in the plant appear to contribute in different levels to its 
antidepressant activity. It is most likely that a cocktail of those ingredients mediates the 
pharmacological action through a combination of the aforementioned mechanisms (Di Carlo et al., 
2001; Butterweck, 2003; Müller, 2003).  
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2.2. Hypericum calycinum L. 
Hypericum calycinum L. (Aaron's beard or creeping St. John’s wort) is an evergreen shrub growing 
to 30 cm height by 1 meter width, usually used as a ground cover. It is distributed mainly in Europe 
and North America. The leaves are large (up to 10 cm long), oval to oblong, with entire margins 
and round to obtuse apices. The flowers are 5–7 cm in diameter, with five bright yellow petals and 
numerous, bushy stamens having reddish anthers. Flowers appear singly or in groups of 2–3 and 
appear only for a few weeks during the summer (Figure I-7). Translucent and dark glands are 
usually absent from leaves and flowers. 
 
Figure I-7. Hypericum calycinum flower showing bright yellow petals and bushy stamens with reddish anthers. 
Few studies are available regarding the secondary metabolites produced by H. calycinum. Those 
include phloroglucinol derivatives, cyclohexadienone derivatives, xanthones, and flavonoids 
(Decosterd et al., 1989; Decosterd et al., 1991; Kirmizibekmez et al., 2009; Win et al., 2012). In 
addition, it has been reported that tissue cultures of H. calycinum can produce adhyperforin and 
hyperforin under certain conditions (Klingauf et al., 2005). The reported biological activities of 
the isolated compounds include antioxidant, antifungal, antimalarial, and cell growth inhibitory 
activities. Moreover, a comparison between the antidepressant activities of several Hypericum 
species extracts suggested that the effect of H. calycinum is as potent as that of H. perforatum and 
that it may be used therapeutically in the treatment of depression (Öztürk et al., 1996). 
3. Xanthones 
Xanthones (9H-xanthen-9-one) are a group of secondary metabolites present in a few members of 
fungi, lichens and higher plant families. The name “xanthone” is derived from the Greek word 
“xanthos” meaning yellow or blond, referring to their color (Masters and Bräse, 2012). Their basic 
structure is based on the planar dibenzo-γ-pyron skeleton (Figure I-8). However, one of the 
constituting aromatic rings could be partially or completely saturated giving rise to the di-, tetra- 
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or hexahydroxanthone skeletons (Figure I-8). Because of the symmetric structure of the xanthone 
nucleus, together with its mixed biosynthetic origin in higher plants, the acetate-derived ring is 
designated as ring A and is numbered 1–4, while the shikimate-derived ring is designated as ring 
B and is numbered 5–8 (Bennett and Lee, 1989; Peres and Nagem, 1997). In certain cases, ring B 
should be given the lowest numbers according to IUPAC nomenclature rules, for example, when 
ring A is not oxygenated. However, when discussing the biosynthetic aspects of xanthones, the 
aforementioned numbering and ring designations should be used whenever relevant (Peres and 
Nagem, 1997). In addition to their chemotaxonomic value, xanthones possess a wide array of 
interesting pharmacological activities (El-Seedi et al., 2010).  
 
 
Figure I-8. Basic skeletons of naturally occurring xanthones. 
3.1. Classification and occurrence 
A review of naturally occurring xanthones in SciFinder® reveals the presence of more than 1500 
xanthone-based molecules isolated from natural origin. Those can generally be classified into six 
major groups: simple xanthones, xanthone glycosides, prenylated xanthones, xanthonolignoids, 
bis-xanthones and miscellaneous xanthones (Vieira and Kijjoa, 2005).  
Occurrence of xanthones in the plant kingdom is restricted to few families, mainly to members of 
the clusioid clade of the order Malpighiales including the Clusiaceae, Hypericaceae, and 
Calophyllaceae, in addition to the Gentianaceae, Polygalaceae, Moraceae and Fabaceae (Vieira 
and Kijjoa, 2005; El-Seedi et al., 2009; El-Seedi et al., 2010). 
3.2. Biosynthesis of xanthones  
Two distinct pathways are known for xanthone biosynthesis depending on the producing organism. 
In plants, the xanthone nucleus is synthesized via a mixed acetate-shikimate pathway. Biosynthesis 
is initiated by benzophenone synthase (BPS), a type III polyketide synthase, which catalyzes the 
iterative condensation of benzoyl- and 3-hydroxybenzoyl-CoA with three molecules of malonyl-
CoA to give 2,4,6-trihydroxybenzophenone and 2,3′,4,6-tetrahydroxybenzophenone (2,3′,4,6-
tetraHB), respectively. The former product was found to be converted to 2,3′,4,6-tetraHB by 
benzophenone 3′-hydroxylase (B3′H) activity (Schmidt and Beerhues, 1997; Liu et al., 2003). The 
key intermediate 2,3′,4,6-tetraHB undergoes regioselective intramolecular oxidative C–O phenol 
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coupling reactions either para or ortho to the 3′-hydroxyl group to give 1,3,7- and 1,3,5-
trihydroxyxanthones, respectively, as shown in cell cultures of Hypericum androsaemum and 
Centaurium erythraea (Figure I-9) (Peters et al., 1997). 
 
Figure I-9. Biosynthesis of xanthones in plants. 
These cyclization reactions are catalyzed by two distinct P450s known as 1,3,7- and 1,3,5-
trihydroxyxanthone synthases (TXSs) (Peters et al., 1997). The isomeric products of the 
cyclization reactions are likely to be the precursors of all plant xanthones (Bennett and Lee, 1989; 
Peters et al., 1997). They can be further hydroxylated at multiple positions, for example, the 
hydroxylation at C-6 is catalyzed by another P450, xanthone 6-hydroxylase (X6H) to yield 1,3,6,7- 
and 1,3,5,6- tetrahydroxyxanthones, respectively (Schmidt et al., 2000). In addition, xanthones can 
undergo stepwise prenylations and concomitant cyclizations to give complex derivatives with 
bridged polycyclic skeletons possessing high pharmaceutical potential (Zhang et al., 2004; 
Rukachaisirikul et al., 2005; Shadid et al., 2007). 
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On the other hand, in fungi and lichens, the xanthone nucleus originates exclusively from acetate. 
One molecule of acetyl-CoA is condensed with seven molecules of malonyl-CoA to form an 
octaketide intermediate that is subsequently cyclized to form an anthroquinone, followed by 
oxidative cleavage to give a carboxylated benzophenone intermediate (Figure I-10). The 
subsequent steps differ according to the organism; in some cases the resulting benzophenone 
intermediate is decarboxylated and cyclized directly into xanthones, while in other cases the 
cyclization yields a tetrahydroxanthone species followed by aromatization (Krohn et al., 2009; 
Masters and Bräse, 2012; Wezeman et al., 2015)  
 
 
Figure I-10. Biosynthesis of xanthones in fungi and lichens. 
3.3. Biological activities of xanthones 
Xanthones exhibit diverse biological activities in a broad spectrum of diseases because of their 
interaction with a wide range of target biomolecules. Therefore, they are referred to as ‘privileged 
structures’ (Masters and Bräse, 2012; Winter et al., 2013). The spectrum of biological activities 
(Figure I-11) includes, but is not limited to, antimicrobial, antioxidant, anti-inflammatory, 
cholinesterase inhibitory and cytotoxic activities (Fotie and Bohle, 2006; El-Seedi et al., 2010). 
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Figure I-11. Summary of the biological activities of naturally occurring xanthones; adapted from (El-Seedi et al., 2010). 
3.3.1. Antimicrobial activity 
3.3.1.1. Antibacterial activity 
Several studies have shown that prenylated xanthone derivatives have pronounced antibacterial 
activities, especially towards resistant strains such as methicillin-resistant Staphylococcus aureus 
(MRSA) and vancomycin-resistant enterococci (VRE) (Iinuma et al., 1996; Fukai et al., 2005; 
Rukachaisirikul et al., 2005). The bactericidal activity is suggested to be mediated through the 
interaction of the prenylated phenolic rings with the membrane lipid bilayer leading to disruption 
of the bacterial membrane and subsequently cell death (Koh et al., 2013).  
3.3.1.2. Antiviral activity 
Simple, prenylated as well as bis-xanthones including 1,7-dihydroxyxanthone (euxanthone), 1,3,8-
trihydroxy-2,4-dimethoxyxanthone, mangostin, γ-mangostin and swertifrancheside showed anti-
HIV-1 activity (Reutrakul et al., 2007). This activity could be due to either the HIV-protease or 
HIV-reverse transcriptase inhibitory properties of the mentioned xanthone derivatives (Wang et 
al., 1994; Chen et al., 1996). 
3.3.1.3. Antiparasitic activity 
Prenylated xanthones such as garciniaxanthone-A and B exhibit antiprotozoal activity against 
Plasmodium, Trypanosoma and Leishmania species (Abe et al., 2003; Hay et al., 2004; Mbwambo 
et al., 2006; Molinar-Toribio et al., 2006; Al-Massarani et al., 2013). In addition, insecticidal and 
anthelmintic activities have been observed for the fungus-produced dimeric xanthone xanthonol. 
Therefore, they may be considered promising leads for the development of new safer and more 
effective systemic antiparasitic drugs (Ondeyka et al., 2006). 
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3.3.2. Antioxidant activity 
Xanthones, like many other phenolic compounds, show pronounced antioxidant activities. They 
act as free radical scavengers as shown by the results of the DPPH (1,1-diphenyl-2-
piccrylhydrazyl) test performed on various naturally occurring xanthones (Deachathai et al., 2005; 
Mahabusarakam et al., 2006). This activity is beneficial in combating several diseases, in which 
oxidative stress and generation of ROS (reactive oxygen species) play a major role. These include 
neurodegenerative diseases such as Parkinson's and Alzheimer’s diseases (Martinez et al., 2012; 
Wang et al., 2012). 
3.3.3. Cardiovascular activities 
Xanthones have beneficial effects on various cardiovascular ailments such as hypertension, 
thrombosis, atherosclerosis and ischemic heart disease (Jiang et al., 2004; El-Seedi et al., 2010). 
Cudraxanthone-D and isocudraniaxanthone-B are examples of xanthones showing 
ani- atherosclerotic activity (Park et al., 2006). This activity is attributed to their acyl 
CoA:cholesterol acyltransferase (ACAT) inhibitory and anti-low density lipoprotein (LDL) 
oxidation activities. Gentiacaulein and gentiakochianin induce vasodilation in rat aorta (Chericoni 
et al., 2003). A simple tetraoxygenated xanthone, namely 1-hydroxy-2,3,5-trimethoxyxanthone, 
caused a concentration-dependent potent relaxation in rat coronary artery (Wang et al., 2007). 
3.3.4. Anti-inflammatory activity 
γ- Mangostin has been demonstrated to have potent inhibitory activity on both inducible and 
constitutive cyclooxygenase (COX) enzymes (Nakatani et al., 2002). In vivo studies showed that 
α-mangostin had an inhibitory effect on carrageenan-induced paw edema in mice (Chen et al., 
2008). 
3.3.5. Cytotoxic activity 
Xanthones are promising molecules as anti-cancer agents. The prenylated xanthones α-, β- and 
γ- mangostin showed inhibitory effect on cell growth in human colon cancer cells. In addition, the 
antiproliferative effect was accompanied by apoptosis (Matsumoto et al., 2003). Gambogic acid 
has a potent cytotoxic activity against a wide array of tumor cells (Felth et al., 2013; Yang and 
Chen, 2013). 
3.3.6. Xanthones as promising agents for the treatment of Alzheimer’s disease 
Alzheimer’s is a neurodegenerative disease characterized by gradual, irreversible memory loss 
leading to dementia, personality changes, unusual behavior and finally death. The etiology 
involves multiple factors that lead to the accumulation of amyloid-β peptide and tau protein in the 
brain neurons, increased lipid peroxidation and oxidative stress and decreased acetylcholine levels. 
Xanthones possess several properties which may be beneficial in combating the condition. 
Inhibition of acetylcholinesterase, free radical scavenging and MAO inhibitory activities have 
been observed for xanthones. Optimizing a balance between activities in one xanthone-based 
molecule would be of great benefit in the one-drug-multiple-target strategy for the treatment of 
Alzheimer’s (Mattson, 2004; Zhang, 2005; Wang et al., 2012). 
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4. Aim of the work 
Regioselective oxidative phenol coupling reactions have been established on the biochemical level 
to be responsible for the cyclization of 2,4,6-trihydroxybenzophenone into 1,3,7- and 
1,3,5- trihydroxyxanthones in Hypericum androsaemum and Centaurium erythraea, respectively 
(Peters et al., 1997). The reactions are catalyzed by two distinct enzymes known as 
trihydroxyxanthone synthases (TXSs). They were demonstrated to be cytochrome P450 enzymes, 
as inferred from their NADPH and atmospheric oxygen dependencies. Furthermore, the 
cyclization reactions were hindered by common CYP inhibitors (Peters et al., 1997). However, no 
cDNA encoding either of those enzymes has been cloned so far and, hence, those xanthone 
synthases have never been studied at the molecular level.  
The focus of interest of this work is to clone and functionally express the xanthone synthases from 
Hypericum sp. and to study their properties. A molecular biological approach has been chosen as 
isolation of CYPs was difficult due to their low expression levels, instability and membrane 
integration nature. The approach is based on an established H. calycinum cell culture system, 
which produces a derivative of 1,3,7- trihydroxyxanthone exclusively upon yeast elicitation (Gaid 
et al., 2012). A suppression subtractive hybridization (SSH) library was established from this 
system and is expected to contain high copy numbers of the transcripts encoding 
1,3,7- trihydroxyxanthone synthase (1,3,7-TXS). The following steps should be performed in order 
to isolate and functionally characterize 1,3,7-TXS. 
- Bioinformatic analysis of the expressed sequence tags (ESTs) of the subtracted library in 
order to identify candidate core fragments that encode CYPs.  
- Completion of the coding sequence of the candidate fragments by rapid amplification of 
cDNA ends (RACE) technology to obtain full- length cDNA(s).  
- As CYP activity requires the presence of an electron donor, a similar strategy would follow 
to clone a full-length cDNA encoding NADPH-dependent cytochrome P450 reductase 
(CPR).  
- Expression of both enzymes in yeast cells and testing the activity of microsomal fractions 
with the potential substrates.  
In order to isolate the gene encoding 1,3,5-trihydroxyxanthone synthase (1,3,5-TXS) the following 
strategy should be followed. 
- Searching the public transcriptomic database of H. perforatum for candidate sequences 
sharing high sequence identity with the isolated 1,3,7-TXS cds. 
- Expression of the isolated genes together with CPR in yeast cells and testing the 
microsomal fraction with the potential substrates. 
Once both variants are successfully identified, a modelling-based reciprocal mutagenesis approach 
should be used to identify their regioselectivity determinants and convert each enzyme to its 
counterpart. 
  
  Materials 
20 
 
II. Materials 
1. Biological materials 
1.1. Plant materials 
Hypericum perforatum plants were grown in the medicinal plants garden of the Institute of 
Pharmaceutical Biology, TU Braunschweig. Leaves were collected during the flowering stage, 
snap-frozen in liquid nitrogen and stored in -80 °C for subsequent use. 
1.2. Cell cultures 
Hypericum calycinum (Hypericaceae) cell cultures were grown in the dark at 25 °C in 50 ml liquid 
LS medium (Linsmaier and Skoog, 1965) with shaking at 120 rpm. Cultures were subdivided every 
14 days in fresh LS media (3 g cells in 50 ml media). 
1.3. Bacterial and yeast strains 
Escherichia coli 
Strain name Genotype 
DH5α F′ φ80lacZΔM15 end A1 rec A1 hsdR17(rk- mk+) supE44 thi-1 λ- gyrA96 
relA1 Δ(lacZYA-argFV169) deoR 
Saccharomyces cerevisiae 
Strain name Genotype 
INVSc1 MATa his3D1 leu2 trp1-289 ura3-52 MAT his3D1 leu2 trp1-289 ura3-52 
2. Vectors 
pGEM®-T Easy vector (Promega) was used for TA cloning of PCR products 
pESC-URA vector (Agilent) were used for functional expression in yeast cells  
3. Primers 
3.1. Primers used for core fragments amplification, 3′ and 5′ RACE 
Primer name Sequence 5′→3′ 
Core fragments amplification: 
Contig59-F1 AAGGTCCCCGTCCTCGTTGTC 
Contig21-R1 CGTATTCCTCGAACCTCTC 
CPR-dpF-1 GCNGARGGNTTYGCHAAGGC 
CPR-R1 CTTGGACAATGGTGTGGAGAGTTC 
3′ and 5′ RACE:  
CYP81-3RACE1 TCCTAATGCAACACCCAGAG 
CYP81-3RACE2 CTACCTAAGGGCCGTCGTGA 
CYP81-5RACE1 CCGCTTCTCCTCCTTGGTGTCC 
CYP81-5RACE2 CGTCGTTCTTGGTGAAGCACTCCTC 
CPR-3RACE1 GCTCCATTCAGGGGTTTCC 
CPR-3RACE2 GGTTAGCCCTGAAAGAATCC 
CPR-5RACE1 ATCCATTTCGGGCCACAATGCCTCTC 
CPR-5RACE2 TGCCTGTTCCCTAAGCCAAACACTGC 
51544-3RACE1 GACGCCATGCGACTTCATCC 
51544-3RACE2 TCCTTAACGGCTTACTTGCCAATA 
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3.2. Primers used for cloning 
Primer name Sequence 5′→3′ (Introduced restriction site sequences are underlined) 
HcCPR2-BamHI-F GTAATGGATCCGATGGAACCGACGGGGAGC 
HcCPR2-HindIII-R GTCTGAAGCTTTCACCATACGTCGCGAAGGTAC 
Hc81AA1-EcoRI-F ATTGAATTCGGATGGAGGACTTGTACTTGTACC 
Hc81AA1-PacI-R ACGTTAATTAATTAGAGCTGGGAAAGGAGACC 
Hp81AA1-SpeI-F TATGACTAGTAATGGAGGACTTGTATCTGTACG 
Hp81AA1-PacI-R ACGTTAATTAATTAGAGCTGGGAGAGGAGG 
Hp81AA2-EcoRI-F ATTGAATTCATGGACGGTTTATACTTAAAACTAGCC 
Hp81AA2-PacI-R ACGTTAATTAACTAGAGTTGGGAAAGGAGCTTG 
Hp81AA2-SpeI-F ATTACTAGTAATGGACGGTTTATACTTAAAACTAGC 
Hp81AA3-SpeI-F TATGACTAGTAATGGAATTGTATTTGTATCTAGCCG 
Hp81AA3-PacI-R ACGTTAATTAACTAAGAGAGTAGAGAACTGAGG 
3.3. Primers used for C-terminal exchanges and site-directed mutagenesis 
Primer name Sequence 5′→3′ 
Overlapping primers used for C-terminal exchanges: 
AA1-AA2-ex CGGAGGGATGGGGACCCACATTGTCTGCGAGACATTGGGAATG 
AA2-AA1-ex CCGGAATGGGAACCCATATCTCGTCCCTGGGGATTGGAATTCTTA 
Primers used for site-directed mutagenesis (mutated positions are highlighted in red): 
AA1-A373S-F CCGCCGTCCCCACTCTCCCTCCCCCACTTCTCCAACCAAG 
AA1-A373S-R GTGGGGACGGCGGGTACATCCTGAGCGTCTCCTTCACGAC 
AA1-ASSL-F CGCCGTCCCCACTCTTGCTCCCCCACTTCTCCAACCAAG 
AA1-T482V-F AGCCACGCGCGTGGTGTCGCGAGTCTGTCAAGGAAGAAG 
AA1-T482F-F AGCCACGCGCGTGGTTTCGCGAGTCTGTCAAGGAAGAAG 
AA1-T482uni-R ACGCGCGTGGCTCATGTCCTCGTCCATGCCGAGGTGGC 
AA1-T482A-F CGTGGTGCCGCGAGTCTGTCAAGGAAGAAGCCATTGGAG 
AA1-T482A-R TCGCGGCACCACGCGCGTGGCTCATGTCCTCGTCCATGC 
AA1-TALMRKKN-F CGTGGTGCCGCGAGTATGTCAAAGAACAAGCCATTGGAG 
AA1-VIMT-F GAATTATTACGATGATGTTTATTGCCGGGACCGAGACG 
AA1-VIMT-R TCATCGTAATAATTCCCTTGACGATGTCATCCGTG 
AA1-W113F-F TCGTGTTCGCCCCGCACGGCCCCATCTGGAAGAGCCTC 
AA1-W113F-R GGGGCGAACACGAGGAAGGTGTAGTCGTAGGTGAGGTGC 
AA1-I220P-F ATGACCCCATGCGACTTCATCCCGGTGATGAGGCTGATC 
AA1-I220P-R TCGCATGGGGTCATGGAGACGATAGGAAAGAAGAGATCC 
AA2-A483T-F GCCGGTACGGCTAGTATGTCCAAGAACAAGCCATTGG 
AA2-A483T-R TAGCCGTACCGGCTTGGTGGGTCATGTCCTCGTCCATAC 
AA2-ATMLKRNK-F GCCGGTACGGCTAGTCTGTCCAGGAAGAAGCCATTGG 
AA2-L378S-F CGCTCTCGCTACCTCGTTATTCGAGCGAGGCTTGCAC 
AA2-L378S-R GGTAGCGAGAGCGGGGACGGAGGATACAGCCTCATCGTC 
AA2-S375A-F CCTCCGGCCCCGCTCTTGCTACCTCGTTATTCGAGCGAG 
AA2-S375A-R GCGGGGCCGGAGGATACAGCCTCATCGTCTCCTTCACG 
AA2-SALS-F CCTCCGGCCCCGCTCTCGCTACCTCGTTATTCGAGCGAG 
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3.4. SMART II RACE primers 
Primer name Sequence 5′→3′ 
SMART II™ oligo AAGCAGTGGTATCAACGCAGAGTACGCGGG 
3′-RACE CDS primer  AAGCAGTGGTATCAACGCAGAGTAC(T)30VN 
5′-RACE CDS primer  (T)25VN 
RACE long CTAATACGACTCACTATAGGGCAAGCAGTGGTATCAACG
CAGAGT 
RACE short CTAATACGACTCACTATAGGGC 
RACE nested AAGCAGTGGTATCAACGCAGAGT 
3.5. Primers used for real-time qRT-PCR 
Primer name Sequence 5′→3′ 
Hc81AA1-qF TCTCGATGACCGTATGTGACTT 
Hc81AA1-qR CGTTAAGGAAGACCTCCCTCT 
HcCPR2-qF TGACTATGCTGCGGATGATGAA 
HcCPR2-qR GCCAAGAAGAGGACAACCAAATC 
HcBPS-qF AAGGAAAGAAGAGGGCTAGTGT 
HcBPS-qR ATGTGCTCGCTGTTAGTGTTC 
Actin-qF CGGCAGTGGTTGTGAACAT 
Actin-qR TCTCGCTGGTCGTGATCTG 
Histone-H2A-qF AACATCTACTCTTTGGACGACTTG 
Histone-H2A-qR AATTGCTGGAGGTGGAGTTATTC 
4. Enzymes 
4.1. Enzymes used for reverse transcription (RT) 
Enzyme name Manufacturer 
RevertAid™ HMinus Reverse Transcriptase Thermo Scientific 
SMARTScribe™ Reverse Transcriptase Takara 
4.2. Enzymes used for polymerase chain reaction (PCR) 
Enzyme name Manufacturer 
peqGOLD Taq DNA polymerase Peqlab 
Phusion® Hot Start II High-Fidelity DNA Polymerase Thermo Scientific 
Q5® Hot Start High-Fidelity DNA Polymerase New England Biolabs 
4.3. Restriction endonucleases 
Enzyme name Sequence Manufacturer 
BamHI  G^GATCC Thermo Scientific 
DpnI GAm
6^TC Thermo Scientific 
EcoRI G^AATTC Thermo Scientific 
HindIII A^AGCTT Thermo Scientific 
PacI TTAAT^TAA Thermo Scientific 
SpeI A^CTAGT Thermo Scientific 
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4.4. Miscellaneous enzymes 
Enzyme name Manufacturer 
FastAP Thermosensitive Alkaline Phosphatase Thermo Scientific 
RiboLock™ RNase Inhibitor Thermo Scientific 
RNase A Thermo Scientific 
RNase-free DNase I Qiagen 
T4 DNA ligase Thermo Scientific 
Instant Sticky-end Ligase Master Mix NEB 
5. Kits 
Name Purpose Manufacturer 
GeneJET™ Plant RNA 
Purification Mini Kit 
 
RNA isolation from 
H. perforatum leaves 
Thermo Scientific 
RNeasy® Plant Mini Kit RNA isolation from H. calycinum 
cell cultures 
 
Qiagen 
S.c. EasyComp™ 
Transformation Kit 
 
Preparation and transformation of 
yeast competent cells  
Invitrogen 
innuPREP DOUBLEpure Kit DNA purification from PCR, 
digestion mixture and agarose gel 
 
Analytik Jena 
iScript™ Reverse Transcription 
Supermix for RT-qPCR 
 
Synthesis of first strand cDNA 
for real-time qRT-PCR 
Bio-Rad 
iTaq™ Universal SYBR® Green 
Supermix 
Real-time qRT-PCR  Bio-Rad 
6. Chemicals 
Chemical Manufacturer 
1,3-Dihydroxyxanthone Lab collection 
1-Naphthylacetic acid (NAA) Fluka 
2,2′,3,4′-Tetrahydroxybenzophenone Prof. You’s lab, China 
2,2′,4,5′-Tetrahydroxybenzophenone Prof. You’s lab, China 
2,3,4-Trihydroxybenzoic acid Acros 
2,3′,4,4′,6-Pentahydroxynenzophenone (maclurin) Aldrich 
2,3′,4,6-Tetrahydroxybenzophenone Lab collection 
2,3-Dihydroxybenzoic acid Acros 
2,4,6-Trihydroxybenzophenone ICN Biomedicals 
2,4-Dichlorophenoxyacetic acid (2,4-D) Fluka 
2,4-Dihydroxybenzophenone Fluka 
2,5-Dihydroxybenzoic acid Acros 
2-Hydroxybenzophenone Merck 
2-Mercaptoethanol (β-ME) Roth 
4-Hydroxybenzophenone Fluka 
Acetic acid Roth 
Acrylamide/Bisacrylamide 30% Bio-Rad 
Agar Kobe Applichem 
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Continued:   
Chemical Manufacturer 
Ammonium persulfate (APS) Roth 
Ampicillin Roth 
Bacto casamino acids Difco 
Betaine Sigma-Aldrich 
Bovine serum albumin (BSA) Sigma-Aldrich 
Bromophenol blue Aldrich 
CaCl2.2H2O Roth 
Chloroform Sigma-Aldrich 
CoCl2.6H2O Riedel-de Haën 
Coomassie blue (G250 and R250) Merck 
CuSO4.5H2O Riedel-de Haën 
Ethanol VWR 
Ethidium bromide solution (1%) Roth 
Ethyl acetate VWR 
Na2EDTA.2H2O Roth 
FeSO4.7H2O Riedel-de Haën 
Formic acid Roth 
Galactose Roth 
Glass beads Sigma-Aldrich 
Glucose Roth 
Glycerol Roth 
Glycine Roth 
H3BO3 Roth 
HCl VWR 
IPTG Applichem 
Isopropanol VWR 
KCl Roth 
KH2PO4 Roth 
KI Riedel-de Haën 
KNO3 Roth 
Methanesulfonic acid Sigma-Aldrich 
MgCl2.6H2O Fluka 
MgSO4.7H2O Roth 
Midori Green Nippon Genetics GmbH 
MnSO4.H2O Riedel-de Haën 
Myo-inositol Roth 
Na2MoO4.2H2O Merck 
NaCl Roth 
NaOH Roth 
NH4NO3 Roth 
o-Phosphoric acid Fischer-Scientific 
PEG 4000 Fluka 
Peptone from casein Roth 
peqGold Universal Agarose Peqlab 
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Continued:  
Chemical Manufacturer 
Phenol Roth 
Phloroglucinol Acros 
Phosphorus pentoxide Acros 
Polyvinylpyrrolidone  Sigma-Aldrich 
Potassium acetate Roth 
Sodium dodecyl sulfate (SDS) Roth 
Sorbitol Roth 
Sucrose Diadem 
Tetramethylethylenediamine (TEMED) Roth 
Thiamine hydrochloride Sigma-Aldrich 
tris(hydroxymethyl)aminomethane (Tris) Roth 
X-Gal Sigma-Aldrich 
Xylene cyanol FF Roth 
Yeast extract Applichem 
Yeast nitrogen base without amino acids Sigma 
ZnSO4.7H2O Riedel-de Haën 
7. Culture media 
7.1. Plant cell culture medium 
LS medium  Final concentration 
Macroelements 10X stock solution  
NH4NO3 16.5 g/l 1650.0 mg/l 
KNO3 19.0 g/l 1900.0 mg/l 
MgSO4.7H2O 3.7 g/l 370.0  mg/l 
KH2PO4 1.7 g/l 170.0 mg/l 
CaCl2.2H2O 4.4 g/l 440.0 mg/l 
Na2EDTA.2H2O 413.0 mg/l 41.3  mg/l 
FeSO4.7H2O 278.0 mg/l 27.8  mg/l 
Microelements 1000X stock solution   
MnSO4.H2O 16.9 g/l 16.9 mg/l 
ZnSO4.7H2O 10.6 g/l 10.6 mg/l 
KI 830.0 mg/l 830.0 μg/l 
H3BO3 6.2 g/l 6.2 mg/l 
Na2MoO4.2H2O 250.0 mg/l 250.0 μg/l 
CuSO4.5H2O 25.0 mg/l 25.0 μg/l 
CoCl2.6H2O 25.0 mg/l 25.0 μg/l 
Vitamins 100X stock sloution   
Thiamine hydrochloride 4.0 mg/100ml 0.4 mg/l 
Myo-inositol 
 
1.0 g/100ml 100.0 mg/l 
Hormones Stock solution   
2,4-Dichlorophenoxyacetic acid (2,4-D) 1.0  mg/ml 220.0 μg/l 
1-Naphthylacetic acid (NAA) 1.0 mg/ml 186.0 μg/l 
Sucrose   30.0 g/l 
- The pH is adjusted to 6.0 and the medium is autoclaved. 
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7.2. Bacterial culture media 
LB medium   Final concentration 
Yeast extract 5.0  g/l 0.5 % (w/v) 
Peptone from casein 10.0 g/l 1.0 % (w/v) 
NaCl 10.0 g/l 1.0 % (w/v) 
- The pH is adjusted to 7.0 with 5N NaOH and the medium is autoclaved. 
- For solid medium, 2% (w/v) agar is added before autoclaving. 
- For selection via ampicillin resistance, sterile filtered ampicillin is added after autoclaving at a final concentration 
of 100 mg/l. 
- For blue-white screening, ampicillin (100 mg/l), IPTG (12 mg/l) and X-GAL (40 mg/l, dissolved in DMF) are added. 
SOC medium   Final concentration 
Yeast extract 5.0  g/l 0.5 % (w/v) 
Peptone from casein 20.0 g/l 2.0 % (w/v) 
NaCl 467.6 mg/l 10.0 mM 
KCl 186.4 mg/l 2.5 mM 
MgSO4. 7H2O (1M) 5.0 ml/l 5.0 mM 
MgCl2 (1M) 5.0 ml/l 5.0 mM 
Dextrose (1M) 20.0 ml/l 20.0 mM 
- The pH is adjusted to 7.5. 
- The first four components are dissolved in 970 ml distilled water and autoclaved. Afterwards, the sterile-filtered 
solutions of the last three components are added. 
7.3. Yeast culture media 
YPD medium   Final concentration 
Yeast extract 10.0 g/l 1.0 % (w/v) 
Peptone from casein 20.0 g/l 2.0 % (w/v) 
Dextrose 20.0 g/l 2.0 % (w/v) 
- The first two components are dissolved in 900 ml distilled water and autoclaved. Afterwards, 100 ml of sterile-
filtered 20% (w/v) dextrose solution are added. 
- For solid medium, 2% (w/v) agar is added before autoclaving. 
Synthetic dextrose minimal medium 
(SD dropout medium) 
  Final concentration 
Yeast nitrogen base (with or without 
amino acids) 
6.7 g/l 0.67 % (w/v) 
Bacto casamino acids 1.0 g/l 0.10 % (w/v) 
Dextrose 20.0 g/l 2.0 % (w/v) 
- The first two components are dissolved in 900 ml distilled water and autoclaved. Afterwards, 100 ml of sterile-
filtered 20% (w/v) dextrose solution are added. 
- For solid medium, 2% (w/v) agar is added before autoclaving. 
YPGE medium   Final concentration 
Yeast extract 10.0 g/l 1.0 % (w/v) 
Peptone from casein 10.0 g/l 1.0 % (w/v) 
Dextrose 5.0 g/l 0.5 % (w/v) 
Ethanol 30.0 ml/l 3.0 % (v/v) 
- The first two components are dissolved in 945 ml distilled water and autoclaved. Afterwards, 25 ml of sterile-filtered 
20% (w/v) dextrose solution and 30 ml absolute ethanol are added. 
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8. Buffers and solutions 
Unless otherwise indicated, all buffers and solutions are autoclaved before first use. 
8.1. Buffers used for plasmid isolation from E. coli 
Buffer I   Final concentration 
Tris 1.5 g/250 ml 50 mM 
Na2EDTA.2H2O 931 mg/250 ml 10 mM 
RNase A (added  immediately before use)   10 μl/ml 
- The pH is adjusted to 8 with 1N HCl 
Buffer II   Final concentration 
NaOH 2 g/250 ml 0.2 M 
SDS 2.5 g/250 ml 1 % (w/v) 
 
Buffer III   Final concentration 
Potassium acetate 73.6 g/250 ml 3 M 
- The pH is adjusted to 5.5 with glacial acetic acid (requires about 55 ml) 
8.2. Buffer used for plasmid isolation from yeast (Hoffman and Winston, 1987) 
Yeast cracking solution   Final concentration 
Tris 60.6 mg/50 ml 10 mM 
Na2EDTA.2H2O 18.6 mg/50 ml 1 mM 
NaCl 292 mg/50 ml 100 mM 
SDS 500 mg/50 ml 1 % (w/v) 
Triton X-100 1 ml/50 ml 2 % (v/v) 
- The pH is adjusted to 8.5 with 1N HCl 
8.3. Buffers used for microsomal protein isolation from yeast 
1M Tris-HCl pH 7.4 stock buffer   Final concentration 
Tris 12.1 g/100 ml 1 M 
- The pH is adjusted to 7.4 with 1N HCl 
TEK buffer   Final concentration 
Tris-HCl pH 7.4 (1M stock buffer) 12.5 ml/250 ml 50 mM 
Na2EDTA.2H2O 93 mg/250 ml 1 mM 
KCl 1.864 g/250 ml 0.1 M 
 
TES buffer   Final concentration 
Tris-HCl pH 7.4 (1M stock buffer) 25 ml/500 ml 50 mM 
Na2EDTA.2H2O 186.1 mg/500 ml 1 mM 
Sorbitol 54.651 g/500 ml 0.6 M 
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TEG buffer   Final concentration 
Tris-HCl pH 7.4 (1M stock buffer) 5 ml/100 ml 50 mM 
Na2EDTA.2H2O 73 mg/100 ml 1 mM 
Glycerol 20 ml/100 ml 20 % (v/v) 
8.4. Buffers and solutions used for agarose gel electrophoresis 
50X TAE buffer   Final concentration 
Tris 242.28 g/l 2 M 
Na2EDTA.2H2O 18.612 g/l 50 mM 
- The pH is adjusted to 8.0 with glacial acetic acid 
6X DNA loading dye   Final concentration 
Tris 60.6 mg/50 ml 10 mM 
Na2EDTA.2H2O 1.117 g/50 ml 60 mM 
Bromophenol blue 15 mg/50 ml 0.03 % (w/v) 
Xylene cyanol FF 15 mg/50 ml 0.03 % (w/v) 
Glycerol 30 ml/50 ml 60 % (v/v) 
- The pH is adjusted to 7.6 with 1N HCl. 
- Stored in -20 °C without autoclaving. 
8.5. Buffers and solutions used for SDS-PAGE 
5% Staking gel (for 2 gels)    
Water 2.72 ml   
Tris-HCl 1M pH 6.8 504 μl   
Acrylamide/Bisacrylamide 30% (w/v) 664 μl   
SDS 10% (w/v) 40 μl   
APS 10% (w/v) 40 μl   
TEMED 4 μl   
 
12% Resolving gel (for 2 gels)    
Water 2.3 ml   
Tris-HCl 1.5M pH 8.8 1.75 ml   
Acrylamide/Bisacrylamide 30% (w/v) 2.8 ml   
SDS 10% (w/v) 70 μl   
APS 10% (w/v) 70 μl   
TEMED 2.8 μl   
 
2X Protein loading buffer     
Distilled water 2.7 ml   
Tris-HCl 0.5M pH 6.8 1.0 ml   
SDS 10% (w/v) 3.3 ml   
Bromophenol blue 0.5% (w/v) 0.5 ml   
Glycerol 2.0 ml   
β-Mercaptoethanol (Added immediately before use) 0.5 ml   
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10X Electrophoresis buffer   Final concentration 
Tris 15 g/500 ml 80.6 mM 
Glycine 72 g/500 ml 1.9 M 
SDS 5 g/500 ml 1 % (w/v) 
 
Coomassie blue R250 stock solution   Final concentration 
Coomassie blue R250 500 mg 1 % (w/v) 
Methanol 50 ml   
- The solution is filtered before further use. 
Staining solution   Final concentration 
Coomassie blue (stock solution) 20 ml/200 ml 0.1 % (w/v) 
Acetic acid 20 ml/200 ml 10 % (v/v) 
Methanol 100 ml/200 ml 50 % (v/v) 
 
Destaining solution   Final concentration 
Acetic acid 20 ml/200 ml 10 % (v/v) 
Methanol 30 ml/200 ml 15 % (v/v) 
8.6. Solution for the determination of protein concentration 
Bradford dye solution   Final concentration 
Coomassie blue G250 100 mg/l 0.01 % (w/v) 
Ethanol absolute 50 ml/l 5 % (v/v) 
o-Phosphoric acid (85%) 100 ml/l 10 % (v/v) 
- Coomassie blue is dissolved first in ethanol and then o-phosphoric acid is added. 
- The solution is filtered before use and kept at 4 °C away from light. 
8.7. Combinatorial enhancer solution for PCR (Ralser et al., 2006) 
5X CES   Final concentration 
Betaine 3.2 g/10 ml 2.7 M 
BSA (1 mg/ml stock solution) 550 μl/10 ml 55 μg/ml 
DMSO 670 μl/10 ml 6.7 % (v/v) 
DTT 10.3 mg/10 ml 6.7 mM 
9. Equipment 
9.1. General equipment 
Equipment Model Manufacturer 
Autoclave Systec VX-120 Systec 
Balance 2254 Sartorius 
Balance Kern 572 Kern & Sohn Gmbh 
Balance LA230S Sartorius 
Centrifuge Biofuge pico Heraeus 
Centrifuge Avanti J-E Beckmann Coulter 
Centrifuge Avanti J-30I Beckmann Coulter 
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Continued:   
Equipment Model Manufacturer 
Centrifuge Universal 32 R Hettich 
Centrifuge Biofuge 13 Heraeus 
Deep freezer (-80 °C) MDF-U53V Sanyo 
Dry block heater Dri-Block DB-3D Techne 
Electrophoresis chamber for agarose gels Wide Mini-Sub Cell GT Bio-Rad 
Electrophoresis chamber for 
polyacrylamide gels 
Mini PROTEAN Tetra Cell Bio-Rad 
Gel documentation  Infinity-3000 Vilber Lourmat 
Heating circulator water bath TopTech MW-4 Julabo 
Laminar air flow LaminAir HLB2472 BS Heraeus 
Laminar air flow LaminAir HBB2460 Heraeus 
Microscope Laborlux 11 Leitz 
pH meter pH 325 WTW GmbH 
Real-Time PCR Detection System CFX Connect™ Bio-Rad 
Rotary evaporator W60 Heidolph 
Rotational Vacuum Concentrator RVC 2-18 Christ 
Shaker incubator Multitron Infors HT 
Shaker incubator KF4 Infors HT 
Spectrophotometer Ultrospec 1000 Pharmacia Biotech 
Spectrophotometer Ultrospec 3100 pro GE Healthcare 
Spectrophotometer Cary 300 UV-Vis Varian 
Spectrophotometer  SimpliNano™ GE Lifesciences 
Thermocycler T-Professional basic gradient Biometra 
Diaphragm vacuum pumps with 
programmable digital vacuum controller 
VCZ 224 Ilmvac 
Vortex shaker VF2 IKA 
Water purification system Arium 611 Sartorius 
9.2. Equipment for HPLC and MS analysis 
Equipment  Model Manufacturer 
HPLC Agilent 1260 Infinity System Agilent 
Pump G1311C Quaternary Pump VL Agilent 
Auto sampler G1329B ALS Agilent 
Column oven G1316A TCC Agilent 
Column HyperClone ODS 120A (C18, 4.6 × 150 mm, 5 μ) Phenomenex 
Diode Array Detector G1315D DAD VL Agilent 
Software Agilent ChemStation for LC 3D System Rev. 
B.04.03(16) 
 
 
 
 
Agilent 
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Continued:   
Equipment  Model Manufacturer 
HPLC LaChrom Elite System VWR-Hitachi 
Pump L-2130 VWR-Hitachi 
Degasser Model 2005 Degasser VWR-Hitachi 
Auto sampler L-2200 VWR-Hitachi 
Column ZORBAX Eclipse Plus (C18, 4.6 × 100 mm, 
3.5 μ) 
Agilent 
Diode Array Detector L-2455 VWR-Hitachi 
Software EZChrom Elite vers. 3.3.2 SP1 
 
Agilent 
Mass spectrometer 3200 QTRAP LC/MS/MS System AB Sciex 
Software Analyst vers. 1.4.2 AB Sciex 
10. Software, online databases and tools  
Name, web address* Use 
Software:  
Chromas Lite 2.1.1 
http://technelysium.com.au/  
Visualization of the sequencing chromatograms 
from .ab1 files.  
 
Lasergene - DNAStar 7.0 A package composed of various individual 
programs for DNA and protein sequence analysis. 
Those programs include:  
MegAlign: generates pairwise and multiple 
sequence alignments of protein or DNA showing 
consensus strength and percent identity matrices. 
EditSeq: helpful in editing protein and nucleotide 
sequences. 
SeqMan: assembles Contigs from individual 
overlapping sequences. 
SeqBuilder: generates plasmid maps, shows 
existing restriction sites within a given nucleotide 
sequence and predicts restriction digestion results. 
 
Beacon Designer 8.0 Design of primers for qRT-PCR experiments. 
 
Primer premier 5.0 Design of primers for RACE experiments. 
 
Bio-Rad CFX Manager 3.1 Design of qPCR plates, calculation of the 
amplification efficiencies and analysis of the data. 
 
MEGA 6.0  
http://www.megasoftware.net/  
Multiple sequence alignment and construction of 
phylogenetic trees (Tamura et al., 2013). 
 
YASARA View 15.9.6 
http://www.yasara.org/index.html  
Visualization of the three dimensional structure of 
macromolecules. 
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Continued:  
Name, web address Use, description  
Online databases:  
NCBI protein and nucleotide databases 
http://www.ncbi.nlm.nih.gov/protein 
http://www.ncbi.nlm.nih.gov/nuccore 
 
Retrieving amino acid and nucleotide sequences of 
deposited CYPs and CPRs. 
MPGR database 
http://medicinalplantgenomics.msu.edu/  
A repository of the transcriptomic and 
metabolomic data of 14 medicinal plants, 
including H. perforatum. 
 
OneKP database 
http://www.onekp.com/  
Transcriptomic data of over 1000 plants including 
H. perforatum, Garcinia oblongifolia, 
G. livingstonei and Mammea americana.  
 
UIC transcriptome database  
http://apps.pharmacy.uic.edu/depts/ 
pcrps/MedTranscriptomePlants/index.html  
 
Transcriptome Characterization of Medicinal 
Plants Relevant to Human Health including 
Calophyllum antillanum. 
PhytoMetaSyn database 
http://www.phytometasyn.ca/index.php  
Transcriptomic data of 75 plant species including 
H. perforatum. 
Online tools:  
BLAST 
http://blast.ncbi.nlm.nih.gov/Blast.cgi  
blastn: Search a nucleotide database using a 
nucleotide query. 
blastp: Search protein database using a protein 
query. 
blastx: Search protein database using a translated 
nucleotide query in all possible frames. 
tblastn: Search translated nucleotide database 
using a protein query. 
 
ExPASy translate tool 
http://web.expasy.org/translate/  
Translation of DNA sequences in all 6 possible 
forward and reverse frames. 
 
CAP3 
http://mobyle.pasteur.fr/cgi-
bin/portal.py#forms::cap3  
 
Assembling the ESTs from the subtractive library 
into Contigs. 
Blast2GO 
https://www.blast2go.com/  
 
Functional annotation of the assembled Contigs. 
Primer 3.0 
http://primer3.ut.ee/  
Rechecking the properties of the designed qPCR 
primers.  
 
ESPript 3.0 
http://espript.ibcp.fr/ESPript/ESPript/  
Display of sequence similarities and secondary 
structure elements of aligned sequences for 
analysis and publication purpose. 
CYtochrome P450 Engineering Database 
(CYPED 6.0) 
https://cyped.biocatnet.de/  
 
Blastable database of all named CYP sequences, 
tool for CYP standard numbering and prediction 
of secondary structure elements. 
* All listed websites have been successfully accessed on October 21, 2015  
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III. Methods 
1. Elicitor treatment of Hypericum calycinum cell cultures 
Hypericum calycinum cell suspension cultures (II.1.2) were treated with of yeast extract as an 
elicitor to induce the production of a 1,3,6,7-tetrahydroxyxanthone derivative known as 
hyperxanthone E (Gaid et al., 2012), whereby all transcripts encoding the enzymes involved in its 
biosynthesis should be overexpressed.  
At the 4th day after subdivision of the cultures, 1 ml of sterile-filtered yeast extract (150 mg/ml) 
were added to 50 ml cultures to a final concentration of 3 g/l. The cells were further incubated for 
7 h and the cells were harvested by vacuum filtration and frozen in liquid nitrogen for subsequent 
RNA extraction. 
2. Molecular biology methods 
2.1. Isolation of nucleic acids 
2.1.1. Isolation of total RNA 
2.1.1.1. Isolation of total RNA from Hypericum calycinum cells 
H. calycinum cell culture were elicited with 3 g/l yeast extract, cells were collected 7 h post 
elicitation. Total RNA was extracted with RNeasy Plant Mini Kit (Qiagen) following the 
manufacturer’s protocol.  
2.1.1.2. Isolation of total RNA from Hypericum perforatum leaves 
H. perforatum middle-aged leaves were collected and total RNA was extracted using GeneJET 
Plant RNA Purification Mini Kit (Thermo Scientific) following the manufacturer’s protocol for 
polyphenol-rich samples. 
2.1.2. Isolation of plasmid DNA from E. coli  
Plasmids were isolated from E. coli by the alkaline lysis method described by Birnboim and Doly 
(1979). This method depends on the selective denaturation of the large linear chromosomal DNA 
in alkaline medium with retaining the small circular plasmid DNA unharmed. After neutralization, 
chromosomal DNA and proteins precipitate, while plasmid DNA remains in the supernatant. 
A single E. coli colony was inoculated in a 5 ml LB tube supplemented with 10 μl of 100 mg/ml 
sterile filtered ampicillin solution to positively select for bacterial cells harboring a plasmid with 
an ampicillin carrying resistance gene. The culture was incubated overnight (16–18 h) at 37 °C 
and 200 rpm. The cells in 2 ml of the overnight culture were pelleted in a 2 ml Eppendorf tubes by 
centrifugation for 5 min at 5000 rpm. The supernatant was discarded and the pellet was 
resuspended in 300 μl of ice-cooled buffer I to which RNase A was freshly added (II.8.1). The 
alkaline lysis was achieved by the addition of 300 μl of buffer II (II.8.1), followed by gentle mixing 
by flipping the tubes 4–6 times and incubation at room temperature for 5 min. Neutralization by 
the addition of 300 μl of buffer III (II.8.1), followed by gentle mixing and incubation on ice for 20 
min resulted in the precipitation of chromosomal DNA and proteins. The white precipitate was 
discarded after centrifugation for 10 min at 13000 rpm, while 800 μl of the supernatant were 
vortexed with an equal volume of chloroform; the two phases were separated by centrifugation for 
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10 min at 13000 rpm. 700 μl of the aqueous phase were carefully transferred to a 1.5 ml Eppendorf 
and the plasmid DNA was precipitated by the addition of 490 μl isopropanol (70 % of the aqueous 
phase volume), followed by vortexing and centrifugation for 35 min at 13000 rpm. The supernatant 
was discarded and the pellet was washed with 500 μl of 70 % ethanol, centrifuged for 10 min at 
13000 rpm and the supernatant was again discarded. The pelleted plasmid was dried in a rotational 
vacuum concentrator and finally dissolved in 30 μl of deionized water. 
The isolated plasmids were checked by restriction digestion and/or by amplification of the inserts 
before sequencing. They could be used for subsequent E. coli or yeast transformations. 
2.1.3. Isolation of plasmid DNA from Saccharomyces cerevisiae 
Plasmid isolation from yeast cells was performed according to the protocol described by Hoffman 
and Winston (1987). The purpose was to control if the picked colonies after transformation actually 
contained the introduced plasmids in the course of protein expression.  
The cells in 2 ml culture were pelleted by centrifugation for 5 min at 5000 rpm, the supernatant 
was discarded and the cells were resuspended in the residual medium left. After addition of 200 μl 
of the yeast cracking solution (II.8.2), 200 μl of phenol:chloroform (1:1) and 300 mg of acid 
washed glass beads, the cells were vigorously vortexed for 2 min. The homogenate was centrifuged 
for 10 min at 13000 rpm and 250 μl of the aqueous phase were transferred to a 1.5 ml Eppendorf. 
The DNA was precipitated by the addition of 175 μl isopropanol (70 % of the aqueous phase 
volume), vigorously mixed and centrifugation for 35 min at 13000 rpm. The supernatant was 
discarded and the pellet was washed with 500 μl of 70 % ethanol, centrifuged for 10 min at 13000 
rpm and the supernatant was again discarded. The pelleted plasmid was dried in a rotational 
vacuum concentrator and finally dissolved in 30 μl of deionized water. 
The plasmids isolated by this method were suitable for transformation in E. coli and for checking 
of the inserts by PCR amplification. However, they were not pure enough to be checked by 
restriction digestion. 
2.1.4. Isolation of DNA from agarose gels 
The desired DNA bands were extracted from agarose gels (III.2.4) by solubilizing the gel and 
selectively adsorbing the DNA on a special silica membrane, washing with an ethanol-containing 
buffer and finally elution of the bound DNA with an aqueous buffer. This was performed using 
the innuPREP DOUBLEpure Kit (Analytik Jena) following the manufacturer’s protocol. In brief, 
the cut band was solubilized in 600 µl of the gel extraction buffer, heated for 10 min at 50 °C. The 
solution was mixed with 50 µl of the binding optimizer solution and transferred to the separation 
column, centrifuged at for 1 min at 8000 rpm. The column was washed twice, each with 700 µl of 
LS buffer (containing ethanol), centrifuged for 1 min at 12000 rpm and finally dried by 
centrifugation for 2 min at 13000 rpm. The DNA was eluted by the addition of 10–35 µl of the 
elution buffer (or dH2O instead), incubated for 1 min at room temperature and finally centrifuged 
for 2 min at 10000 rpm.  
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2.1.5. Isolation of DNA from digestion or dephosphorylation reaction mixtures 
The DNA was isolated from digestion or dephosphorylation reaction mixtures using the same 
principle described in (III.2.1.4). The same innuPREP DOUBLEpure Kit (Analytik Jena) was also 
used. The reaction mixture was mixed with 500 µl of the binding buffer, transferred to the 
separation column, centrifuged at for 1 min at 12000 rpm. The column was washed once with 
700 µl of LS buffer, centrifuged for 1 min at 12000 rpm. The DNA was eluted by the addition of 
10–20 µl of the elution buffer (or dH2O instead), incubated for 1 min at room temperature and 
finally centrifuged for 2 min at 10000 rpm. 
2.2. Quantification of nucleic acids 
The concentration of nucleic acids solutions could be determined spectrophotometrically by 
measuring the UV absorbance at 260 nm. 5 µl of the DNA or RNA sample solution are diluted to 
500 µl with deionized water and the absorbance at 260 and 280 nm were measured and the 
concentration was calculated using the Beer-Lambert law: 
C =
OD260
L
× ε × D 
Where, C is the concentration of nucleic acid sample in ng/µl 
OD260 is the blank-normalized absorbance of the nucleic acid sample at 260 nm 
L is the path length in cm 
ε is the extinction coefficient depending on the type of nucleic acid measured (50 µg/ml for double 
stranded DNA, 33 µg/ml for single stranded DNA and 40 µg/ml for RNA) 
D is the dilution factor  
Because proteins and some reagents commonly used in nucleic acids isolation have absorbance at 
260 nm, this can lead to increase the measured concentrations than the true values. However, unlike 
nucleic acids, most of those contaminants have absorbance at 280 nm. Therefore, the ratio of 
OD260/OD280 can be used to control DNA or RNA purity. Generally, values of OD260/OD280 ratio 
should be ≥ 1.8 for DNA and of about 2.0 in case of RNA. When a ratio less than 1.8 is obtained, 
it indicates a contaminated DNA or RNA sample. The most common sources of contamination 
include proteins, phenols, guanidine and other aromatic compounds that may be invplved in the 
purification process. 
2.3. Enzymatic modifications of DNA 
2.3.1. Restriction digestion 
Type II restriction endonucleases were utilized to cut DNA inserts and vectors in a manner that 
allows subsequent ligation between the fragments cut with the same (or compatible) restriction 
enzymes. Typically, each type II restriction enzyme recognizes a specific palindromic sequence of 
4–8 bp and cuts the DNA double strands within or close to the recognition sequence generating 3′ 
or 5′ overhangs suitable for subsequent sticky-end ligation. Some restriction enzymes do not 
generate overhangs and their products are suitable for blunt end ligation. However, in the course 
of this work, only enzymes generating sticky ends were used to construct expression plasmids. 
The restriction enzymes were chosen so that their recognition sequences were present in the 
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multiple cloning site (MCS) of the vector but not in the insert sequence. The composition of the 
digestion reactions were as follows: 
Component Inserts Vectors Constructed plasmids 
DNA solution add to 10.0 µl add to 20.0 µl 2.0 µl 
10X buffer* 1.0 µl 2.0 µl 2.0 µl 
1st restriction enzyme* 0.5–1.0 µl 0.5–1.0 µl 0.5–1.0 µl 
2nd restriction enzyme* 0.5–2.0 µl 0.5–2.0 µl 0.5–2.0 µl 
dH2O -  -  add to 20.0 µl 
* During this work, the following combinations were used: 
EcoRI/PacI: were used in buffer EcoRI, 0.5 µl EcoRI, 2.0 µl PacI 
SpeI (BcuI)/PacI: were used in buffer PacI, 1.0 µl SpeI (BcuI), 0.5 µl PacI 
BamHI/HindIII: were used in buffer BamHI, 0.5 µl BamHI, 1.0 µl HindIII 
The vector and insert digestions were incubated for 3 h at 37 °C, while plasmid digestion was 
incubated for 1 h at 37 °C. 
Restriction digestion followed by agarose gel electrophoresis was used to control for positive insert 
ligation in the constructed plasmids. In addition, DpnI, a type IIM restriction endonuclease, was 
used to digest the methylated template plasmids during site-directed mutagenesis protocol 
(III.2.10). 
2.3.2. Ligation 
DNA ligation is the technique by which two DNA fragments (for example, linearized vector and 
insert) are connected together through the formation of a phosphodiester bond between a 5′ 
phosphate group in one fragment and a free 3′ hydroxyl group in the other. This reaction is 
catalyzed by T4 DNA ligase and requires ATP and Mg2+ as cofactors. This enzyme can be used in 
blunt or sticky end ligations and can also repair single-strand nicks in duplex DNA, RNA or 
DNA/RNA hybrids. 
The vectors used were either pGEM-T easy vector for sequencing of the RACE products or pESC-
URA and pESC-TRP vectors for expression in yeast cells. 
The components of the ligation reaction were as follows: 
Insert DNA 6 µl 
Linearized vector DNA 2 µl 
10X T4 DNA ligase buffer 1 µl 
T4 DNA ligase 0.2 µl 
50 % PEG 4000 1 µl 
The used insert to vector molar ratios were in the range of 1:1 to 5:1, the ligation reaction was 
incubated overnight at 4 °C. 
In the course of this work an instant Sticky-end Ligase Master Mix from NEB was also utilized. 
The components of the reaction were as follows: 
Insert DNA 3.5 µl 
Linearized vector DNA 1.5 µl 
2X instant ligase master mix 5 µl 
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The components were mixed thoroughly by pipetting 7–10 times, incubated for 10 min at room 
temperature. Subsequently, 5 µl of the transformation mixture were transformed in DH5α E. coli 
as described in (III.3.3.1). 
2.3.3. Dephosphorylation of the digested vectors 
During the ligation step, the digested vector can be recircularized by ligation with its digested 
fragment instead of the desired insert, resulting in an empty vector that carries the same marker as 
the desired plasmid. Both will be processed together and could only be distinguished after plasmid 
isolation and control of the presence of the right insert by restriction digestion or PCR. 
Dephosphorylation of the vector after digestion serves to the remove the 5′ phosphate groups from 
the vector as well as from the cut fragment to minimize the possibility of self-ligation. On the other 
hand, the digested insert (which should not be dephosphorylated) has the 5′ terminal phosphates 
and can be ligated efficiently to the dephosphorylated plasmid giving a circular plasmid with nicks 
(open circular plasmids) that could be transformed into competent E. coli and the nicks are 
removed by the DNA-repair mechanism in the bacteria. Therefore, most of the transformed 
bacterial cells will contain the recombinant but not the recircularized plasmid. 
FastAP Thermosensitive Alkaline Phosphatase (Thermo Scientific) was used for the 
dephosphorylation of the digested vectors. The reaction components were as follows: 
Digested vector 3–4 µg 
10X reaction buffer for AP 2 µl 
FastAP Thermosensitive Alkaline Phosphatase 2 µl 
dH2O add to 20 µl 
The reaction was incubated for 10 min at 37 °C followed by heat-inactivation of the enzyme for 5 
min at 75 °C. The DNA is purified from the protein and salts in the reaction mixture as indicated 
in (III.2.1.5). 
2.4. Agarose gel electrophoresis 
Native agarose gel electrophoresis is the method used to separate DNA fragments according to 
their sizes in a cross-linked agarose matrix by applying an electric field across the gel matrix. As 
the phosphate groups on the DNA backbone are negatively charged, the DNA will migrate to the 
positive pole. The migration rate depends on the ionic strength of the used buffer, the size and 
shape of DNA and the concentration of agarose in the gel. Normally, 1 % agarose gel can be used 
to separate DNA fragments from 0.2–20 kb. However, the concentration can be increased to 2 % 
for a better resolution of lower-size fragments (less than 500 bp) or decreased to 0.5 % for a better 
resolution of high-size fragments. Electrophoresis is mainly a sieving process; where large 
fragments are entangled in the matrix and, therefore, run more slowly than small fragments. A 
linear relation exists between the logarithm of the fragment length and its relative migration 
distance on the gel. 
To prepare a medium-size 1 % agarose gel enough for 15–20 samples, 80 ml of 1X TAE buffer 
(II.8.4) were added to 800 mg of agarose and the mixture was cooked in the microwave for about 
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1:30 min until it became a transparent solution. When the solution cooled down to about 60 °C, 3 
µl of Midori Green were added, thoroughly mixed and directly poured in a gel tray to which a 
suitable comb is attached. When the gel solidified, the comb was removed, the tray was transferred 
to the electrophoresis chamber, loading dye (II.8.4) was added to the samples (at 1X final 
concentration), briefly mixed by pipetting and loaded into the wells formed by the comb. The gel 
was run in TAE buffer for 30–35 min at 120 V and 400 mA. 5 µl of DNA ladder were loaded into 
one of the wells to help identifying the sizes of the detected bands. The gel was visualized with a 
UV-equipped transilluminator. The desired band(s) were cut and DNA was isolated from them as 
described in (III.2.1.4) 
2.5. Primer design 
The following points should be taken into consideration during primer design: 
To bind specifically to the desired template, the ideal length of the designed primers should be 
between 18–24 bp, with a GC content in the 40–60 % range and melting temperatures (Tm) ranging 
from 55 to 65 °C. The selection of the Tm of the primer depends on the application in which it 
would be used. For example, when a large mix of DNA is used as a template like in the case of 
genomic DNA or cDNA templates, a primer with relatively higher Tm (typically > 60 °C) should 
be designed to increase specificity and allow the use of touchdown PCR (III.2.7.2). While in case 
of using plasmid DNA as a template as in the sequencing reactions, a primer with a Tm of about 
50 °C would be sufficient. The melting temperatures for the forward and reverse primers should 
not differ by more than 5 °C. It is also advisable that the 3′-end nucleotide of the primer should be 
a C or a G. This GC clamp helps to anchor the primer on its template for efficient priming. Tm 
above 72 °C as well as runs of multiple Cs or Gs should be avoided especially at the 3′-end as they 
can lead to mispriming. 
Whenever possible, significant homology to other regions on the desired template or to other 
templates in the cDNA pool should be avoided. This could be checked by performing a BLAST 
search against the available datasets. Palindromic sequences at the 3′-end of the primes should be 
also avoided as the can cause the formation of homo- or heterodimers. The tendency of a primer 
to make hairpins or primer dimers could be checked online (IDT Oligoanalyzer: 
http://eu.idtdna.com/calc/analyzer). 
When designing primers with restriction sites at their 5′-ends for subsequent cloning of the 
amplified fragment, 3–4 extra nucleotides should be added before the restriction sites to help the 
enzyme cut the linear amplified DNA. The added restriction sites and extra nucleotides should not 
be taken into consideration when calculating the Tm. 
2.6. Rapid amplification of cDNA ends (RACE) 
Rapid amplification of cDNA ends (RACE) is a technique used to recover full-length sequence of 
cDNA clones using a known part of their internal sequences. The process is done in two halves 
(3′-RACE and 5′-RACE) and involves two steps. In the first step, a single-stranded cDNA is 
synthesized by primer extension using reverse transcriptase with the introduction of a 3′- or 5′-
anchor. In the second step, PCR is used to amplify the synthesized cDNA using a gene-specific 
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primer (GSPs) designed from the known internal sequence together with a primer similar to the 
anchor sequence. The amplification product is subsequently cloned into a suitable vector and 
sequenced to identify the missing part. 
2.6.1. 3′-RACE  
In the 3′-reaction, an oligo(dT) primer with a unique anchor sequence at its 5′-end primes the 
synthesis of a DNA copy of the mRNA starting from the poly(A) tail by the action of reverse 
transcriptase. Subsequently, a PCR amplifies the fragment between a forward GSP from the known 
internal sequence and a reverse primer similar to the sequence of the introduced anchor. The PCR 
will amplify from the poly(A) tail to the middle of the gene (Figure III-1). 
 
Figure III-1. Schematic presentation of 3′-RACE PCR. 
The first-strand cDNA for 3′-RACE was synthesized as follows: 
In a nuclease-free PCR tube placed on ice, 1 µl of 3′-RACE CDS primer (10 µM) were added to 
5 µg of the total RNA isolated under (III.2.1.1) and the volume was completed to 12.5 µl with 
DEPC-treated water. After brief mixing, the solution was incubated for 5 min at 65 °C and directly 
chilled on ice. 7.5 µl of following master mix were then added: 
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5X reaction buffer 4.0 µl 
RiboLock™ RNase inhibitor (40 u/µl) 0.5 µl 
dNTPs (10 mM each) 2.0 µl 
RevertAid™ H Minus reverse transcriptase (200 u/µl) 1.0 µl 
Total volume 7.5 µl 
The reaction mixture was incubated for 90 min at 42 °C, followed by heating for 10 min at 70 °C 
to deactivate the enzyme. The synthesized 3′-RACE ready cDNA was utilized as a template for 
PCR as described under (III.2.7). 
2.6.2. 5′-RACE using TdT 
In the 5′-reaction, a reverse GSP from the internal known sequence is used to initiate DNA 
synthesis from mRNA by reverse transcriptase. Subsequently, an artificial poly(A) tail is added to 
the 3′ end of the synthesized DNA strand by the action of terminal deoxynucleotidyl transferase 
(TdT) in the presence of dATP. An oligo(dT) with a 5′-anchor sequence anneals to the introduced 
adenosines. Then, A primer with the same sequence as the anchor together with a reverse GSP are 
used in the PCR amplification for the 5′-reaction (Figure III-2). 
 
Figure III-2. Schematic presentation of 5′-RACE PCR using TdT. 
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2.6.3. 5′-RACE using SMART system 
SMART 5′-RACE (standing for: Switching Mechanism At 5′-end of RNA-Transcript) is almost 
similar to TdT 5′-RACE except that the 5′-anchor is introduced during the reverse transcription 
reation. SMARTscribe™ reverse transcriptase adds 3–5 cytosine nucleotides to the 3′-end of the 
synthesized cDNA strand because of its terminal nucleotide transferase activity. Next, 
SMART II™ oligo anneals to the introduced cytosines and template switching occurs allowing the 
oligo to serve as a template for the SMARTScribe™ RT, thus, generating a complete cDNA copy 
of the original RNA with an anchor attached at its end. As in TdT 5′-RACE, a forward primer 
having the same sequence as the introduced 5′-anchor together with a reverse GSP are used in the 
PCR amplification (Figure III-3).  
 
Figure III-3. Schematic presentation of 5′-RACE using SMART system. 
 
The first-strand cDNA for 5′-RACE was synthesized by this method as follows: 
In a nuclease-free PCR tube placed on ice, 1 µg of the total RNA (III.2.1.1) were mixed with 1 µl 
of a reverse GSP (10 µM) and the volume was completed to 3.75 µl with DEPC-treated water. The 
mixture was incubated for 3 min at 72 °C followed by 2 min at 42 °C, centrifuged for 10 s at 13000 
rpm. 6.25 µl of the following master mix were then added: 
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SMART II™ A oligo (10 µM) 1.0 µl 
5X reaction buffer 2.0 µl 
DTT (20 mM) 1.0 µl 
dNTPs (10 mM each) 1.0 µl 
RiboLock™ RNase inhibitor (40 u/µl) 0.25 µl 
SMARTScribe™ reverse transcriptase (100 u/µl) 1.0 µl 
Total volume 6.25 µl 
The reaction mixture was incubated for 90 min at 42 °C, followed by heating for 10 min at 70 °C 
to deactivate the enzyme. The synthesized 5′-RACE ready cDNA was utilized as a template for 
PCR as described under (III.2.7). 
2.7. Polymerase chain reaction (PCR) 
It is a technique developed by Kary Mullis in the 1980s in which billions of copies of a specific 
DNA sequence are synthesized by repeated reciprocal extension of two primers oppositely 
hybridized to the separate strands of a particular DNA sequence by the action of a DNA 
polymerase (Mullis, 1994). The reaction requires a DNA template (genomic, plasmid, or cDNA), 
a pair of primers that hybridize in opposite directions to the peripheries of the target sequence, 
deoxynucleotide triphosphates (dNTPs), and a thermostable DNA polymerase. DNA polymerase 
synthesizes complementary strands of DNA using a DNA template and primers by adding single 
nucleotides to the 3′-end of the primer. The process is repeated and the synthesized DNA is used 
as a template resulting in exponential amplification of the target sequence. The reaction proceeds 
in three main steps that are repeated in 25–35 cycles:  
The denaturation step: heating the DNA for 20–30 s at 95–98 °C leads to disruption of the 
hydrogen bonds between the complementary bases resulting in the separation of the double strands 
to form single stranded DNA. 
The annealing step: the temperature is decreased to 45–70 allowing the primers to anneal to their 
specific template. The annealing temperature used usually is 3–5 °C below the Tm of the primers, 
this prevents non-specific annealing of the primers to other template DNA molecules present in 
the reaction mixture. 
The extension step: the temperature is raised again to 72 °C which is the optimum temperature for 
most thermostable DNA polymerases. The duration of this step depends on the length of the 
fragment to be amplified and the speed by which the enzyme adds nucleotides to the newly-
synthesized strand. 
The PCR product is analyzed by agarose gel electrophoresis (III.2.4) and could be separated as 
previously described (III.2.1.4).  
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2.7.1. Standard PCR 
This method was used during this work to check for proper ligation of the insert in the constructed 
plasmids and occasionally in RACE-PCR. The components of the reaction were as follows: 
Component   Final concentration 
10X reaction buffer  2.5 µl 1 X 
dNTPs (10 mM each) 1 µl 400 µM each 
Forward primer (10 µM or pmol/µl) 1 µl 0.4 µM 
Reverse primer (10 µM or pmol/µl) 1 µl 0.4 µM 
Template DNA 1 µl 1–10 ng/µl 
Taq DNA Polymerase (5 U/µl) 0.25 µl 1.25 U/µl 
dH2O add to 25 µl   
 
The cycling was performed as follows: 
Step Temperature Time        Cycles 
Initial denaturation 95 °C 3 min            1 
Denaturation  95 °C 30 s 
           35 Annealing Tm - 5 °C 30 s 
Extension 72 °C 2 min 30 s 
Final extension 72 °C 8 min 30 s            1 
Storage 12 °C Pause  
 
2.7.2. Touchdown PCR 
This method was frequently used during this work in RACE-PCR to increase specificity and 
decrease the possibility of non-specific amplifications. To use touchdown PCR, primers were 
designed with Tm around 65 °C. In the first cycle, a high annealing temperature was used that was 
equal to the lowest Tm of the used primer pair. The annealing temperature was decreased by - 0.5 °C 
per cycle for the first 10 cycles, followed by 30 cycles with an annealing temperature of Tm - 5. 
This allows enrichment of the target sequence during the first few cycles due to the high annealing 
temperatures used, followed by exponential amplification in the next cycles which would surpass 
that of any non-specific sequence due to the initial enrichment. The reaction components were the 
same as in standard PCR but the cycling was performed as follows: 
Step Temperature Time        Cycles 
Initial denaturation 95 °C 3 min            1 
Denaturation  95 °C 30 s 
           10 Annealing Tm (ΔT = -0.5 °C/cycle) 30 s 
Extension 72 °C 2 min 30 s 
Denaturation  95 °C 30 s 
           30 Annealing Tm - 5 °C 30 s 
Extension 72 °C 2 min 30 s 
Final extension 72 °C 8 min 30 s            1 
Storage 12 °C Pause  
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2.7.3. Nested PCR 
This is another technique that could be used to increase the amplification specificity, whereby, the 
PCR product of one reaction is used as a template for the subsequent PCR using one or both 
primers in the second amplification to the 3′-direction of those originally used in the first reaction. 
This technique can be used with either the standard or touchdown PCR.  
Occasionally, an enhancer solution (II.8.7) was used in Taq-catalyzed PCR to increase 
amplification efficiency by decreasing the DNA melting temperature and therefore decrease the 
possibility of the formation of secondary structures such as hairpins which would interfere with 
the polymerase function (Ralser et al., 2006). 
2.7.4. PCR using high-fidelity DNA polymerases 
For experiments requiring absolutely correct DNA sequences such as cloning of genes into 
expression vectors and site-directed mutagenesis, high-fidelity (proofreading) DNA polymerases 
have been employed. The advantage of those polymerases is that they have very low replication 
error rate compared to Taq DNA polymerase. This is due to their ability to bind preferentially to 
the correct nucleotide during polymerization. However, if a mismatched nucleotide is inserted, 
those enzymes possess an extra line of defense, their 3′→5′ exonuclease domain, also known as 
the proofreading domain, enables the polymerase to excise the incorrect nucleotide in the 3′→5′ 
direction, thus increasing fidelity of replication. Unlike the products of Taq-polymerase, products 
of high-fidelity polymerases are blunt-ended and cannot be used directly for TA cloning. 
The components of the PCR were as follows: 
Component     Final concentration 
5X Phusion HF buffer * 10 µl 4 µl 1 X 
dNTPs (10 mM each) 1 µl 0.4 µl 200 µM each 
Forward primer (10 µM or pmol/µl) 2.5 µl 1 µl 0.5 µM 
Reverse primer (10 µM or pmol/µl) 2.5 µl 1 µl 0.5 µM 
Template cDNA  1 µl 1 µl 50 - 250 ng 
Phusion Hot Start II DNA 
Polymerase (2 U/µl) * 
0.5 µl 0.2 µl 0.02 U/µl 
dH2O add to 50 µl add to 20 µl   
* Q5 Hot Start High-Fidelity DNA Polymerase (NEB) was also successfully used with its own reaction buffer. 
The cycling was performed as follows: 
Step Temperature Time        Cycles 
Initial denaturation 98 °C 30 s            1 
Denaturation  98 °C 10 s 
           35 Annealing Tm + 3 °C 30 s 
Extension 72 °C 1 min 30 s 
Final extension 72 °C 10 min            1 
Storage 12 °C Pause  
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2.8. Gene transcript analysis by real-time qRT-PCR 
Total RNA was extracted from control and yeast-extract-treated H. calycinum cell cultures at 4, 8, 
12, 16, 20, 24, 36 and 48 h post-elicitation as described in (III.2.1.1.1). On-column digestion was 
applied to each sample using the RNase-Free DNase Set (Qiagen) to get rid of genomic DNA 
contamination. The RNA quality was checked on a gel. Concentrations and 260/280 ratios were 
determined using the SimpliNano™ Spectrophotometer (GE Lifesciences). For each time point, 
cDNA was synthesized from 1 µg RNA using iScript™ Reverse Transcription Supermix for RT-
qPCR (Bio-Rad). Subsequent measurements were performed on the CFX Connect™ Real-Time 
PCR Detection System (Bio-Rad) using iTaq™ Universal SYBR® Green Supermix (Bio-Rad), 
following the manufacturer’s protocol. The 20 µl reaction contained 1 µl cDNA, 10 µl (2x) 
supermix and 0.5 µM of each primer (II.3.5). Samples were initially denatured at 95 °C for 30 s, 
run for 40 cycles at 95 °C for 5 s and 59 °C for 30 s. Data were recorded after the 
annealing/extension step. The specificity of the amplification product was confirmed from melt 
curves and by running the samples on an agarose gel. Pooled cDNA of all time points was used in 
a serial dilution to determine the efficiency of amplification for each primer pair. Based on the Cq 
values obtained during the efficiency tests, 1 µl of 1:50 dilution of the original cDNA of each time 
point was used as a template for the subsequent expression analysis. Actin and Histone H2A served 
as reference genes. The non-elicited sample (0 h) served as a calibrator. Amplification efficiencies 
as well as normalized expression relative to the calibrator were determined using the Bio-Rad CFX 
Manager software (version 3.1, Bio-Rad). 
2.9. C-terminal exchanges 
Reciprocal exchange of the terminal 55 amino acids between HpCYP81AA1 and HpCYP81AA2 
was performed using the one-pot fusion PCR protocol described in (Buttner and Barleben, 2012). 
In this protocol, a PCR is set up with two templates, a small concentration of an overlapping primer 
between the two domains to be fused and higher concentrations of the 5′- and 3′-gene specific 
primers (GSPs) with suitable restriction sites for subsequent cloning. In the first few PCR cycles, 
the overlapping primer (green/red arrow) together with the 3′-GSP (red arrow) generate a mega-
primer (red/green arrow) from the C-terminal domain. After depletion of the overlapping primer, 
the synthesized mega-primer together with the 5′-GSP (green arrow) can prime the formation of 
the chimeric gene from the N-terminal domain. The formed chimeric gene is exponentially 
amplified with the 5′- and 3′-GSPs (Figure III-4). 
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Figure III-4. Schematic presentation of the one-pot fusion PCR protocol; adapted from Buttner and Barleben (2012). 
The components of the PCR were as follows: 
Component   Final concentration 
5X Phusion HF buffer  10 µl 1 X 
dNTPs (10 mM each) 1 µl 200 µM each 
5′-GSP (10 µM) 1 µl 0.2 µM 
3′-GSP (10 µM) 1 µl 0.2 µM 
Overlapping primer (1 µM) 2 µl 0.04 µM 
Template plasmid 1 (1 µg/µl) 0.5 µl 10 ng/µl 
Template plasmid 2 (1 µg/µl) 0.5 µl 10 ng/µl 
Phusion Hot Start II DNA 
Polymerase (2 U/µl) 
0.5 µl 0.02 U/µl 
dH2O add to 50 µl   
HpCYP81AA1 with the C-terminus of HpCYP81AA2 (HpCYP81AA1-AA2) was generated using 
Hp81AA1-SpeI-F, Hp81AA2-PacI-R and AA1-AA2-ex primers. While CYP81AA2 with the C-
terminus of CYP81AA1 (HpCYP81AA2-AA1) was generated using Hp81AA2-SpeI-F, 
Hp81AA1-PacI-R, and AA2-AA1-ex primers. 
The PCR started with an initial denaturation at 98°C for 30 s, then 35 cycles at 98°C for 10 s, 60°C 
for 30 s, and 72°C for 1:30 min, followed by a final extension at 72°C for 10 min. The PCR product 
with the expected size (~1500 bp) was excised from agarose gel (III.2.5), purified (III.2.1.4), 
digested with SpeI and PacI restriction enzymes (III.2.3.1), ligated to pESC-URA-HcCPR2 
plasmid previously digested with the same restriction enzymes (III.2.3.2), transformed into DH5α 
(III.3.3.1) and sequenced to verify the generation of a chimeric gene. 
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2.10. Site-directed mutagenesis (SDM) 
Site-directed mutagenesis (SDM) was performed according to the QuickChange™ protocol 
following the modified primer design described by Liu and Naismith (2008). In the original design, 
the mutagenic primers anneal to the same sequence on opposite strands of the parental plasmid to 
replicate its sequence and introduce the desired mutations. Therefore, the product has a strand 
break (nick) and cannot be used as a template for the subsequent PCR cycles (Figure III-5a). In 
addition, the primers are completely complementary to one another, and therefore, they tend to 
form primer-dimers instead of annealing to the template plasmid DNA, resulting in primers 
depletion and finally low yield of the mutated product. 
The modification suggested by Liu and Naismith (2008) utilizes partially complementary primers 
with a short overlapping part and a significantly longer non-overlapping parts (Figure III-6) to 
decrease the possibility of primer-dimer formation. Moreover, the non-overlapping parts of the 
primers are long enough to bridge the nicks (Figure III-5b) and therefore can use the parental 
plasmid as well as newly-synthesized DNA as templates resulting in increasing the PCR efficiency 
and reducing the amount of template plasmid needed. 
 
Figure III-5. Schematic presentation of SDM-PCR. (a) Using a pair of complementary primers as recommended by 
the QuickChange™ protocol, and (b) using partially overlapping primers that gap the nicks in the newly-synthesized 
plasmids and use them as templates; adapted from (Liu and Naismith, 2008). 
a b 
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The following points should be considered when designing primers for SDM (Figure III-6) 
- Each primer pair consist of long non-overlapping parts of about 26 nucleotides at their 3′ 
ends and an overlapping (complementary) part of about 13 nucleotides at their 5′ ends. 
- The melting temperature of the non-overlapping parts should be 5–10 °C higher than the 
melting temperature of the complementary part. 
- Single or multiple mutations could be introduced either in the complementary or non-
overlapping parts. 
This primer design can also be used for the introduction of insertion or deletion mutations as 
illustrated in (Figure III-6) 
 
Figure III-6. Schematic presentation of the primer design for SDM, deletion (DEL) and insertion (INS) mutations; 
adapted from (Liu and Naismith, 2008). 
The components of the PCR were as follows: 
Component   Final concentration 
5X Phusion HF buffer * 10 µl 1 X 
dNTPs (10 mM each) 1 µl 200 µM each 
Forward primer (10 µM or pmol/µl) 2.5 µl 0.5 µM 
Reverse primer (10 µM or pmol/µl) 2.5 µl 0.5 µM 
Template plasmid (1:20 dilution) 1 µl 0.5–1.0 ng/µl 
Phusion Hot Start II DNA 
Polymerase (2 U/µl) * 
0.5 µl 0.02 U/µl 
dH2O add to 50 µl   
* The SDM-PCR was sometimes successfully performed using Q5 Hot Start High-Fidelity DNA Polymerase (NEB) 
using its own reaction buffer. 
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The cycling was performed as follows: 
Step Temperature Time        Cycles 
Initial denaturation 98 °C 30 s            1 
Denaturation  98 °C 10 s 
           25 Annealing 70 °C 30 s 
Extension 72 °C 6 min 30 s 
Final extension 72 °C 10 min            1 
Storage 12 °C Pause  
1 µl of DpnI (10 U/µl) were added to the PCR product and incubated at 37°C for 3 h to digest the 
methylated parental plasmid. 5 µl of the digestion mixture were run on an agarose gel (III.2.4) to 
control for the presence of a band at the expected size of the mutated plasmid; another 5 μl were 
directly transformed into DH5α E. coli (III.3.3.1), plasmids were isolated (III.2.1.2) and sequenced 
to confirm the introduction of the designed mutations. The sequences of the primers used for SDM 
are listed in (II.3.3); the templates and primers combinations used to generate each mutant were as 
follows: 
Template Primers Mutant 
Wild-type CYP81AA1 AA1-A373S-F 
AA1-A373S-R 
A373S 
AA1-AA2 AA1-A373S-F 
AA1-A373S-R 
AA1-AA2 A373S 
A373S AA1-AS-SL-F 
AA1-A373S-R 
A373S/S376L 
AA1-AA2 A373S AA1-AS-SL-F 
AA1-A373S-R 
AA1-AA2 A373S/S376L 
A373S/S376L AA1-T482A-F 
AA1-T482A-R 
A373S/S376L/T482A 
A373S/S376L AA1-TALMRKKN-F 
AA1-T482A-R 
A373S/S376L/T482A/L485M/R487K/ 
K488N 
A373S/S376L AA1-T482V-F 
AA1-T482uni-R 
A373S/S376L/T482V 
A373S/S376L AA1-T482F-F 
AA1-T482uni-R 
A373S/S376L/T482F 
A373S/S376L/T482A AA1-W113F-F 
AA1-W113F-R 
W113F/A373S/S376L/T482A 
CYP81AA1 A373S/S376L/T482A AA1-I220P-F 
AA1-I220P-R 
I220P/A373S/S376L/T482A 
A373S/S376L/T482A/L485M/R487K/ 
K488N 
AA1-VIMT-F 
AA1-VIMT-R 
A373S/S376L/T482A/L485M/R487K/ 
K488N/V302I/ M303T 
A373S/S376L/T482A/L485M/R487K/ 
K488N/ V302I/M303T 
AA1-W113F-F 
AA1-W113F-R 
W113F/A373S/S376L/T482A/L485M/ 
R487K/K488N/V302I/M303T 
W113F/A373S/S376L/T482A/L485M/ 
R487K/K488N/V302I/M303T 
AA1-I220P-F 
AA1-I220P-R 
W113F/I220P/A373S/S376L/T482A/ 
L485M/R487K/K488N/V302I/M303T 
Wild-type CYP81AA2 AA2-S375A-F 
AA2-S375A-R 
S375A 
AA2-AA1 AA2-S375A-F 
AA2-S375A-R 
AA2-AA1 S375A 
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Continued:    
Template Primers Mutant 
Wild-type CYP81AA2 AA2-L378S-F 
AA2-L378S-R 
L378S 
Wild-type CYP81AA2 AA2-A483T-F 
AA2-A483T-R 
A483T 
S375A AA2-SALS-F 
AA2-S375A-F 
S375A/L378S 
AA2-AA1 S375A AA2-SALS-F 
AA2-S375A-F 
AA2-AA1 S375A/L378S 
S375A AA2-A483T-F 
AA2-A483T-R 
S375A/A483T 
L378S AA2-A483T-F 
AA2-A483T-R 
L378S/A483T 
S375A/L378S AA2-A483T-F 
AA2-A483T-R 
S375A/L378S/A483T 
S375A/L378S AA2-ATMLKRNK-F 
AA2-A483T-R 
S375A/L378S/A483T/M486L/K488R/ 
N489K 
3. Bacteria and yeast methods 
3.1. Determination of microbial count 
The count of Escherichia coli or Saccharomyces cerevisiae during culture growth was determined 
using a spectrophotometer by measuring the optical density at 600 nm of 1 ml of bacterial or yeast 
culture with fresh media as blank. An OD600 of 0.1 corresponds 1 × 10
8 cells/ml in case of E. coli, 
or 3 × 106 cells/ml of S. cerevisiae (Lech and Brent, 2001; Treco and Winston, 2001). 
3.2. Preparation of competent cells 
3.2.1. Preparation of competent E. coli cells 
The DH5α E. coli cells described in (II.1.3) were made competent using the calcium chloride 
method (Mandel and Higa, 1970). A single E coli colony was inoculated in a 5 ml LB tube and 
incubated overnight at 37 °C with shaking at 200 rpm. 1 ml of the overnight culture was diluted in 
50 ml LB medium to obtain an OD600 of 0.2–0.3, the culture was allowed to grow until reaching 
an OD600 of 0.6–0.9. The bacteria were centrifuged in a 50 ml sterile falcon tube for 5 min at 4 °C 
and 5000 rpm. The supernatant was discarded and the pellet was washed with 50 ml 50 mM CaCl2 
precooled solution, centrifuged again, the supernatant was discarded and the pellet was 
resuspended in 20 ml 50 mM CaCl2 solution and kept on ice for 20 min. The suspension was 
centrifuged again and the pellet was resuspended in 860 μl 50 mM CaCl2 solution, transferred to 
a sterile 1.5 ml Eppendorf tube and incubated on ice for 15 min. 140 μl of sterile glycerol were 
added and briefly mixed with the tube content. The suspension was divided into 50 μl aliquots, 
stored at -80 °C for later transformation as described in (III.3.3.1). 
3.2.2. Preparation of competent Saccharomyces cerevisiae cells 
The INVSc1 Saccharomyces cerevisiae cells described in (II.1.3) were made competent using the 
S.c. EasyComp Transformation Kit (Invitrogen), based on the lithium acetate method described in 
(Dohmen et al., 1991; Becker and Lundblad, 2001). Yeast cells from a stock culture prepared as 
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described in (III.3.4.2) were streaked onto YPD plate and incubated at 30 °C for 48 h. A single 
colony was picked and inoculated in 10 ml YPD medium, incubated at 30 °C and 250 rpm for 
about 24–28 h until the OD600 reached 2.6–5.0. About 600 μl of the starter culture were diluted in 
10 ml fresh YPD medium to obtain an OD600 of 0.2–0.4. The cells were grown for about 6 h until 
the OD600 reached 0.6–1.0 (it is advisable to allow the OD600 to triple to obtain higher 
transformation efficiency). The cells were pelleted by centrifugation at 1500 rpm for 5 min at room 
temperature, the supernatant was discarded. The resulting pellet was washed with 10 ml of 
Solution I, centrifuged and the supernatant was discarded. The pellet was resuspended in 1 ml of 
Solution II and divided into 50 μl aliquots, stored at -80 °C for later transformation as described 
in (III.3.3.3). 
3.3. Transformation of competent cells 
3.3.1. Transformation of competent E. coli cells 
A 50 μl aliquot of DH5α E. coli cells made competent as described in (III.3.2.1) were thawed 
slowly on ice, gently mixed by pipetting with 5–10 μl of the ligation mixture described in (III.2.3.2) 
or 100 ng of the isolated plasmids described in (III.2.1.2 or III.2.1.3) and incubated for 20 min on 
ice. The transformation was performed by the heat shock method; the mixture was heated in a 42 
°C water bath for 45 s followed by rapid cooling on ice for 2 min. Afterwards, 250 μl of SOC 
medium were added and the transformation mixture was incubated for 60 min at 37 ºC and 200 
rpm. 200 μl of the transformation mixture were spread on a suitable LB plate and incubated 
overnight (16–18 h) at 37 °C. 
3.3.2. Control for positive insert ligation 
Control for successful ligation of a DNA fragment on pGEM®-T Easy vector could be done by α- 
complementation of the lacZ gene. The E. coli strain used (DH5α) carries only the α-galactosidase 
subunit of the gene and therefore cannot use the substrate X-Gal enzymatically. The multiple 
cloning site of the vector lies in a β-galactosidase coding region. If no insertion takes place and 
self-ligation of the vectors occurs, the β-galactosidase will be expressed after induction by IPTG 
in the medium. Together, the expressed β-galactosidase subunit of the empty plasmid with the α-
galactosidase encoded in genome of the bacteria can utilize the substrate X-Gal and convert it into 
a blue dye. Therefore, bacterial colonies with an empty plasmid appear blue. On the other hand, 
bacteria containing plasmids, in which the ligation of a DNA fragment in the MCS disrupts the 
expression of the β-galactosidase are not capable of utilizing X-Gal enzymatically and form white 
colonies. 
3.3.3. Transformation of competent Saccharomyces cerevisiae cells 
Transformation was performed using S.c. EasyComp Transformation Kit (Invitrogen). A 50 μl 
aliquot of INVSc1 cells made competent as described in (III.3.2.2) were thawed at room 
temperature. 1–5 μg of the expression plasmids isolated from E. coli as described in (III.2.1.2) 
dissolved in a maximum volume of 5 μl were added to the cells. 500 μl of Solution III equilibrated 
to room temperature were subsequently added and the transformation mixture was mixed by 
vortexing vigorously. The transformation mixture was incubated in a water bath for 1 h at 30 °C 
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with mixing by vigorous vortexing every 15 min. 200 μl were spread on appropriate SD dropout 
plates lacking the marker(s) in the transformed plasmid(s) for auxotrophic selection. 
3.4. Preparation of stock cultures 
3.4.1. Preparation of E. coli stock cultures 
A single colony of E. coli growing on LB/ampicillin solid medium was inoculated in 5 ml LB 
liquid medium supplemented with 10 μl of 100 mg/ml ampicillin solution and grown overnight 
(16–18 h) at 37 °C and 200 rpm. The stock culture was prepared in screw-capped 2 ml tubes by 
mixing 750 μl of the overnight culture with 250 μl of sterile LB/glycerol (4:6). The cultures were 
stored at -80 °C. 
3.4.2. Preparation of S. cerevisiae stock cultures 
A single colony of S. cerevisiae growing on a suitable selective solid medium was inoculated in 5 
ml of the same selective liquid medium, incubated for 24 h at 30 °C and 250 rpm. The stock culture 
was prepared in screw-capped 2 ml tubes by mixing 250 μl of the starter culture with 300 μl of 
YPD medium and 450 μl of sterile glycerol (86 %). The cultures were stored at -80 °C. 
4. Protein methods 
4.1. Protein expression in yeast 
The P450s together with CPR proteins were heterologously expressed in INVSc1 yeast cells 
according to the high density procedure described by Pompon et al. (1996). A single colony from 
the transformed yeast obtained under (III.3.3.3) was picked, inoculated in a 5 ml of synthetic 
dextrose medium (SD) and incubated at 30°C with shaking at 250 rpm for 24 h. 1 ml of the grown 
culture was transferred to 150 ml YPGE medium, grown for 28–30 h until the OD600 reached 
1.5– 1.7, protein expression was induced by the addition of 16.7 ml of 20% sterile-filtered galactose 
solution (2% final concentration) and the culture was further incubated for 14–16 h at 30°C with 
shaking at 250 rpm. 
4.2. Isolation of the microsomal fraction 
The induced yeast cells obtained as described in (III.4.1) were harvested by centrifugation at 
5000 rpm for 5 min; the supernatant was discarded while the pellet was resuspended in 10 ml of 
TEK buffer. The suspension was transferred into a 15 ml falcon tube and centrifuged at 5000 rpm 
(2900 g) for 5 min. The supernatant was discarded and the pellet was resuspended in 5 ml of TEK 
buffer, divided equally into two 15 ml falcon tubes (each contained about 4 ml) and incubated at 
room temperature for 5 min. The suspensions were centrifuged again, the supernatant was 
discarded and the pellet in each falcon tube was resuspended in 3 ml of TES buffer. 3 gm of 0.45-
mm acid-washed glass beads were added to each tube and shaken in the cold room for 20 min to 
mechanically break the yeast cells. The cracked cells were centrifuged and the supernatant was 
collected. The sediment in each tube was resuspended in 2 ml of TES buffer, centrifuged and the 
supernatant was collected. The last step was repeated once. 20 ml of TES buffer were added to the 
total collected supernatant (14 ml) and then centrifuged at 15000 rpm for 10 min to sediment nuclei 
and mitochondria. The pellet was discarded and the supernatant was centrifuged at 100000 g for 
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60 min. The supernatant was discarded and the pelleted microsomes were resuspended in 1 ml of 
TEG buffer using a Pasteur pipette and stored at -80°C. All steps for microsomal preparation were 
performed at 0–4°C. The concentration of the microsomal protein was determined as described 
in (III.4.3). 
4.3. Determination of protein concentration 
The determination of protein concentrations was performed according to Bradford (1976). The 
principle of this method is based on the shift of the absorption maximum of Coomassie Brilliant 
Blue G-250 dye from 465 to 595 nm upon binding to proteins. 
In 1.5 ml Eppendorf tubes, 2–5 μl of the protein solutions were completed to 100 μl with deionized 
water. 900 μl of Bradford solution (II.8.6) were added and mixed by flipping, followed by 
incubation for 5 min at room temperature. As the absorbance could be affected by the pH of the 
solution as well as the presence of certain salts and detergents, a blank was carried out by mixing 
900 μl of Bradford solution with 2–5 μl of the buffer in which the protein was dissolved completed 
to 100 μl of deionized water. The blank solution was used to zero the spectrophotometer and the 
absorbance at 595 nm of test solution was subsequently measured. The concentration of the protein 
was calculated according to the following equation: 
C =  
OD595
Bradford factor × V
 
Where, C is the concentration of the protein solution in μg/μl 
OD595 is the blank-normalized absorbance of the protein solution with Bradford reagent at 595 nm 
V is the volume in microliters of the protein solution measured 
The Bradford factor is calculated from the slope of the calibration curve generated by plotting the 
absorbance of different concentrations (1–10 µg/ml) of BSA solution in deionized water on the 
Y axis against the amount of BSA in micrograms on the X axis.  
4.4. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) 
It is a technique employed for the separation of proteins based on their sizes in a cross-linked 
polymer under the influence of an electric field. Under these conditions, the speed by which a 
protein migrates is directly proportional to its net charge and inversely proportional to its size. The 
anionic surfactant sodium dodecyl sulfate serves to coat all proteins uniformly with negative 
charges causing them to unfold so that the proteins migrations are exclusively dependent on their 
respective molecular weights. 
The polyacrylamide gel is divided into two parts differing in their pH and acrylamide percentage. 
The upper part (the stacking gel) has a pH of 6.8 and 5% acrylamide, while the lower part (the 
resolving or running gel) has a pH of 8.8 and 12% acrylamide. The reason for using this 
composition is to squeeze the protein bands into a very thin layer in the stacking gel before being 
separated in the resolving gel so that the separation will start at the same time for all samples. The 
main current-carrying species in SDS-PAGE are the chloride ions and the glycine molecules 
present in the electrophoresis buffer. The charge of the chloride ions is independent on the pH, 
whereas, glycine is present in a zwitterionic form at pH 6.8 while it is negatively charged at pH 8.8. 
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In the stacking gel with a pH of 6.8, the neutral glycine moves slowly behind chloride ions and the 
proteins creating a region of low conductivity (high voltage drop) causing the proteins to move 
slowly and therefore deposit as a very narrow band on top of the resolving gel. In the resolving gel 
with a pH of 8.8, both the glycine and chloride ions are negatively charged moving faster than the 
proteins which are then separated in the highly cross-linked gel according to their sizes. 
Acrylamide chains are cross linked with bisacrylamide by the action of the radical donor APS in 
the presence of TEMED which acts as a radical stabilizer. To prepare the gels, the components of 
resolving gel were mixed together in a flask, poured between the glass plates of the instrument and 
covered with a thin layer of water to avoid interaction with air. After gel solidification, the water was 
removed with a filter paper. The components of the stacking gel were then mixed and poured over the 
solidified resolving gel, a comb was added to create the sample pockets. The gel was allowed to 
solidify. The protein samples were denatured in presence of the sample buffer at 95 °C for 5 min. 
Samples were loaded on the gel and run at 200 V. The run was ended when the dye bromophenol blue 
reached the front of the gel. The gel was stained by immersing in the staining solution for 30 min with 
gentle shaking, then destained by immersing in the destaining solution overnight. 
4.5. Enzyme assays 
4.5.1. NADPH-dependent Cytochrome P450 reductase (CPR) activity assay 
The test depends on the ability of NADPH-dependent cytochrome P450 reductase to reduce 
cytochrome c. The reduced cytochrome c has a characteristic absorption maximum at 550 nm and 
can be measured spectrophotometrically (Guengerich et al., 2009). 
The components of the reaction were as follows: 
Phosphate buffer (1 M, pH 7.7) 300 μl 
Cytochrome c (1 mM, in 10 mM phosphate buffer) 40 µl 
Microsomal protein 5 μg 
NADPH (4 mM, in dH2O) 25 µl 
dH2O add to 1 ml 
The reaction was started by the addition of NADPH and the absorbance is measured at 550 nm. 
The specific activity of the CPR (μmol min−1 mg−1) could be calculated from the following 
equation: 
E = (ΔA550 × V) / (ε × t × p) 
ΔA550 : Change in the absorption at 550 nm 
ε : Absorption coefficient cytochrome c (ε = 21000 cm-1 mM-1) 
V : Reaction volume 
t : Reaction time 
p : Protein amount 
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4.5.2. Cytochrome P450 activity assay 
The standard in vitro cytochrome P450 activity assay consisted of the following: 
Phosphate buffer (1 M, pH 7.0) 20 μl 
Substrate (10 mM, in methanol) 4 μl 
Microsomal protein 50 μg 
NADPH (4 mM, in dH2O) 50 μl 
dH2O add to 200 μl 
All ingredients except for the NADPH were mixed, briefly centrifuged and the reaction was started 
by the addition of 50 μl of 4 mM NADPH solution. The reaction was incubated in a water bath for 
1 h at 30 °C. The reaction was stopped by the addition of 20 μl of 1 N HCl and was extracted 
twice, each with 250 μl ethyl acetate. The combined ethyl acetate extract was evaporated to dryness 
in a rotational vacuum concentrator at 37 °C, redissolved in 60 μl of HPLC-grade methanol, 25 μl 
of which were analyzed by HPLC-DAD or LC-MS as described in (III.5.1 and III.5.2). 
5. Analytical methods 
5.1. High performance liquid chromatography (HPLC) 
The following gradients were utilized with the VWR-Hitachi system equipped with ZORBAX 
eclipse plus C18 rapid resolution column. The mobile phases used were double distilled water 
containing 0.1 % formic acid (A) and HPLC-grade acetonitrile (C). The flow rate was 1 ml/min 
and the detection was carried out at a wavelength of 260 nm. 
Gradient 1 
Compounds analyzed 
Time % C 
0 5 2,4,6-trihydroxybenzophenone 
4 5 2,3′,4,6-tetrahydroxybenzophenone 
12 30 1,3,7-trihydroxyxanthone 
25 34 1,3,5-trihydroxyxanthone 
28 95  
33 95  
35 5  
45 5  
 
Gradient 2 
Compounds analyzed 
Time % C 
0 5 2,4-dihydroxybenzophenone 
4 5 2,3′,4-trihydroxybenzophenone 
10 30 2,2′,3,4′-tetrahydroxybenzophenone 
22 40 2,2′,4,5′-tetrahydroxybenzophenone 
26 95  
30 95  
32 5  
42 5  
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Gradient 3 
Compounds analyzed 
Time % C 
0 5 2,3′,4,4′,6-pentahydroxy-benzophenone (maclurin) 
4 5 1,3,6,7-tetrahydroxyxanthone 
12 20 1,3,5,6-tetrahydroxyxanthone 
25 27  
28 95  
33 95  
35 5  
45 5  
5.2. Liquid chromatography–Mass spectrometry (LC-MS) 
Products of 30 enzymatic incubations were purified by HPLC and corresponding peaks were 
collected as individual fractions. These fractions were directly infused into the mass spectrometer 
(3200QTrap mass spectrometer; Applied Biosystems/MDS SCIEX, Darmstadt, Germany), 
equipped with an electrospray ionization (ESI) interface (Turbo V), using the integrated syringe 
pump of the 3200 QTrap instrument (Syringe; 1000 µL, i.d. 2.3 mm; Hamilton, Nevada, USA) at 
a flow rate of 10 µL/min. The mass spectrometer was operated in the positive mode with a source 
voltage and declustering potential of 5.5 kV and 76 V, respectively. Nitrogen gas was used for 
nebulization, with the curtain gas, gas 1, and gas 2 settings at 10, 14, and 0, respectively. 
Parameters were optimized for benzophenones using standard 2,4,6- trihydroxybenzophenone and 
for xanthones using 1,3,7-trihydroxyxanthone in methanol at 10 µg/ml. The molecular ion peaks 
[M + H]+ of the products were further analyzed by MS/MS experiments in the enhanced product 
ion mode (EPI) of the instrument using nitrogen gas for collision-induced dissociation at the high-
level setting. The collision energy was 30–50 V. Data acquisition and processing were performed 
using the Analyst software (version 1.4.2; Applied Biosystems/MDS SCIEX). 
6. Bioinformatic methods 
6.1. Phylogenetic analysis 
Phylogenetic analysis of CPR as well as CYP81 sequences was performed using MEGA6 program 
(Tamura et al., 2013). The sequences were collected from public databases (II.10) together with 
the deduced amino acid sequences of the products of the cloned genes within this work and 
multiple sequence alignment was performed using ClustalW (Larkin et al., 2007). The alignment 
was used to select the best settings using the “Find Best DNA/Protein Models (ML)” tool in 
MEGA6.  
For CYP81s, the evolutionary history was inferred by using the Maximum Likelihood method 
based on the Le_Gascuel_2008 model (Le and Gascuel, 2008). The tree with the highest log 
likelihood (-15166.6046) was displayed. Initial tree(s) for the heuristic search were obtained by 
applying the Neighbor-Joining method to a matrix of pairwise distances estimated using a JTT 
model (Jones et al., 1992). A discrete Gamma distribution was used to model evolutionary rate 
differences among sites (5 categories (+G, parameter = 1.9675)). The rate variation model allowed 
for some sites to be evolutionarily invariable ([+I], 2.7835 % sites). The tree was drawn to scale, 
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with branch lengths measured in the number of substitutions per site. The analysis involved 45 
amino acid sequences. All positions containing gaps and missing data were eliminated. There were 
a total of 326 positions in the final dataset. For CPRs, the evolutionary history was inferred by 
using the Maximum Likelihood method based on the JTT matrix-based model (Jones et al., 1992). 
The tree with the highest log likelihood (- 9756.9348) was displayed. Initial tree(s) for the heuristic 
search were obtained by applying the Neighbor-Joining method to a matrix of pairwise distances 
estimated using a JTT model. A discrete Gamma distribution was used to model evolutionary rate 
differences among sites (5 categories (+G, parameter = 0.6957)). The rate variation model allowed 
for some sites to be evolutionarily invariable ([+I], 21.5937 % sites). The tree is drawn to scale, 
with branch lengths measured in the number of substitutions per site. The analysis involved 20 
amino acid sequences. All positions containing gaps and missing data were eliminated. There were 
a total of 599 positions in the final dataset. The percentage of trees in which the associated taxa 
clustered together is (bootstrap values of 1000 replicates) were indicated for each node. 
6.2. Homology modeling  
The HHpred server (Soding et al., 2005) was used to identify homologous CYP X-ray crystal 
structures as 3D-templates for comparative modeling utilizing the software Modeler (Sali and 
Blundell, 1993). The identified homologous template structures were all in the low sequence 
identity range (between 20-25 % sequence identity) and an alternative homology modeling attempt 
using YASARA Structure 14.7.17 was used to identify the most suitable template structures by 
another independent method (Krieger et al., 2003; Krieger and Vriend, 2014). Structures from two 
matching CYP-families were identified by sequence search using Psi-BLAST (Altschul et al., 
1997) and Psi-Pred secondary structure prediction employing position specific patterns (Jones, 
1999). The generated homology models were refined using MD-simulations with the YAMBER 
(Krieger et al., 2009) force field and ranked according to knowledge-based structural descriptors 
as implemented in YASARA. The best scoring structures were obtained using the X-ray crystal 
structure from eukaryotic CYP2B4 (Gay et al., 2010) in the closed conformation with the bound 
inhibitor ticlopidine (PDB: 3kw4) as template. In the alignment, 400 of 508 target residues 
(78.7 %) are aligned to template residues of HpCYP81AA1. Among these aligned residues, the 
sequence identity is 30.8 % and the sequence similarity is 48.0 % ('similar' means that the 
BLOSUM62 score is > 0). A second reference structure showing good scores was human 
CYP17A1 (steroid 17-alpha-hydroxylase) in closed conformation with bound substrate mimetic. 
In the alignment, 378 of 508 target residues (74.4 %) are aligned to template residues of 
HpCYP81AA1. Among these aligned residues, the sequence identity was 27.8 % and the sequence 
similarity was 47.4 % ('similar' means that the BLOSUM62 score is > 0). This model structure 
based on CYP17A1 showed a different orientation of the C-terminal beta-loop (SRS-6) and the 
adjacent α-helix containing SRS-2 and it was crystallized in the dimeric form. The final 3D-models 
of HpCYP81AA1 and HpCYP81AA2 were generated from a hybrid model using the three best 
matching template structures: 3kw4 (CYP2B4), 3swz (CYP17A1), 3qz1 (steroid 21-hydroxylase) 
and 2hi4 (CYP1A2).  
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6.3. Product docking 
The model structures of HpCYP81AA1 and HpCYP81AA2 were overlaid by MUSTANG 
(Konagurthu et al., 2006) with heme and the ticlopidine inhibitor bound structure (PDB: 3kw4) 
using YASARA Structure Ver. 14.7.17. The initial binding mode of the respective products (1,3,5-
triHX and 1,3,7-triHX) was introduced into the apo-model structures. Based on this initial product 
bound model, the binding mode was manually built and energy minimized using YASARA 
(Krieger et al., 2004). To remove bumps and correct the covalent geometry, first a short steepest 
descent minimization was performed. After removal of conformational stress, the procedure was 
continued by simulated annealing (timestep 2 fs, atom velocities scaled down by 0.9 every 10th 
step) until convergence was reached, i.e. the energy improved by less than 0.05 kJ/mol per atom 
during 200 steps using the AMBER03 (Duan et al., 2003) force field for protein residues and the 
general amber force field GAFF (Wang et al., 2004). AM1BCC (Jakalian et al., 2002) calculated 
partial charges and a force cutoff of 0.786 Å and particle mesh Ewald for exact treatment of long 
range electrostatics by periodic boundary conditions were employed. The same procedure was 
applied to the active site mutation S375A/L378S/A483T/M486L/K488R/N489K (mut6). 
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IV. Results 
1. Bioinformatic analysis of Hypericum calycinum SSH library 
Yeast extract-treated H. calycinum cell cultures synthesize a 1,3,7-trihydroxyxanthone derivative 
known as hyperxanthone E (Figure IV-1) which is not detectable in untreated cultures. These 
conditions were utilized to construct a suppression subtractive hybridization (SSH) cDNA library, 
where mRNA pools were isolated from elicitor-treated and non-treated cell cultures, converted 
into cDNA pools and used for subtraction, resulting in a high enrichment of those mRNAs/cDNAs 
which are elicitor-induced (Gaid et al., 2012). 
 
Figure IV-1. Proposed biosynthetic pathway of hyperxanthone E in H. calycinum cell cultures. PAL is phenylalanine 
ammonia lyase, BPS is benzophenone synthase, B3′H is benzophenone 3′ hydroxylase, 1,3,7-TXS is 1,3,7-
trihydroxyxanthone synthase, X6H is xanthone 6 hydroxylase, PT is prenyltransferase. 
A portion of the SSH library was sequenced and 2005 clones were bioinformatically processed, 
assembled into 277 contigs using CAP3 program (Huang and Madan, 1999) and functionally 
annotated using Blast2GO program (Conesa et al., 2005). Contigs annotated to encode CYPs were 
individually blasted against the non-redundant protein database (NR) of NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). When showing E-values lower than (1.0 E-6) with one or 
more CYP sequences in the database, contigs were collected and the subfamily of the closest 
classified CYP as well as the number of copies per contig (retrieved from CAP3 output) were 
listed in Table IV-1. Moreover, the contigs encoding CYPs were blasted against H. perforatum 
MPGR trascriptome database (http://medicinalplantgenomics.msu.edu/mpgr_blast.shtml). For 
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each contig, the percentage identity with the closest locus was also listed in Table IV-1. The 
assembled contigs represented candidate CYP cDNA fragments that encoded proteins belonging 
to the CYP71, CYP72, CYP81 and CYP706 families. Most transcripts coded for members of the 
CYP81 and CYP72 families. CYP81 family proteins belong to the CYP71 clan, whose members 
are known to catalyze various reactions in the shikimate pathway. On the other hand, CYP72 
family proteins belong to the CYP72 clan, whose members are mainly recruited for modification 
of isoprenoids (Nelson et al., 2004). 
Table IV-1. CYP contigs identified in a H. calycinum subtracted cDNA library. 
Contig number Number of copies Closest NCBI match 
Closest MPGRa match 
(% identity) 
21 22 CYP81C hpa_locus_416 (95.0) 
41 7 CYP81C hpa_locus_416 (91.6) 
50 11 CYP81C hpa_locus_416 (97.2) 
56 2 CYP71A hpa_locus_18081 (98.2) 
59 33 CYP81C hpa_locus_416 (97.3) 
62 36 CYP72A hpa_locus_60 (78.2) 
86 3 CYP81D hpa_locus_12223 (70.8) 
103 2 CYP81C hpa_locus_416 (97.4) 
110 3 CYP81C hpa_locus_416 (97.2) 
158 2 CYP706 hpa_locus_19031 (81.9) 
181 3 CYP706 hpa_locus_19031 (82.2) 
199 3 CYP81D hpa_locus_13843 (89.7) 
219 5 CYP81C hpa_locus_416 (92.0) 
a Medicinal Plant Genomics Resource (http://medicinalplantgenomics.msu.edu) 
2. Cloning of full-length HcCYP81AA1 cDNA 
2.1. Amplification of the core fragment 
Among the overexpressed genes in the SSH library, CYP81 candidates were particularly encoded 
by several contigs, of which contigs 21 and 59 were represented by 22 and 33 copies, respectively 
(Table IV-1). These copy numbers were significantly higher than those for any other CYP that 
belonged to the shikimate metabolizing CYP71 clan present in the library, indicating the high 
inducibility upon elicitation. Contigs 21 and 59 shared 95.0 and 97.3% amino acid sequence 
identity, respectively, with the predicted peptide sequence of hpa_locus_416 from the MPGR 
H. perforatum transcriptome, suggesting that they belong to the same sequence. To test this 
hypothesis, a forward primer from the upstream contig 59 (Conig59-F1) and a reverse primer from 
the downstream contig 21 (Contig21-R1) were used and a core fragment of 1075 bp was amplified, 
confirming that both contigs belonged to the same sequence (Figure IV-2). The amplified core 
fragment lacked stretches of 204 bp toward the start codon and 248 bp toward the stop codon. The 
missing parts were obtained through Rapid amplification of cDNA ends (RACE), as described 
subsequently. 
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Figure IV-2. Schematic representation of the relative positions of contigs and primers used for the cloning of the full-
length cDNA encoding HcCYP81AA1. The contigs obtained from the SSH library are shown in red, the missing parts 
of the ORF in grey and the UTRs in orange. The primers used to amplify the core fragment are shown in blue, those 
used for 3′-RACE in green and those employed for 5′-RACE in brown. 
2.2. Rapid amplification of cDNA ends (RACE) 
Two forward primers (CYP81-3RACE1 and CYP81-3RACE2) were designed based on the 
sequence of the amplified core fragment. They were used to amplify the remaining 3′ stretch 
towards the stop codon, in addition to the 3′-UTR and polyA tail by 3′-RACE technique, as 
previously described (III.2.6.1). Likewise, two reverse primers (CYP81-5RACE1 and CYP81-
5RACE2) were designed and the downstream primer (CYP81-5RACE1) was used for transcript-
specific reverse transcription. The remaining 5′ stretch together with the 5′-UTR was amplified by 
5′-RACE technique, as previously described (III.2.6.3) (Figure IV-2). 
The complete cDNA comprised 1830 bp, of which 1527 bp constituted the ORF, 89 bp the 5′- UTR, 
185 bp the 3′-UTR and 29 bp the polyA tail. The predicted protein product consisted of 508 aa 
with a predicted molecular mass of 57.1 kDa and a pI of 8.16. The deduced amino acid sequence 
shared 41 % identity with CYP81K1 from Arabidopsis thaliana (NP_196623.1), 45 % with 
CYP81W1 from Vitis vinifera (XP_002285066.1), and 52 % with CYP81C3 from Populus 
trichocarpa (XP_006374861.1), all of which have not been functionally characterized. The protein 
sequence was submitted to the cytochrome P450 nomenclature committee and was given the name 
CYP81AA1 (Nelson, 2006). The enzyme constituted a new CYP81 subfamily. 
3. Cloning of full-length NADPH-cytochrome P450 reductase HcCPR cDNA 
The activity of most eukaryotic cytochrome P450 enzymes requires the presence of NADPH-
cytochrome P450 reductase (CPR) as a redox partner. CPR receives two electrons from NADPH 
and transfers them one at a time to the CYP in the course of the catalytic cycle (Jensen and Moller, 
2010). Therefore, a full-length CPR transcript from H. calycinum cell culture was also cloned. 
3.1. Identification of a candidate CPR fragment from the SSH library 
In order to identify a core fragment encoding CPR from the SSH library, the TBLASTN algorithm 
in NCBI (Gertz et al., 2006) was utilized. All ESTs in the library were queried against the amino 
acid sequence of NADPH-cytochrome P450 reductase 1 from Arabidopsis thaliana (AtCPR1) 
(Mizutani and Ohta, 1998) and the results were ordered according to the calculated maximum 
score. Only two ESTs that belong to a single contig were identified, they shared about 80 % 
identity with the amino acid sequence of AtCPR1 (Figure IV-3). Therefore, this sequence was 
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used as a core fragment to clone a full-length CPR transcript from H. calycinum. This core 
fragment lacked 1707 and 244 bp toward the start and stop codons, respectively. 
 
Figure IV-3. Representation of TBLASTN result from the alignment of AtCPR1 protein sequence (NP_194183.1) 
against the translated nucleotide sequences of all 2005 ESTs from the SSH library, showing in purple the two ESTs 
that represent the HcCPR2 core fragment. The upper color key represents the alignment score. 
3.2. Extension of the CPR core fragment in the 3′ direction 
Two forward primers (CPR-3RACE1 and CPR-3RACE2) were designed based on the sequence 
of the identified core fragment. They were used to amplify by the 3′-RACE technique (III.2.6.1) 
the remaining 244 bp towards the stop codon, in addition to 309 bp 3′-UTR and 34 bp polyA tail 
(Figure IV-4).  
 
Figure IV-4. Schematic representation of the relative positions of the CPR core fragment and the primers used for the 
cloning of full-length HcCPR2 cDNA. The core fragment obtained from the SSH library is shown in red, the missing 
parts of the ORF in grey, the UTRs in orange. The primers used to extend the core fragment towards the 5′-end are 
shown in blue, those used for 3′-RACE in green and those used for 5′-RACE in brown.  
3.3. Extension of the CPR core fragment in the 5′ direction 
The identified CPR core fragment lacked 1707 bp towards the start codon. Initial trials to extend 
it by 5′-RACE (III.2.6.2 or III.2.6.3) were not successful. Therefore, we searched for an upstream 
conserved region to design a degenerate primer that could be used for partial extension of the 
fragment into the 5′ direction. Multiple alignment of the nucleotide sequences of 20 plant CPRs 
collected from the NCBI database was created using ClustalW (Thompson et al., 1994). An 
upstream forward degenerate primer for CPRs was designed based on the sequence of the 
conserved FMN binding domain observed in the alignment (Figure IV-5). Standard PCR utilizing 
the designed degenerate primer (CPR-dpF-1) with a reverse gene-specific primer (CPR-R1) and 
5′ RACE-ready cDNA as a template led to extension of the core fragment 1362 bp in the 
5′ direction (Figure IV-4).  
Subsequently, two reverse primers (CPR-5RACE1 and CPR-5RACE2) were designed based on 
the sequence of the extended fragment. The CPR-5RACE1 primer was used for CPR transcript-
specific reverse transcription and the remaining 5′ stretch together with the 5′-UTR was amplified 
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by 5′-RACE (III.2.6.3). The complete cDNA comprised 2599 bp, of which 2139 bp constituted 
the ORF, 117 bp the 5′-UTR, 309 bp the 3′-UTR and 34 bp the polyA tail. The predicted protein 
product consisted of 712 aa with a predicted molecular mass of 78.7 kDa and a pI of 5.39. The 
deduced amino acid sequence shared 75, 79.1 and 79.2% identity with the CPR2 enzymes from 
Arabidopsis thaliana (Mizutani and Ohta, 1998), Gossypium hirsutum (Yang et al., 2010), and 
Populus trichocarpa (Ro et al., 2002), respectively. 
 
Figure IV-5. Multiple sequence alignment of the nucleotide sequences corresponding to FMN binding domains of 20 
plant CPRs for designing the upstream degenerate primer (CPR-dpF-1), which was used to extend the CPR core 
fragment in the 5′ direction. The colored bars represent consensus strength. Ammi majus CPR2 (AY532374.1), 
Arabidopsis thaliana CPR1 (NM_118585.3), A. thaliana CPR2 (NM_179141.2), Artemisia annua CPR2 
(DQ984181.1), Centaurium erythraea CPR1 (AY596976.1), Glycine max CPR1 (NM_001249813.1), Gossypium 
hirsutum CPR1 (FJ719368.1), G. hirsutum CPR2 (FJ719369.1), Hypericum androsaemum CPR1 (AY520902.1), 
Lotus japonicus CPR2 (AB433810.1), Medicago truncatula CPR2 (XM_003610061.1), Papaver somniferum CPR1 
(U67185.1), Petunia x hybrida CPR2 (DQ099545.1), Populus trichocarpa CPR1 (XM_002307300.2), P. trichocarpa 
CPR2 (AF302497.1), P. trichocarpa CPR3 (AF302498.1), Triticum aestivum CPR2 (AJ303373.1), Zea mays CPR2 
(AJ303373.1), Zingiber officinale CPR1 (AB566408.1), Z. officinale CPR2 (AB566409.1). 
4. Analysis of the HcCPR2 amino acid sequence 
The deduced amino acid sequence of HcCPR2 was aligned with the CPR homologs from 
Arabidopsis thaliana (AtCPR1 and 2) and Gossypium hirsutum (GhCPR1 and 2) (Figure IV-6). 
All conserved functional domains characteristic for CPRs, which included FMN-, FAD-, NADPH- 
and P450-binding domains, were identified in HcCPR2 (Figure IV-6). An N-terminal 
hydrophobic domain spanning the region between amino acids 50-70 was also identified. It acts 
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as a membrane anchor attaching HcCPR2 to the endoplasmic reticulum, as previously proposed 
for other CPRs (Mizutani and Ohta, 1998; Yang et al., 2010). 
 
Figure IV-6. Multiple sequence alignment of the deduced amino acid sequence of HcCPR2 with Arabidopsis and 
Gossypium CPR homologs showing the common conserved domains characteristic for CPRs. Conserved amino acid 
residues in all five CPRs are shown in white on a red background. 
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5. Functional characterization of HcCPR2 in yeast cells 
5.1. Construction of the expression plasmid and protein expression 
For functional expression, the HcCPR2 ORF was amplified with a proofreading polymerase using 
yeast-elicited H. calycinum cDNA as a template (Figure IV-7a) and cloned between BamHI and 
HindIII restriction sites in multiple cloning site 2 (MCS2) of the pESC-URA vector 
(Figure IV-7b), as described under (III.2.3). The constructed plasmid was transformed into 
INVSc1 yeast cells (III.3.3.3) and transcription was commenced under the effect of GAL1 
promoter as described under (III.4.1). The crude microsomal fraction was isolated (III.4.2) and 
used for enzymatic incubations.  
 
  
Figure IV-7. (a) Amplification of full-length HcCPR2 with a proofreading polymerase. (b) Construction of the pESC-
URA:HcCPR2 plasmid by cloning the HcCPR2 ORF in MCS2 of the pESC-URA yeast expression vector. 
5.2. Reduction of cytochrome c (Cyt c) 
The activity of HcCPR2 was examined through its ability to transfer electrons from NADPH to 
Cyt c as described in III.4.5.1. HcCPR2 reduced cytochrome c, as shown by the increase of 
absorbance at 550 nm directly after the addition of NADPH (Figure IV-8). By measuring the 
reaction rates at various Cyt c concentrations ranging from 1– 300 µM, the Km value for HcCPR2 
a 
b 
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with cytochrome c was determined to be 35.1 ± 5.7 µM (Figure IV-9a). Similarly, the reaction 
rates were measured at various NADPH concentrations ranging from 5–500 µM and the Km value 
was determined to be 43.9 ± 6.5 µM (Figure IV-9b). Therefore, this enzyme could be used as a 
redox partner for the cloned CYP. 
 
 
a 
 
b 
 
 
Figure IV-9. Michaelis-Menten hyperbolic regression curves for the determination of Km values of HcCPR2 with 
(a) cytochrome c and (b) NADPH. 
 
6. Functional characterization of HcCYP81AA1 
6.1. Construction of the expression plasmid and protein expression 
The HcCYP81AA1 ORF was amplified with a proofreading polymerase from the cDNA obtained 
from yeast-treated H. calycinum cell culture (Figure IV-10a) and cloned between EcoRI and PacI 
restriction sites in MCS1 of the pESC-URA:HcCPR2 plasmid (Figure IV-10b), as described 
in III.2.3. The constructed expression plasmid containing both ORFs encoding HcCYP81AA1 and 
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Figure IV-8. Cyt c reduction assay showing 
increased absorbance at 550 nm upon addition of 
NADPH. 
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HcCPR2 was transferred into INVSc1 yeast cells as described in III.3.3.3. Co-expression of 
HcCYP81AA1 and HcCPR2 was induced under the effect of GAL10 and GAL1 promoters, 
respectively. The microsomal fraction was isolated (III.4.2) and used for enzymatic incubations. 
 
 
Figure IV-10. (a) Amplification of full-length HcCYP81AA1 with a proofreading polymerase. (b) Construction of 
the pESC-URA:HcCYP81AA1/HcCPR2 plasmid by cloning the HcCYP81AA1 ORF in MCS1 of the pESC-
URA:HcCPR2 plasmid. 
 
6.2. Enzymatic activities of HcCYP81AA1 
The isolated yeast microsomes expressing both HcCYP81AA1 and HcCPR2 were incubated with 
eleven potential benzophenone and xanthone substrates (Figure IV-11) in the presence of NADPH 
(III.4.5.2). The products formed were analyzed by HPLC-DAD and LC-MS (III.5.1, III.5.2).  
a 
b 
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Figure IV-11. Potential benzophenone and xanthone substrates. 
Incubation with 2,3′,4,6-tetrahydroxybenzophenone (2,3′,4,6-tetraHB) resulted in the formation of 
a single product (Rt 19.6 min) (Figure IV-12a). This product was identified as 
1,3,7- trihydroxyxanthone (1,3,7-triHX). Its UV spectrum showed four characteristic absorption 
maxima at 234, 257, 309 and 374 nm, which matched those of authentic 1,3,7-triHX 
(Figure IV-12b). In addition, its MS spectrum showed a molecular ion peak at m/z 245 equivalent 
to [M + H]+ of trihydroxylated xanthones (Figure IV-12c) and the fragmentation pattern agreed 
with that of the reference compound. 
 
Figure IV-12. Incubation of the microsomes containing HcCYP81AA1 and HcCPR2 with 2,3′,4,6-tetraHB. 
(a) Stacked HPLC-DAD chromatograms for incubation, standard, and negative control; S stands for the substrate 
peak. (b) UV spectra of the enzymatic product and standard. (c) EPI mass spectrum of the enzymatic product. 
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Incubation with 2,4,6-trihydroxybenzophenone (2,4,6-triHB) led to the formation of two products 
with Rt values of 15.1 and 19.6 min, respectively (Figure IV-13a). The product with Rt 19.6 min 
was identified as 1,3,7-triHX, as described in the previous incubation. The product with Rt 
15.1 min was identified as 2,3′,4,6-tetraHB by its UV and MS spectra. The UV spectrum matched 
that of authentic 2,3′,4,6-tetraHB and showed absorption maxima at 205, 258 and 305 nm 
(Figure IV-13b). EPI-MS revealed a molecular ion peak at m/z 247 equivalent to [M + H]+ of 
tetrahydroxylated benzophenones. Beside the molecular ion peak, two other prominent peaks were 
identified (m/z 121 and 153). They correspond to the ions resulting from breaking the bond at 
either side of the carbonyl group, thereby confirming the presence of three hydroxyl groups on the 
first aromatic ring (m/z 153) and one hydroxyl group on the second ring (m/z 121) of the 
benzophenone skeleton (Figure IV-13c). 
 
 
Figure IV-13. Incubation of the microsomes containing HcCYP81AA1 and HcCPR2 with 2,4,6-triHB. (a) Stacked 
HPLC-DAD chromatograms for incubation, standards and negative control; S stands for the substrate peak. 
(b) UV spectra of the enzymatic products and standards. (c) EPI mass spectra of the enzymatic products. 
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Similarly, incubation with 2,4-dihydroxybenzophenone (2,4-diHB) yielded two products with Rt 
values of 13.7 and 17.1 min, respectively (Figure IV-14a). The product with Rt 13.7 min was 
identified as 2,2′,4,5′-tetrahydroxybenzophenone (2,2′,4,5′-tetraHB) by its UV and MS spectra. 
The UV spectrum matched that of authentic 2,2′,4,5′-tetraHB and showed absorption maxima at 
215 and 282 nm (Figure IV-14b). EPI-MS revealed a molecular ion peak at m/z 247 equivalent 
to [M + H]+ of tetrahydroxylated benzophenones. Beside the molecular ion peak, only one 
prominent peak was identified in the mass spectrum (m/z 137). It corresponds to the ions resulting 
from breaking the bond at either side of the carbonyl group, thereby confirming the presence of 
two hydroxyl groups on each aromatic ring of the benzophenone skeleton (Figure IV-14c).The Rt 
17.1 product was tentatively identified by MS as 2,3′,4-trihydroxybenzophenone (2,3′,4-triHB), as 
a standard was not available. EPI-MS revealed a molecular ion peak at m/z 231 equivalent to 
[M + H]+ of trihydroxylated benzophenones. The fragmentation pattern confirms the presence of 
two hydroxyl groups on the first aromatic ring (m/z 137) and one hydroxyl group on the second 
ring (m/z 121) of the benzophenone skeleton (Figure IV-14c). 
 
 
Figure IV-14. Incubation of the microsomes containing HcCYP81AA1 and HcCPR2 with 2,4-diHB. (a) Stacked 
HPLC-DAD chromatograms for the incubation, the available standard and the negative control; S stands for the 
substrate peak. (b) UV spectra of the enzymatic products and available standard. (c) EPI mass spectra of the enzymatic 
products. 
 
  Results 
71 
 
Incubation with 2,3′,4,4′,6-pentahydroxybenzophenone (2,3′,4,4′,6-pentaHB, maclurin) yielded a 
single product (Rt 22.4 min) (Figure IV-15a). This compound was identified as 1,3,6,7-
tetrahydroxyxanthone (1,3,6,7-tetraHX, norathyriol) by its UV spectrum, which showed four 
characteristic absorption maxima at 236, 253, 314 and 363 nm matching those of authentic 1,3,6,7-
tetraHX (Figure IV-15b). In addition, the MS spectrum showed a molecular ion peak at m/z 261 
equivalent to [M + H]+ of tetrahydroxylated xanthones (Figure IV-15c), the fragmentation pattern 
agreeing with that of the reference compound. Traces of 1,3,6,7-tetraHX were  also detected in the 
negative control. The presence of 1,3,6,7-tetraHX as a natural contaminant in 2,3′,4,4′,6-pentaHB 
samples was previously described (Jefferson and Scheinmann, 1965).  
 
 
Figure IV-15. Incubation of the microsomes containing HcCYP81AA1 and HcCPR2 with 2,3′,4,4′,6-pentaHB. 
(a) Stacked HPLC-DAD chromatograms for incubation, standard and negative control; S stands for the substrate peak. 
(b) UV spectra of the enzymatic product and standard. (c) EPI mass spectrum of the enzymatic product. 
 
For all substrates, no enzymatic products were detectable in assays lacking NADPH. Likewise, 
microsomes from yeast cells harboring the empty plasmid failed to produce any of the products. 
No activity was detectable with 2-hydroxybenzophenone (2-HB), 4-hydroxybenzophenone 
(4- HB), 1,3-dihydroxyxanthone (1,3-diHX), 1,3,7-trihydroxyxanthone (1,3,7-triHX), 1,3,5-
trihydroxyxanthone (1,3,5-triHX), 1,3,5,6-tetrahydroxyxanthone (1,3,5,6-tetraHX) and 1,3,6,7-
tetraHX. 
In conclusion, activity was detected with four benzophenones of the eleven benzophenone and 
xanthone substrates tested (Table IV-2). Accordingly, HcCYP81AA1 was identified as a 
bifunctional enzyme possessing both benzophenone 3′-hydroxylase (B3′H) and 1,3,7-
trihydroxyxanthone synthase (1,3,7-TXS) activities. 
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Table IV-2. Summary of the enzymatic activities of HcCYP81AA1. 
Substrate Product(s) 
 
2,3′,4,6-tetraHB 
 
1,3,7-triHX 
 
2,4,6-triHB 
 
2,3′,4,6-tetraHB 
 
1,3,7-triHX 
 
2,4-diHB 
 
2,3′,4-triHB 
 
2,2′,4,5′-tetraHB 
 
2,3′,4,4′,6-pentaHB 
 
1,3,6,7-tetraHX 
2-HB No product detected 
4-HB No product detected 
1,3-diHX No product detected 
1,3,7-triHX No product detected 
1,3,5-triHX No product detected 
1,3,6,7-tetraHX No product detected 
1,3,5,6-tetraHX No product detected 
 
6.3. Improvement of incubation conditions 
6.3.1. Effect of pH and temperature 
The pH value of the surrounding solution affects the protein folding through changing the degree 
of ionization of its acidic and basic amino acid residues. Therefore, enzymes are usually active 
within a limited range of pH values with highest activity achieved at the optimum pH. Likewise, 
the enzyme activity increases with increasing incubation temperature until a certain limit where 
the hydrogen bonds start to break, leading to disruption of the tertiary and quaternary structures; 
the enzyme starts to denature. 
2,3′,4,6-TetraHB was used as a substrate to determine the optimal pH and temperature for 
HcCYP81AA1. The optimum pH was 7.0 with loss of 46.7 and 30.7 % activity at pH 6.5 and 7.5, 
respectively (Figure IV-16a). The optimum temperature was 30 °C with loss of 18.3 and 24.3 % 
activity at 25 and 35 °C, respectively (Figure IV-16b). 
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a 
 
b 
 
Figure IV-16. Effect of pH and temperature on the activity of HcCYP81AA1. Data represent means ± s.d. (n = 3). 
6.3.2. Effect of incubation time and protein amount 
The accumulation of 1,3,7-triHX upon incubation with 2,3′,4,6-tetraHB increased over the period 
of 120 min tested. However, the product formation rate was linear only within the first 15 min of 
incubation (Figure IV-17a). With increasing protein amounts, product accumulation was linear 
over the whole range tested, i.e. between 6 – 96 μg microsomal proteins in the standard assay 
(Figure IV-17b). 
a 
 
b 
 
Figure IV-17. Effect of incubation time and protein amount on the activity of HcCYP81AA1. Data represent 
means ± s.d. (n = 3). 
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7. Elicitor-induced expression of HcCYP81AA1 in H. calycinum cell cultures 
The expression profiles of HcBPS, HcCPR2 and HcCYP81AA1 were analyzed by quantitative real-
time RT-PCR. RNA was isolated from untreated H. calycinum cell cultures (0 h) as well as 4, 8, 
12, 16, 20, 24, 36 and 48 h after elicitation with 3 g/l of yeast extract. The purity of the isolated 
RNA was checked by measuring the A260/A280 ratio. All samples showed a ratio of ~2.1 
indicating pure RNA. Moreover, the integrity of the isolated RNA samples was verified using 
agarose gel electrophoresis. Two distinct bands corresponding to 28S and 18S rRNA were 
observed with an approximate 28S:18S ratio of 2:1 (Figure IV-18). 
 
Figure IV-18. Agarose gel-electrophoresis of 3 µg each of the RNA samples used for real-time qRT-PCR. 
Primer pairs were designed to amplify fragments of 75–150 bp from the genes under investigation 
as well as the reference genes using Beacon Designer™ software (PREMIER biosoft, California, 
USA) and were rechecked with Primer 3.0 software (http://primer3.ut.ee/). Before carrying out the 
expression analysis experiment, the amplification efficiencies of the designed primers were first 
determined from the slope of the standard curve based on the Cq values of a serial dilution of the 
pooled cDNA from each time point. The equation E=10(-1/slope) was used to calculate the 
efficiencies, while the efficiency in percentage was equal to (E - 1) x 100 (Pfaffl, 2001). All 
designed primers had an efficiency in the range of 90–110 % (Table IV-3).  
Table IV-3. Amplification efficiency of qPCR with the targets studied. 
Target name Efficiency percentage R2 value Standard curve slope 
HcCYP81AA1 91.5 % 0.998 -3.544 
HcBPS 93.2 % 0.999 -3.497 
HcCPR2 99.0 % 0.997 -3.346 
Actin 100.3 % 0.999 -3.315 
Histone H2A 100.9 % 0.998 -3.299 
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Furthermore, the specificity of each primer pair was checked from the melt curve and by running 
the final amplification products on a 2 % agarose gel, where a single band was observed in every 
reaction. No amplification was found with the no-template controls (NTC) and the no-reverse 
transcription controls (NRT). Actin and Histone H2A served as reference genes 
The qRT-PCR results show that all the tested genes had similar expression profiles. Their 
transcripts levels increased rapidly reaching a maximum at 8 h post-elicitation and decreased 
afterwards. The increase in HcBPS and HcCPR2 transcription levels did not exceed 8-fold, while 
expression of HcCYP81AA1 was more strongly induced reaching about 16-fold (Figure IV-19). 
These expression profiles come in accordance with the previously published data for 
hyperxanthone E accumulation in yeast-treated H. calycinum cell cultures (Gaid et al., 2012), 
where the product accumulated in the range between 12–24 h after elicitation. The phenylalanine 
ammonia-lysae (PAL) and cinnamate:CoA ligase (CNL) genes responsible for upstream steps in 
xanthone biosynthesis followed the same expression profile (Gaid et al., 2012).  
 
Figure IV-19. Changes in the transcript levels of HcBPS, HcCPR2 and HcCYP81AA1 in elicitor-treated H. calycinum 
cell cultures relative to those in untreated control cultures. Relative normalized expression was determined by qRT-
PCR using Actin and Histone H2A as reference genes. Data represent means ± s.e.m (n = 3). 
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8. Identification of HcCYP81AA1 homologs in transcriptomes of H. perforatum 
H. perforatum was reported to synthesize both 1,3,7- and 1,3,5-triHX derivatives (Crockett et al., 
2011; Tocci et al., 2011), indicating occurrence of 1,3,7-TXS and 1,3,5-TXS genes. The 
HcCYP81AA1 sequence was used to search for homologs in the MPGR databank 
(http://medicinalplantgenomics.msu.edu/). Four closely related CYP loci (416, 928, 8128 and 
51544) were identified, which shared 95.3, 70.6, 66.4 and 67.0% amino acid sequence identity 
with HcCYP81AA1, respectively. The locus 51544 lacked about 430 bp toward the stop codon. 
All trials to complete the sequence failed, suggesting a pseudogene. Notably, expression of this 
gene was low in all organs studied, as indicated by the ′fragments per kilobase per million mapped 
fragments′ (FPKM) values, which are available in the MPGR database. In contrast, the other three 
loci existed as full-length sequences in the database. The FPKM values of the loci 416 and 928 
indicated preferential expression in roots and leaves, which resembles the tissue distribution 
pattern of BPS transcripts (locus 13339) (Figure IV-20). In contrast, transcripts encoded by locus 
8128 were more abundant in flower organs. 
 
Figure IV-20. Tissue distribution of transcripts encoded by the loci 13339 (HpBPS), 416 (HpCYP81AA1), 928 
(HpCYP81AA2) and 8128 (HpCYP81AA3). Data are taken from the MPGR database 
(http://medicinalplantgenomics.msu.edu). FPKM, fragments per kilobase per million mapped fragments. 
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9. Functional characterization of locus 416 from H. perforatum transcriptome 
9.1. Construction of the expression plasmid and protein expression 
Primers were designed based on the sequence of ‘hpa_locus_416_iso_3_len_1885_ver_2’ from 
the MPGR databank. The cDNA obtained from H. perforatum mid-aged leaves was used as a 
template to amplify the ORF of locus 416 with a proofreading polymerase (Figure IV-21). It was 
subsequently cloned between SpeI and PacI restriction sites in MCS1 of the pESC-URA:HcCPR2 
plasmid as described in III.2.3. The deduced amino acid sequence of locus 416 was referred to as 
HpCYP81AA1, an ortholog of H. calycinum 1,3,7-TXS. The two proteins differed in only 24 
amino acids. The constructed expression plasmid containing both ORFs encoding HpCYP81AA1 
and HcCPR2 was transferred into INVSc1 yeast cells as described in III.3.3.3. After induction of 
co-expression, the microsomal fraction was isolated (III.4.2) and used for enzymatic incubations. 
 
9.2. Enzymatic activities of HpCYP81AA1 (locus 416) 
The isolated yeast microsomes containing both HpCYP81AA1 and HcCPR2 were incubated with 
the above-mentioned list of potential benzophenone and xanthone substrates (Figure IV-11) in the 
presence of NADPH and the products formed were analyzed by HPLC-DAD and LC-MS. The 
activity profile of this enzyme resembled that of HcCYP81AA1 as a bifunctional enzyme 
possessing both B3′H and 1,3,7-TXS activities (Table IV-4).  
Table IV-4. Summary of the enzymatic activities of HpCYP81AA1. 
Substrate Product(s) 
2,3′,4,6-tetraHB 1,3,7-triHX 
2,4,6-triHB 2,3′,4,6-tetraHB 1,3,7-triHX 
2,4-diHB 2,3′,4-triHB 2,2′,4,5′-tetraHB 
2,3′,4,4′,6-pentaHB 1,3,6,7-tetraHX 
2-HB No product detected 
4-HB No product detected 
1,3-diHX No product detected 
1,3,7-triHX No product detected 
1,3,5-triHX No product detected 
1,3,6,7-tetraHX No product detected 
1,3,5,6-tetraHX No product detected 
Figure IV-21. Amplification of the full-length HpCYP81AA1 cds 
(locus 416) from H. perforatum cDNA using a proofreading polymerase.  
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10. Functional characterization of locus 928 from H. perforatum transcriptome 
10.1. Construction of the expression plasmid and protein expression 
Similar to the previous locus, primers were designed according to the sequence 
‘hpa_locus_928_iso_9_len_1841_ver_2’ from the MPGR databank. The cDNA obtained from 
H. perforatum mid-aged leaves was used as a template to amplify the ORF of locus 928 with a 
proofreading polymerase (Figure IV-22). It was subsequently cloned between EcoRI and PacI 
restriction sites in MCS1 of the pESC-URA:HcCPR2 plasmid (III.2.3). The enzyme encoded by 
the ORF of locus 928 was designated by the Cytochrome P450 Nomenclature Committee (Nelson, 
2006) as HpCYP81AA2, a paralog of CYP81AA1. The constructed expression plasmid (pESC-
URA:HpCYP81AA2/HcCPR2) was transferred into INVSc1 yeast cells (III.3.3.3). Following 
induction of co-expression, the microsomal fraction was isolated (III.4.2) and used for enzymatic 
incubations. 
 
10.2. Enzymatic activities of HpCYP81AA2 (locus 928) 
Incubation of the microsomes containing HpCYP81AA2 with 2,3′,4,6-tetraHB resulted in the 
formation of one major and two minor products (Figure IV-23a). The major one with Rt 20.9 min 
represented 79.8 ± 1.1 % of the total product amount and was identified as 
1,3,5- trihydroxyxanthone (1,3,5-triHX) by its UV spectrum, which showed three absorption 
maxima at 217, 245 and 313 nm matching those of authentic 1,3,5-triHX (Figure IV-23b). In 
addition, its MS spectrum showed a molecular ion peak at m/z 245 equivalent to [M + H]+ of 
trihydroxylated xanthones (Figure IV-23c). The fragmentation pattern agreed with that of the 
reference compound. 
The first minor product with Rt 19.6 min represented 11.0 ± 0.2 % of the total product amount and 
was identified as 1,3,7-triHX based on its UV and MS spectra. Another minor product with Rt 21.3 
min represented 9.3 ± 0.9 % of the total enzymatic product. Its UV spectrum showed three 
absorption maxima at 236, 263 and 324 nm (Figure IV-23b) and did not match any spectrum of 
the available reference benzophenones and xanthones. ESI-MS could not identify the molecular 
mass of this compound which, therefore, was named unidentified product 1 (UIP1). 
Figure IV-22. Amplification of the full-length HpCYP81AA2 cds 
(locus 928) from H. perforatum cDNA using a proofreading polymerase. 
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Figure IV-23. Incubation of the microsomes containing HcCYP81AA2 and HcCPR2 with 2,3′,4,6-tetraHB. 
(a) Stacked HPLC-DAD chromatograms for incubation, standard and negative control; S stands for the substrate peak. 
(b) UV spectra of the enzymatic products and standards. (c) EPI mass spectra of the enzymatic products. 
 
Incubation with 2,4,6-triHB led to the formation of two major and two minor products 
(Figure IV-24a). The major product with Rt 20.9 min was identified as 1,3,5- triHX by UV and 
MS data as described in the previous incubation. The other major product with Rt 15.1 min was 
identified as 2,3′,4,6- tetraHB. Its UV spectrum matched that of authentic 2,3′,4,6- tetraHB and 
showed absorption maxima at 205, 258 and 305 nm (Figure IV-24b). EPI-MS showed a molecular 
ion peak at m/z 247 equivalent to [M + H]+ of tetrahydroxylated benzophenones, in addition to 
two other peaks (m/z 121 and 153), which correspond to the ions resulting from breaking the bond 
at either side of the carbonyl group of the benzophenone skeleton (Figure IV-24c). 
Similar to the previous incubation, the first minor product with Rt 19.6 min was identified as 
1,3,7- triHX based on its UV and MS spectra (Figure IV-24b,c). The other minor product with 
Rt 21.3 min could not be identified but had a similar retention time and UV spectrum as the 
unidentified product 1 (UIP1), detected in the incubation with 2,3′,4,6- tetraHB. 
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Figure IV-24. Incubation of the microsomes containing HcCYP81AA2 and HcCPR2 with 2,4,6-triHB. (a) Stacked 
HPLC-DAD chromatograms for incubation, standards and negative control; S stands for the substrate peak. 
(b) UV spectra of the enzymatic products and standards. (c) EPI mass spectra of the enzymatic products. 
Incubation with 2,4-diHB yielded one major and two minor products (Figure IV-25a). The major 
product with Rt 15.1 min was identified as 2,2′,3,4′-tetrahydroxybenzophenone (2,2′,3,4′-tetraHB) 
by its UV and MS spectra. The UV spectrum matched that of authentic 2,2′,3,4′-tetraHB and 
showed absorption maxima at 218, 285 and 319 nm (Figure IV-25b). EPI-MS showed a molecular 
ion peak at m/z 247 equivalent to [M + H]+ of tetrahydroxylated benzophenones. The peak at m/z 
137 corresponds to the ions resulting from breaking the bond at either side of the carbonyl group, 
thereby confirming the presence of two hydroxyl groups on each aromatic ring of the 
benzophenone skeleton (Figure IV-25c). Similar to the incubation of CYP81AA1 with 2,4- diHB, 
the Rt 17.1 product was identified as 2,3′,4-triHB by MS. The peaks at m/z 137 and 121 confirmed 
the presence of mono- and dihydroxylated aromatic rings of the benzophenone skeleton 
(Figure IV-25c). The product with Rt 16.2 min showed UV absorption maxima at 234, 264, 313 
and 376 nm which did not match any data of the available benzophenone and xanthone reference 
compounds. Therefore, xanthone cyclization products of 2,2′,3,4′- and 2,2′,4,5′-tetraHB can be 
ruled out. Again, ESI-MS failed to identify its molecular mass and it was named unidentified 
product 2 (UIP2).  
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Figure IV-25. Incubation of the microsomes containing HcCYP81AA2 and HcCPR2 with 2,4-diHB. (a) Stacked 
HPLC-DAD chromatograms for the incubation, the available standard and the negative control; S stands for the 
substrate peak. (b) UV spectra of the enzymatic products and available standard. (c) EPI mass spectra of the enzymatic 
products. 
 
Figure IV-26. Incubation of the microsomes containing HcCYP81AA2 and HcCPR2 with 2,3′,4,4′,6-pentaHB. 
(a) Stacked HPLC-DAD chromatograms for incubation, standard and negative control; S stands for the substrate peak. 
(b) UV spectra of the enzymatic product and standard. (c) EPI mass spectrum of the enzymatic product. 
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Incubation with 2,3′,4,4′,6-pentaHB (maclurin) yielded a single product (Rt 22.4 min) 
(Figure IV-26a). This product was identified as 1,3,6,7-tetraHX (norathyriol) by its UV and MS 
spectra (Figure IV-26b,c). No trace of the expected 1,3,5,6-tetraHX could be detected. Again, 
traces of 1,3,6,7-tetraHX as a natural contaminant in 2,3′,4,4′,6-pentaHB samples were present in 
the negative control (Jefferson and Scheinmann, 1965). 
Negative controls lacking NADPH or containing microsomes of yeast cells harboring the empty 
plasmid failed to produce any of the previous products. No activity was detectable with 2-HB, 
4- HB, 1,3-diHX, 1,3,7-triHX, 1,3,5-triHX, 1,3,5,6-tetraHX and 1,3,6,7-tetraHX.  
In conclusion, activity was detected with four benzophenones of the eleven substrates tested 
(Table IV-5). Accordingly, HpCYP81AA2 was identified as a bifunctional enzyme possessing 
both B3′H and 1,3,5-trihydroxyxanthone synthase (1,3,5-TXS) activities. 
Table IV-5. Summary of the enzymatic activities of HpCYP81AA2. 
Substrate Product(s) 
2,3′,4,6-tetraHB 
 
1,3,5-triHX 
1,3,7-triHX 
(minor) 
UIP1 (minor)  
 
2,4,6-triHB 2,3′,4,6-tetraHB 
1,3,5-triHX 
1,3,7-triHX 
(minor) 
UIP1 
(minor) 
 
2,4-diHB 2,3′,4-triHB 
 
2,2′,3,4′-tetraHB 
UIP2 (minor)  
2,3′,4,4′,6-pentaHB 
 
 
1,3,6,7-tetraHX 
  
2-HB No product detected 
4-HB No product detected 
1,3-diHX No product detected 
1,3,7-triHX No product detected 
1,3,5-triHX No product detected 
1,3,6,7-tetraHX No product detected 
1,3,5,6-tetraHX No product detected 
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10.3. Improvement of incubation conditions 
10.3.1. Effect of pH and temperature 
The optimum pH was 7.0 with loss of 18.0 and 6.5 % activity at pH 6.5 and 7.5, respectively 
(Figure IV-27a). The optimum temperature was 30 °C with loss of 19.6 and 17.1 % activity at 25 and 
35 °C, respectively (Figure IV-27b). 
 
a 
 
b 
 
Figure IV-27. Effect of  pH and incubation temperature on the activity of HpCYP81AA2. Data represent means ± s.d. 
(n = 3). 
 
10.3.2. Effect of incubation time and protein amount 
The accumulation of 1,3,5-triHX after incubation with 2,3′,4,6-tetraHB increased over the tested 
period of 120 min. The product formation rate was linear in the first 30 min of incubation 
(Figure IV-28a). For the protein concentration, product accumulation was linear up to 
approximately 50 μg microsomal protein in the standard assay (Figure IV-28b). 
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a 
 
b 
 
Figure IV-28. Effect of incubation time and protein amount on the activity of HpCYP81AA2. Data represent 
means ± s.d. (n = 3). 
 
11. Functional characterization of locus 8128 from H. perforatum transcriptome 
Primers with suitable restriction sites were designed according to the sequence of 
‘hpa_locus_8128_iso_3_len_1785_ver_2’ from the MPGR databank. The cDNA obtained from 
H. perforatum mid-aged leaves was used as a template to amplify the ORF of locus 8128 with a 
proofreading polymerase. It was subsequently cloned between SpeI and PacI restriction sites in 
MCS1 of the pESC-URA:HcCPR2 plasmid (III.2.3). The enzyme encoded by the ORF of locus 
8128 was named HpCYP81AA3 (Nelson, 2006). The constructed expression plasmid (pESC-
URA:HpCYP81AA3/HcCPR2) was transferred into INVSc1 yeast cells (III.3.3.3), co-expression 
was induced and the microsomal fraction was isolated (III.4.2) and used for enzymatic incubations 
with the above list of potential substrates (Figure IV-11). The only reaction that was catalyzed by 
this enzyme was the formation of 1,3,6,7-tetraHX from 2,3′,4,4′,6-pentaHB (Figure IV-29). 
Neither B3′H nor TXS activity were detectable. 
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Figure IV-29. Incubation of the microsomes containing HcCYP81AA3 and HcCPR2 with 2,3′,4,4′,6-pentaHB. 
(a) Stacked HPLC-DAD chromatograms for incubation, standard and negative control; S stands for the substrate peak. 
(b) UV spectra of the enzymatic product and standard. (c) EPI mass spectrum of the enzymatic product. 
12. Selection of targets for reciprocal mutagenesis 
To gain insight into the regioselectivity-determining elements of CYP81AA1 and CYP81AA2, 
their amino acid sequences were aligned, secondary structure elements were predicted (Sirim et 
al., 2010), residues were numbered according to the standardized numbering scheme for class II 
CYPs (Gricman et al., 2014), and the putative six substrate recognition sites (SRSs) were identified 
(Gotoh, 1992). The predicted secondary structure elements of the two enzymes matched, except 
for β3-3, β4-1 and β4-2 located toward the C-termini (Figure IV-30). Therefore, the 55 C-terminal 
amino acids were reciprocally exchanged between the two enzymes (III.2.9) as a first round of 
mutations. 
The second round involved reciprocal site-directed mutagenesis of individual amino acids 
(III.2.10). The two CYP81AA1 orthologs differed in only one residue (V/I220, standard position 
189) within the six predicted SRSs. In contrast, CYP81AA1 and CYP81AA2 had 15 different 
residues within the SRSs, some of which were expected to be responsible for the alternative 
regioselectivities (Figure IV-30). Thus, changing one or more of these residues toward their 
counterparts in the other enzyme was likely to affect the nature of the cyclization product. To 
reduce the number of possible single and multiple reciprocal mutations to be studied, homology 
models of both enzymes were built (III.6.2), based on the structure of the closed conformation of 
mammalian CYP2B4 in complex with ticlopidine (3KW4) (Gay et al., 2010). Examination of the 
superimposed models revealed that 17 residues were located within a 4 Å radius of the bound 
inhibitor in either protein model. Five of these residues belonging to the SRSs 5 and 6 differed 
between the two enzymes (Table IV-6, Figure IV-31). In addition, S375 in CYP81AA1, which 
corresponds to L378 in CYP81AA2 (standard position 330.1), was selected as a mutagenesis target 
because this position was previously predicted to affect the selectivity of CYPs (Seifert and Pleiss, 
2009) and undergoes a change from hydrophilic to hydrophobic. 
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Figure IV-30. Multiple sequence alignment of HpCYP81AA1, HcCYP81AA1 and HpCYP81AA2. Amino acids 
expected to be present in SRSs 1-6 are highlighted by orange boxes. Dissimilar residues are written in black letters 
and conserved residues outside the SRSs are represented in white with a red background. The conserved secondary 
structures of HpCYP81AA1 and HpCYP81AA2 are indicated at the top and the bottom, respectively. The black 
triangles point to positions selected for mutation and the red triangles refer to the major regioselectivity-determining 
residues in HpCYP81AA2. The black square refers to the position of the C-terminal exchange. 
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Table IV-6. Contact residues located within a 4 Å radius of the bound inhibitor and their standard positions and SRS 
numbers. Divergent residues are underlined. 
CYP81AA1  CYP81AA2 Standard numbering 
position 
SRS number 
Residue Position  Residue Position 
PHE 110  PHE 113 85 1 
PHE 212  PHE 215 181 2 
ILE 215  ILE 218 184 2 
VAL 216  VAL 219 185 2 
ILE 307  ILE 309 263 4 
ALA 308  ALA 310 264 4 
GLU 311  GLU 313 267 4 
THR 312  THR 314 268 4 
ALA 315  ALA 317 271 4 
TYR 370  TYR 372 325 5 
PRO 372  PRO 374 327 5 
ALA 373  SER 375 328 5 
LEU 377  LEU 379 331 5 
THR 482  MET 486 437/439 6 
ALA 483  SER 487 437.3/440 6 
SER 484  LYS 488 438/441 6 
LEU 485  ASN 489 439/441.1 6 
 
 
Figure IV-31. Superimposed models of CYP81AA1 (cyan) and CYP81AA2 (green) showing (a) all contact residues 
within a 4 Å radius of the product and (b) the divergent residues. 
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13. Control of the 1,3,5-TXS (CYP81AA2) regioselectivity 
Wild-type CYP81AA2 released 79.5 % of the total product as 1,3,5-triHX and 11.0 % as 1,3,7-
triHX. Reciprocal mutation of six individual residues in SRSs 5 and 6 toward their counterparts in 
CYP81AA1 led to a gradual change in the 1,3,5-triHX to 1,3,7-triHX ratio (Figure IV-32). In the 
homology model built, the standard positions 437 and 328 were the closest divergent contact 
residues of the bound inhibitor. Reciprocal single substitutions at the positions 437 in SRS-6 
(A483T) and 328 in SRS-5 (S375A) increased the 1,3,7-triHX portion from 11.0 to 19.2 and 30.2 
%, respectively. Single substitution at the selected standard position 330.1 in SRS-5 (L376S) 
yielded only 16.7 % 1,3,7-triHX. Of the double mutants generated, L378S/A483T formed 22.9 % 
1,3,7-triHX, however, S375A/L378S and S375A/A483T, which contained the standard position 
328, resulted in 50.5 and 59.3 % 1,3,7-triHX, respectively. This outcome was increased to 80.7 % 
by combining all three positions in the S375A/L378S/A483T mutant. Finally, the sextuple mutant 
S375A/L378S/A483T/M486L/K488R/N489K (mut6), which involved all mismatching contact 
residues, released 91.1 % of the total product as 1,3,7-triHX (Figure IV-32). None of the mutants 
generated could mimic the absolute regiospecificity of CYP81AA1 toward formation of 1,3,7-
triHX. No appreciable changes in the level of the unidentified product were observed. 
 
 
 
Figure IV-32. Product profiles of wild-type HpCYP81AA2 and mutant enzymes. Data represent means ± s.d. (n = 4). 
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14. Attempts toward changing the regiospecifity of CYP81AA1 
Wild-type CYP81AA1 showed absolute specificity toward the production of 1,3,7-triHX. 
Substitution of the 55 C-terminal residues by those of CYP81AA2 failed to cause any change in 
the regiospecificity. Similarly, reciprocal mutations in SRSs 5 and 6 had only minor effects on the 
regioselectivity (Table IV-7). For example, the sextuple mutation A373S/S376L/T482A/L485M/ 
R487K/K488N caused only 6.5 % of the total product to be released as 1,3,5-triHX. This result 
resembled the effect of the single mutant A373S, which formed 5.1 % 1,3,5-triHX. Replacing 
alanine in the T482A position of the triple mutant (A373S/S376L/T482A) with larger hydrophobic 
residues (T482V and T482F) failed to further shift the regioselectivity. Finally, a third set of 
mutations were created by selecting divergent residues within an increased radius (< 15 Å of the 
inhibitor ticlopidine), such as W113F in SRS-1, I220P in SRS-2, and V302I/M303T in SRS-4. 
However, none of the additional mutations in SRSs 1 and 2 led to further changes in the 
regioselectivity. Mutations performed on SRS-4 even resulted in the loss of enzyme activity. 
Table IV-7. Product profiles of HpCYP81AA1 mutants 
Enzyme mutant 
1,3,7-triHX 1,3,5-triHX 
(% of total product) 
Wild-type CYP81AA1  100 0 
CYP81AA1-AA2 100 0 
CYP81AA1 A373S 94.9 ± 1.1 5.1 ± 1.1 
CYP81AA1-AA2 A373S 93.2 ± 0.2 6.8 ± 0.2 
CYP81AA1 A373S/S376L 95.0 ± 0.4 5.0 ± 0.4 
CYP81AA1-AA2 A373S/S376L 96.0 ± 0.8 4.0 ± 0.8 
CYP81AA1 A373S/S376L/T482A 95.5 ± 0.3 4.5 ± 0.3 
CYP81AA1 A373S/S376L/T482A/L485M/R487K/K488N 93.5 ± 0.6 6.5 ± 0.6 
CYP81AA1 A373S/S376L/T482V 94.6 ± 0.5 5.4 ± 0.5 
CYP81AA1 A373S/S376L/T482F 95.9 ± 0.3 4.1 ± 0.3 
CYP81AA1 W113F/A373S/S376L/T482A 95.2 ± 0.1 4.8 ± 0.1 
CYP81AA1 I220P/A373S/S376L/T482A 99.4 ± 0.1 0.6 ± 0.1 
CYP81AA1 
A373S/S376L/T482A/L485M/R487K/K488N/V302I/M303T  
No activity detected 
CYP81AA1 
W113F/I220P/A373S/S376L/T482A/L485M/R487K/K488N/ 
V302I/M303T 
No activity detected 
 
15. Product docking 
Docking of 1,3,5- and 1,3,7-triHX into the homology models of wild-type CYP81AA2 and its 
sextuple mutant S375A/L378S/A483T/M486L/K488R/N489K (mut6) revealed different modes of 
product binding, indicating hindrance of internal rotation in the 2,3′,4,6-tetraHB substrate 
(Figure IV-33). In the wild-type enzyme (1,3,5-TXS), the 3-hydroxy group of the product can 
form a hydrogen bond with S375, orienting it toward the heme loop. The 5-hydroxy group points 
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toward the heme group. At the substrate level, rotation of the 3′-hydroxyphenyl ring of 2,3′,4,6-
tetraHB is hindered by the side chains of the I-helix residues. In the sextuple mutant, the 3-hydroxy 
group of the product can form a new hydrogen bond with A483T, orienting it toward the C-
terminal loop. This hydrogen bond switching can explain the observed cooperative effect of the 
double mutant S375A/A438T. The mutation introduced in the former H-bonded residue S375A 
together with the nearby mutation L378S may alter the conformation of the heme loop to 
cooperatively support the reorientation of the substrate. The 7-hydroxy group of the product is 
located between the I-helix and the heme group, which again indicates hindrance of free rotation 
of the 3′-hydroxyphenyl ring of 2,3′,4,6-tetraHB. 
 
Figure IV-33. Product docking. (a) Active site of wild-type CYP81AA2 (lime) with bound 1,3,5-triHX (green sticks). 
The 3-hydroxy group forms a hydrogen bond with S375, orienting it toward the heme loop. (b) Active site of the 
sextuple mutant (mut6) of CYP81AA2 (orange) with bound 1,3,7-triHX (yellow sticks). The 3-hydroxy group forms 
a hydrogen bond with A483T, orienting it toward the C-term-loop. 
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V. Discussion 
Plants produce a variety of secondary metabolites which play a major role in their defense against 
pathogens and herbivores. In addition, many of those metabolites possess valuable 
pharmacological activities, beneficial to human health and therefore serve as potential lead 
compounds for the production of new drugs. The biosynthesis of secondary metabolites in plants 
involves series of reactions catalyzed by various classes of enzymes which direct the metabolic 
flux towards the production of complex molecules from relatively simple primary building blocks. 
Deciphering the biosynthetic methodology, by which plants synthesize those products, and 
studying the involved enzymes would enable us utilizing them in metabolic engineering 
applications for the heterologous production of natural products (Renault et al., 2014). In addition, 
overexpression of some genes and suppression of others may lead to generation of transgenic 
plants with customized metabolite profiles. 
Among the enzymes responsible for biosynthesis of natural products are cytochrome P450 
enzymes (CYPs). They constitute a large superfamily of heme-thiolate proteins found in almost 
all living organisms. CYPs catalyze regio- and stereoselective oxidative attack of non-activated 
carbons at physiological conditions (Werck-Reichhart and Feyereisen, 2000). In plants, they are 
encoded by around 1% of the protein-coding genes and the catalytic functions for most of their 
gene products remain unknown (Nelson and Werck-Reichhart, 2011). Assigning functions to new 
CYPs is a challenge because of their large numbers, lack of reliable sequence-function correlations 
and the structural similarities between family members (Mizutani and Ohta, 2010). They are 
responsible for various reactions in plant primary as well as secondary metabolism. Generally, 
plant CYPs catalyze hydroxylation (monooxygenation) reactions. However, few enzymes exhibit 
less common unusual activities (Mizutani and Sato, 2011; Guengerich and Munro, 2013), 
including methylenedioxy bridge formation (Ikezawa et al., 2003; Ono et al., 2006; Ikezawa et al., 
2007), successive oxidation of a single carbon (Helliwell et al., 2001; Carelli et al., 2011), 
rearrangement of carbon skeletons (Akashi et al., 1999), lactone ring formation (Zhang et al., 
2014), sterol desaturation (Morikawa et al., 2006; Field and Osbourn, 2008), S-heterocyclization 
(Klein and Sattely, 2015), C–C bond cleavage (Irmler et al., 2000), and phenol coupling (Kraus 
and Kutchan, 1995; Ikezawa et al., 2008; Gesell et al., 2009). Intramolecular C–O phenol 
couplings were biochemically established in plant xanthone biosynthesis (Peters et al., 1997). 
However, no genes encoding those enzymes have been isolated so far. Several CYP-catalyzed 
intramolecular phenol coupling reactions in plants, bacteria and humans have been extensively 
studied at the gene level as subsequently surveyed.  
1. CYP-catalyzed intramolecular phenol coupling reactions 
1.1. Glycopeptide antibiotic biosynthesis in bacteria 
Crosslinking of aromatic residues by intramolecular phenol coupling reactions is critical in 
conferring the three-dimensional structure in glycopeptide antibiotic biosynthesis (Haslinger et al., 
2014; Yim et al., 2014). Four CYPs (OxyA, B, C and E) catalyze intramolecular C–O and C–C 
phenol couplings during the biosynthesis of vancomycin and teicoplanin-type glycopeptide 
antibiotics (Figure V-1) (Bischoff et al., 2001; Cryle et al., 2011). However, those CYPs do not 
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act on the free substrates. Their heptapeptide substrates are covalently bound to an acyl carrier 
domain of the non-ribosomal peptide synthase (NRPS) (Woithe et al., 2007; Cryle et al., 2011). 
Recently, the involvement of an X-domain in the NRPS in the recruitment of those oxygenases 
has been established (Haslinger et al., 2015). The order of the coupling reactions has been 
identified (Bischoff et al., 2001; Stegmann et al., 2006) and crystal structures for some of the 
bacterial soluble proteins have been solved (Cryle et al., 2011; Li et al., 2011). However, the exact 
mechanism of the phenol coupling reaction in light of the catalytic cycle of CYPs has never been 
discussed in detail for those enzymes. 
 
 
Figure V-1. Phenol couplings catalyzed by the Oxy CYPs in vancomycin and teicoplanin-type antibiotic biosynthesis. 
(a) Structure of the vancomycin and teicoplanin aglycone peptides bound to the peptidyl carrier protein (PCP), 
showing the bonds synthesized by the phenol coupling Oxy enzymes highlighted in red. (b) Schematic representation 
of the peptides sequences of vancomycin and teicoplanin, showing the order of cross-linking steps and the enzymes 
involved; adapted from Cryle et al. (2011). 
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1.2. Mycocyclosin biosynthesis in Mycobacterium tuberculosis  
The M. tuberculosis genome contains 20 CYP-coding genes, of which CYP121 was found to be 
essential for the viability of the bacterium (McLean et al., 2008). Moreover, a correlation was 
established between the binding constants of azole antifungal drugs to CYP121 and the MIC values 
of these drugs, indicating that CYP121 is the main target of azoles in vivo (McLean et al., 2008). 
The catalytic function of CYP121 was elucidated by Belin et al. (2009). The enzyme was found to 
convert the substrate cyclodityrosine (cYY) into a product called mycocyclosine (mcyc) through 
intramolecular C–C phenol coupling reaction (Figure V-2). The coupling occurs between the two 
tyrosine aromatic rings in ortho position to the hydroxyl group of each tyrosine moiety (Belin et 
al., 2009). 
 
 
Figure V-2. Cyclodityrosine is converted via a C–C phenol coupling reaction to mycocyclosin by CYP121 
in M. tuberculosis. 
 
1.3. Isoquinoline alkaloid biosynthesis in plants 
Intramolecular C–C and intermolecular C–O phenol coupling reactions were studied at the gene 
level in benzylisoquinoline alkaloid metabolism (Kraus and Kutchan, 1995; Ikezawa et al., 2008; 
Gesell et al., 2009). Such reactions are common in plant biosynthetic pathways and are often 
critical in the biosynthesis of plant secondary metabolites (Mizutani and Sato, 2011; Guengerich 
and Munro, 2013). To date, only three transcripts for plant CYPs catalyzing phenol coupling 
reactions have been cloned, all of which contribute to the biosynthesis of isoquinoline alkaloids. 
CYP80G2 and CYP719B1 catalyze intramolecular C–C couplings to convert (S)- and (R)-
reticuline to (S)-corytuberine and salutaridine, respectively (Figure V-3) (Ikezawa et al., 2008; 
Gesell et al., 2009). CYP80A1 is the only known plant CYP that is able to catalyze an 
intermolecular C–O phenol coupling reaction between (R)- and (S)-N-methylcoclaurine to form 
the bisbenzylisoquinoline alkaloid berbamunine (Figure V-3) (Kraus and Kutchan, 1995). None 
of the previously characterized phenol coupling CYPs shows multifunctionality and no plant CYP 
catalyzing an intramolecular C–O phenol coupling reaction has been cloned previous to the present 
study.  
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Figure V-3. Phenol coupling reactions catalyzed by plant CYPs in isoquinoline alkaloid biosynthesis. 
 
1.4. Endogenous morphine biosynthesis in mammals  
Analogous to plant salutaridine synthase (CYP719B1), human CYP2D4 and CYP3A4 were found 
to catalyze the phenol coupling of (R)-reticuline in the course of endogenous morphine 
biosynthesis. However, the reactions lacked the absolute regiospecificity observed for their plant 
counterpart, leading to the production of all four possible phenol coupling products (Figure V-4). 
A broad substrate spectrum and the lack of absolute regiospecificity are typical features of 
mammalian liver microsomal CYPs, as they are involved in xenobiotic detoxification (Grobe et 
al., 2009). 
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Figure V-4. Phenol coupling reactions in mammals. Human CYP2D6 and CYP3A4 catalyze the enzymatic conversion 
of (R)-reticuline into salutaridine, (+)-pallidine, (-)-isoboldine, and (-)-corytuberine by oxidative phenol coupling 
reactions; adapted from Grobe et al. (2009). 
 
2. The role of CYP81AA subfamily members in plant xanthone biosynthesis 
Xanthone (9H-xanthen-9-one) compounds constitute a group of natural products found in fungi, 
lichens and a few families of higher plants (Vieira and Kijjoa, 2005; El-Seedi et al., 2009; El-Seedi 
et al., 2010). Their distribution as well as oxygenation and prenylation patterns are considered of 
significant chemotaxonomic value (Demirkiran, 2007; Crockett and Robson, 2011). To date, more 
than 1,500 xanthone-based natural products are present in chemical databases. Plant xanthones 
function as defense compounds against herbivores and microorganisms (Franklin et al., 2009; 
Tocci et al., 2011). In humans, they exhibit a wide array of interesting pharmacological activities 
including anti-microbial, anti-protozoal, anti-HIV-1, anti-inflammatory, anti-atherosclerotic, 
cytotoxic and cancer chemopreventive activities (Demirkiran, 2007; El-Seedi et al., 2010). In 
addition, some xanthones possess a combination of acetylcholinesterase inhibitory, free radical 
scavenging and monoamine oxidase inhibitory activities. This combination of activities leads to 
growing interest in use for combating neurodegenerative diseases such as Alzheimer′s (Zhang, 
2005; Martinez et al., 2012; Wang et al., 2012). 
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In plant xanthone biosynthesis, the interface between benzophenone and xanthone skeletons is a 
ring closure event, which converts the diphenyl ketone scaffold to a tricyclic ring system. This 
cyclization is preceded by a 3′-hydroxylation step, which favors subsequent substitution at the 
ortho and para positions. In the present work, it is demonstrated that both consecutive reactions 
are catalyzed by bifunctional CYPs, two variants of which (CYP81AA1 and CYP81AA2) 
accomplish the ring closure regioselectively (Figure V-5). Hp and HcCYP81AA1 catalyze the 
exclusive formation of 1,3,7-triHX as a final product either from 2,4,6-triHB or 2,3′,4,6-tetraHB 
and therefore received the name 1,3,7-trihydroxyxanthone synthase (1,3,7-TXS). On the other 
hand, HpCYP81AA2 accepted the same physiological substrates (2,4,6-triHB and 2,3′,4,6-
tetraHB) to form a mixture of three final products, the major of which was 1,3,5- triHX and hence 
was named 1,3,5-trihydroxyxanthone synthase (1,3,5- TXS).  
 
 
Figure V-5. The reactions catalyzed by CYP81AA1 and CYP81AA2 using the physiological substrates. 
 
No hydroxylation at the xanthone level took place, as indicated by the non-acceptance of 
1,3- dihydroxyxanthone and related compounds. Notably, 2,4-diHB was 3′-hydroxylated by both 
CYP81AA1 and CYP81AA2, however, the product failed to be cyclized because of the lack of the 
6-hydroxy group and instead underwent 2′-hydroxylation, yielding 2,2′,4,5′- and 2,2′,3,4′-tetraHB, 
respectively. Subsequent loss of water, as previously proposed for ortho-ortho′-hydroxylated 
benzophenones (Kitanov and Nedialkov, 2001), was hindered by hydrogen bonding between the 
2-hydroxy and carbonyl groups. With 2,3′,4,4′,6-pentaHB, the ring closure took place but lacked 
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regioselectivity, as both enzymes formed 1,3,6,7-tetraHX. This conversion was the only reaction 
catalyzed by CYP81AA3, whose physiological function remains open. None of the three CYPs 
converted monohydroxylated benzophenones, such as 2- and 4-hydroxybenzophenone. 
The previously identified plant phenol coupling CYPs are members of CYP719 and CYP80 
families, which are represented by a limited number of members in a restricted quantity of plant 
taxa (Bak et al., 2011). In contrast, CYP81 is a large enzyme family consisting of multiple 
members in all plant genomes sequenced to date (Nelson et al., 2008; Nelson, 2009). However, 
only a few members of the CYP81 family have been functionally characterized, linking them to 
specialized metabolism in response to biotic and abiotic stress (Akashi et al., 1998; Cabello-
Hurtado et al., 1998; Pfalz et al., 2009; Kai et al., 2011).  
For example, CYP81E members in Medicago truncatula catalyze regiospecific hydroxylations on 
ring B of the isoflavone skeleton in either the 2′ or 3′ positions, yielding products that are involved 
in pathogen defense and insect-induced responses, respectively (Figure V-6a) (Liu et al., 2003). 
In Arabidopsis thaliana, members of the CYP81F subfamily are essential for the production of 
indole-type glucosinolates which accumulate upon pathogen attack (Pfalz et al., 2009; Pfalz et al., 
2011). CYP81F2/CYP81F3 catalyze the C- hydroxylation of indol-3-yl-methyl glucosinolate 
(I3M) at position 4 to yield 4- hydroxy-indol-3-yl-methyl glucosinolate (4OH-I3M), while 
CYP81F4 catalyzed the N- hydroxylation of the same substrate to yield 1-hydroxy-indol-3-yl-
methyl glucosinolate (1OH- I3M). Methylation of the introduced hydroxyl groups by indole 
glucosinolate methyltransferases (IGMT1 and IGMT2) gives rise to the final products 4MO-I3M 
and 1MO-I3M (Figure V-6b).  
CYP81Q members catalyze stepwise formation of two methylenedioxy bridges in the biosynthesis 
of the lignan (+)- sesamin, which widely occurs in vascular plants (Figure V-6c) (Ono et al., 2006). 
The previous examples show that different members of individual CYP81 subfamilies catalyze 
various reactions using the same substrate but show alternative regioselectivities yielding different 
products that are essential for plant defense.  
Comparably, CYP81AAs utilize one substrate (2,4,6- triHB) and convert it into either 1,3,7- or 
1,3,5-triHX. The ability of CYP81s to catalyze N-hydroxylation, methylenedioxy bridge formation 
and phenol coupling may suggest that other members of the same family are involved in catalyzing 
further unusual reactions yet to be characterized and encourage deeper investigation of the 
members of this family in different plants. 
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Figure V-6. Examples of reactions catalyzed by CYP81 family members. (a) Regiospecific hydroxylation of 
isoflavonoids by CYP81E subfamily members. (b) Regiospecific hydroxylation of indol-3-yl-methyl glucosinolate 
(I3M) by CYP81F subfamily members in the biosynthesis of 4-methoxy-indol-3-yl-methyl (4MO-I3M) and 
1- methoxy-indol-3-yl-methyl (1MO-I3M) glucosinolates. (c) Consecutive formation of two methylenedioxy bridges 
during the biosynthesis of the lignan (+)-sesamin.  
A search for sequences homologous to the isolated CYP81AAs in the transcriptomes of other 
xanthone-producing plants revealed the existence of sequences sharing more than 55 % amino acid 
identity with both CYP81AA1 and CYP81AA2, which therefore fall within the same subfamily 
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and can be classified as putative TXSs. These sequences were identified in families closely related 
to the Hypericaceae, namely the Clusiaceae and the Calophyllaceae. In contrast, transcriptomes of 
Gentianaceae species, which also produce xanthones, lacked CYP81AA homologs, indicating that 
other CYPs may be involved in xanthone biosynthesis in this family. Phylogenetic analysis of the 
sequences together with the isolated TXSs and representative members of other CYP81 
subfamilies shows that all putative TXSs cluster together with the identified CYP81AAs in one 
clade with a bootstrap value of 100 (Figure V-7), indicating that they have evolved from a 
common ancestor. All other functionally related members in lignan, isoflavonoid or glucosinolate 
biosynthesis also clustered together in distinct clades with bootstrap values equal to or approaching 
100 (Figure V-7). 
 
Figure V-7. Phylogenetic analysis of established and putative xanthone synthases together with representative 
members of the CYP81 family based on amino acid sequences. Tree reconstruction was performed with the maximum 
likelihood algorithm using MEGA 6 program. Bootstrap values (percent of 1000 replicates) for each cluster are shown 
at the nodes. CYP73A1 served as an outgroup to root the tree. The functionally characterized TXSs are designated by 
black circles.  
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3. Gene expression analysis 
In H. calycinum cell cultures, expression of HcCYP81AA1 (1,3,7-TXS) was induced by the 
addition of yeast extract as an elicitor and the increase in the transcript level preceded the 
accumulation of hyperxanthone E. Coordinated upregulation was not only observed for expression 
of HcCYP81AA1 and HcBPS, which are directly associated to xanthone formation, but also for 
expression of CNL. Cinnamate:CoA ligase (CNL) catalyzes the upstream activation of cinnamic 
acid, thereby channeling the carbon flow from general phenylpropanoid metabolism to 
biosynthesis of the benzoyl unit, one of the building blocks of the xanthone scaffold (Gaid et al., 
2012). In addition, the transcript level for HcCPR2, which indirectly contributes to 
hyperxanthone E biosynthesis, underwent similar changes. 
Analysis of publicly available H. perforatum transcriptomes revealed that mainly roots and leaves 
express CYP81AA1, CYP81AA2 and BPS. Roots of Hypericum species are the major site of 
xanthone accumulation while lower quantities are found in leaves (Avato, 2005).  
4. Proposed mechanism for CYP-catalyzed phenol coupling reactions 
The exact mechanism of CYP-catalyzed phenol couplings is not yet fully understood and cannot 
be easily rationalized in context of the traditional catalytic cycle of CYPs (Guengerich, 2007; 
Grobe et al., 2009). Hydroxylation by the oxygen rebound mechanism described in (I.1.4) is the 
classical CYP-catalyzed reaction, inserting one atom of molecular oxygen into the substrate and 
reducing the second to water (Munro et al., 2013). The cyclization step, however, involves an 
oxidative phenol coupling reaction, reducing both atoms of molecular oxygen to water (Mizutani 
and Sato, 2011). Two mechanisms have been outlined for the previously studied phenol coupling 
reactions. 
4.1. The radical-pairing mechanism 
The postulation of the radical-pairing mechanism for the formation of phenolic C–C or C– O–C 
bonds finds its origin back to the 1950s when Braton and Cohen (1957) suggested that the coupling 
proceeds via one-electron oxidation of phenols to generate a phenoxy radical. This radical 
possesses significant electron density at the ortho and para carbon atoms of the hydroxyl group as 
well as at the oxygen atom. Two radicals can afterwards undergo either intra- or intermolecular 
coupling to form new C– O or C–C bonds. New bonds to carbon atoms are formed exclusively at 
the ortho and para positions. Consistently, in natural products known to involve phenol coupling 
reactions between two aromatic rings during their biosynthesis, the reaction requires a free 
phenolic group to be located at the appropriate position in both precursor rings and occurs 
exclusively ortho and/or para to the respective hydroxyl groups (McDonald, 2008). 
The intermolecular C–O phenol coupling between two molecules of (S) and (R)-N-
methylcoclaurine catalyzed by berbamunine synthase (CYP80A1) is proposed to follow this 
mechanism (Figure V-8a). Two radicals are postulated to be generated by the Cpd I during two 
CYP oxidation cycles and coupling of the two species leads to the formation of berbamunine 
(Stadler and Zenk, 1993; Kraus and Kutchan, 1995). Likewise, the intramolecular C–C phenol 
coupling reaction of (S)-reticuline to corytuberine catalyzed by CYP80G2 in the plant Coptis 
japonica is postulated to follow the same mechanism (Figure V-8b). However, the generation of 
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the biradical species is proposed to occur within one catalytic cycle by Cpd I and Cpd II, 
respectively (Ikezawa et al., 2008). 
 
Figure V-8. (a) Postulated catalytic mechanism of oxidative phenol coupling of chiral benzyltetrahydroisoquinoline 
alkaloids involving two one-electron oxidation steps. Adapted from Stadler and Zenk (1993). (b) Proposed phenol 
coupling mechanism for the reaction catalyzed by CYP80G2 in Coptis japonica. The formation of (S)-corytuberine 
from (S)-reticuline is suggested to proceed by two one-electron transfers with subsequent diradical coupling within 
one CYP catalytic cycle; adapted from Ikezawa et al. (2008). 
Recently, the C–C phenol coupling reaction catalyzed by CYP121 in M. tuberculosis was also 
proposed to proceed via the formation of a radical species on each tyrosyl moiety of 
cyclodityrosine (cYY), followed by radical coupling to form the cyclic dipeptide product 
mycocyclosin (Figure V-9) (Belin et al., 2009). 
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Figure V-9. Proposed phenol coupling mechanism for the formation of mycocyclosin from cyclodityrosine by 
CYP121 in M. tuberculosis; adapted from Belin et al. (2009). 
The crystal structure of CYP121 bound to the substrate has been solved (Belin et al., 2009) and 
the mechanism was further investigated by quantum and molecular mechanics (Dumas et al., 
2014). The crystal structure shows that one of the tyrosine moieties is located close to the heme 
(close-Tyr), while the other tyrosine is located far from it (far-Tyr). The close-Tyr is proposed to 
be initially oxidized by Cpd I to form the first radical. Several theories can explain the formation 
of the second radical on the far-Tyr. It is assumed that the mono radical may leave the active site 
and re-enter with the second Tyr (far-Tyr) facing the heme to yield the diradical species by the 
action of Cpd II from the same catalytic cycle or Cpd I from a new cycle. Another possibility is 
the internal electron transfer from the (close-Tyr) to the (far-Tyr) leading to the formation of a 
radical on the (far- Tyr) and then a new radical is formed on the (close-Tyr) by the action of Cpd I 
or Cpd II. The final step of radical coupling can occur inside or outside the protein core to yield 
the product (Figure V-9) (Dumas et al., 2014).  
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4.2. Single iron oxidation cycle mechanism 
The formal diradical species suggested in the previous mechanism is energetically unstable. 
Therefore, the C–C coupling of (R)-reticuline to form salutaridine was favorably suggested to 
proceed within one CYP catalytic cycle, where the abstraction of a hydrogen by Cpd I leads to the 
formation of a phenoxy radical. Partial rotation of the substrate within the active site occurs, 
followed by a concomitant abstraction of a second hydrogen on the second aromatic ring by Cpd II 
together with electron transfer leading to the formation of the C–C bond. A water molecule is 
eliminated from the heme iron which returns to the resting state (Figure V-10). Finally, enolization 
of the intermediate yields the salutaridine product (Gesell et al., 2009; Grobe et al., 2009). 
 
 
Figure V-10. Proposed phenol coupling mechanism for the reaction catalyzed by CYP719B1 in Papaver somniferum 
as well as CYP2D4 and CYP3A4 in mammals. The formation of salutaridine from (R)-reticuline is suggested to pass 
through a single cycle of iron oxidation; adapted from Grobe et al. (2009) and Gesell et al. (2009). 
5. Proposed mechanisms for the reactions catalyzed by TXSs 
As previously discussed, TXSs catalyze two consecutive reactions during xanthone biosynthesis. 
The first reaction is a conventional hydroxylation, while the second is a regioselective oxidative 
phenol coupling. Thus, TXSs can function as both monooxygenases and oxidases. The detection 
of 2,3′,4,6-tetraHB intermediate after incubation of either enzymes with 2,4,6-triHB suggests that 
this intermediate leaves the active site and re-enters in a conformation favorable for the cyclization 
reaction. In the first (monooxygenation) reaction, the rules of the classical catalytic cycle for CYPs 
apply. Cpd I abstracts a hydrogen from the non-hydroxylated aromatic ring to form a phenyl 
radical. Next, the formed Cpd II introduces a hydroxyl group at the 3′-position by the oxygen 
rebound mechanism (Figure V-11a). On the other hand, several theories may explain the second 
reaction in light of the previously studied phenol coupling mechanisms. Peters et al. (1997) 
proposed that the underlying reaction mechanism involves two one-electron oxidation steps. The 
first one-electron transfer and a deprotonation generate a phenoxy radical, whose electrophilic 
attack at C- 2′ or C-6′ leads to the cyclization of the benzophenone. The intermediate 
hydroxycyclohexadienyl radical cation is transformed by loss of another electron and proton to 
1,3,5- and 1,3,7-trihydroxyxanthones. However, the discovered ability of those enzymes to 
hydroxylate 2,4,6-triHB at the 3′ position and the fact that they introduce two hydroxyl groups on 
the non-hydroxylated ring of 2,4- diHB may afford revision of the previously hypothesized 
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mechanism. In my view, abstraction of a hydrogen atom from the monohydroxylated ring by Cpd I 
generates a resonance-stabilized radical with high electron density at C-2′/C-6′. Subsequently, 
instead of the classical oxygen rebound mechanism leading to the introduction of a hydroxyl group, 
a C–O bond is formed when this radical attacks the hydroxyl group at the C-2 position of the 
trihydroxylated ring and this hydroxyl group in concert undergoes abstraction of a hydrogen by 
Cpd II. This leads to the formation of the pyrone ring characteristic for the xanthone skeleton 
(Figure V-11b). Another possibility involves the radical-paring mechanism, where Cpd I and 
Cpd II form two radicals, one at the interchangeable 2/6-hydroxyl group and another at 2'/6'-
position during the catalytic cycle. Radical coupling leads to cyclization of the benzophenone to a 
xanthone. However, as previously discussed by Grobe et al. (2009), the proposed formal diradical 
species would not be energetically stable. An alternative mechanism which was suggested by 
Kitanov and Nedialkov (2001) for the biosynthesis of xanthones involving water elimination from 
ortho-ortho′-dihydroxylated benzophenones might also be considered. However, the proposed 
intermediate was not detected in any of the TXSs-catalyzed reactions. 
 
 
Figure V-11. Proposed reaction mechanisms of CYP81AA1 and CYP81AA2. (a) Hydroxylation reaction at the 3′-
position catalysed by both enzymes. (b) Regioselective C–O phenol coupling reactions occurring either para or ortho 
to the introduced 3′-hydroxy group catalysed by CYP81AA1 and CYP81AA2, respectively. 
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Crystallization of each of the enzymes with the physiological substrates 2,4,6-triHB and 2,3′,4,6-
tetraHB bound should reveal more about the decisive factors and the mechanism of CYP-catalyzed 
phenol coupling and answer the question why those enzymes can act as conventional hydroxylases 
with 2,4,6-triHB while performing C–O phenol couplings on the structurally related 2,3′,4,6-
tetraHB. 
6. NADPH-dependent cytochrome P450 reductase (CPR) 
Most eukaryotic CYPs obtain their reducing equivalents from NADPH through CPR (Hannemann 
et al., 2007). In contrast to animals having a single CPR (Porter et al., 1990), each plant species 
has two or more CPRs that can be phylogenetically classified within two distinct classes (class I 
or class II) (Jensen and Moller, 2010). They differ mainly in their N-terminal membrane anchor 
sequences suggesting that they are forming metabolons together with different sets of CYPs 
localized on the membranes of endoplasmic reticulum (Jensen and Moller, 2010). Phylogenetic 
analysis of the identified H. calycinum CPR sequence together with 19 other CPR homologs from 
various plant species indicated that the identified H. calycinum CPR sequence falls within class II 
(Figure V-12). 
It is worth mentioning that members of CPR class II are more abundant than those of class I. For 
example, all three rice CPRs, two of the three Populus trichocarpa (poplar) reductases (CPR2 and 
CPR3) as well as one of the two CPRs in Gossypium hirsutum (cotton) and Arabidopsis thaliana 
fall within class II CPRs (Schuler and Rupasinghe, 2011). In Arabidopsis, cotton and centaury, 
expression of class II CPR is induced by wounding, light and elicitation, whereas class I CPR is 
constitutively regulated (Mizutani and Ohta, 1998; Schwarz et al., 2009; Yang et al., 2010). 
Consistently, class II CPR transcripts were cloned from the SSH cDNA library of H. calycinum 
and isolated from cell cultures after elicitor treatment. Despite its indirect role in xanthone 
biosynthesis as an electron carrier between NADPH and TXSs, real-time qRT-PCR data 
demonstrated that the expression of HcCPR2 exhibited the same pattern as the other genes 
involved in xanthone biosynthesis in yeast-extract-treated H. calycinum cell cultures.  
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Figure V-12. Phylogenetic analysis of established and putative plant CPRs based on their amino acid sequences. Tree 
reconstruction was performed with the maximum likelihood algorithm using the MEGA 6 program. Bootstrap values 
(percent of 1000 replicates) for each cluster are shown at the nodes. Ammi majus CPR2 (AAS90127.1), Arabidopsis 
thaliana CPR1 (NP_194183.1), A. thaliana CPR2 (NP_849472.2), Artemisia annua CPR2 (ABI98819.1), Centaurium 
erythraea CPR1 (AAS92623.1), Glycine max CPR1 (NP_001236742.1), Gossypium hirsutum CPR1 (ACN54323.1), 
G. hirsutum CPR2 (ACN54324.1), Hypericum androsaemum CPR1 (AAS00459.1), Lotus japonicus CPR2 
(BAG68945.1), Medicago truncatula CPR2 (XP_003610109.1), Papaver somniferum CPR1 (AAC05021.1), Petunia 
hybrida CPR2 (AAZ39649.1), Populus trichocarpa CPR1 (XP_002307336.1), P. trichocarpa CPR2 (AAK15260.1), 
P. trichocarpa CPR3 (AAK15261.1), Triticum aestivum CPR2 (CAC83301.1), Zea mays CPR2 (ACG28940.1), 
Zingiber officinale CPR2 (BAJ41269.1), Homo sapiens (NP_000932.3). 
7. Identification of regioselectivity determinants  
In spite of the low primary sequence identities between members of different CYP families that 
can reach as low as 20 %, they show distinct secondary structural elements and share a common 
fold. This allows modeling of CYPs using the available crystal structures even when they share 
relatively low identity on the primary sequence level. Most of the highly conserved structural 
elements of CYPs are involved in binding the heme prosthetic group and in activating molecular 
oxygen. However, due to the broad spectrum of substrates oxidized by CYPs with different 
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regio- and stereoselectivities, high sequence variability is observed in the regions responsible for 
interaction with substrates. Gotoh (1992) identified six substrate recognition sites (SRSs) in the 
crystal structure of CYP101A1 (P450cam) in complex with its substrate. Mutations targeting 
residues within those sites in various CYPs were shown to affect their substrate and product 
specificities.  
Recently, a standard numbering system based on structure-guided sequence alignment was 
introduced for CYPs facilitating identification and comparisons between structurally 
corresponding residues in different proteins from the primary sequence data (Gricman et al., 2014).  
Identification of genes encoding TXSs with alternative regioselectivities offered the opportunity 
to explore their selectivity determinants. Sequence comparison, homology modeling and 
reciprocal site-directed mutagenesis demonstrated the impact of individual SRS residues on the 
selection of the alternative substrate conformers used. CYP81AA2 (1,3,5-TXS) was almost 
completely converted by mutagenesis to CYP81AA1 (1,3,7-TXS). Three amino acids in close 
proximity to the heme group (S375, L378 and A483; equivalent to the standard positions 328, 
330.1 and 437, respectively; Gricman et al., 2014) were found to be most influential in orienting 
the coupling reaction ortho to the 3′-hydroxy group. S375 and L378 are located within SRS-5, 
which spans the loop between the EXXR motif and the β1-4 strand, whereas A483 belongs to SRS-
6 (Figure V-13, Figure V-14). ; 
 
Figure V-13. Alignment of the SRS sequences of HpCYP81AA1, HcCYP81AA1, and HpCYP81AA2. Amino acids 
expected to be present in SRSs 1-6 are highlighted by orange boxes. Dissimilar residues are written in black letters 
and conserved residues outside the SRSs are represented in white with a red background. The conserved secondary 
structures of HpCYP81AA1 and HpCYP81AA2 are indicated at the top and the bottom, respectively. The black 
triangles point to positions selected for mutation and the red triangles refer to the major regioselectivity-determining 
residues in HpCYP81AA2. 
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Figure V-14. Structural overlay of the homology models of HpCYP81AA1 (magenta, dark grey) and HpCYP81AA2 
(green, light grey). Colored parts indicate the location of the six SRSs around the heme-containing active center with 
bound inhibitor ticlopidine (shown in stick representation) from the template X-ray structure 3kw4 (mammalian 
CYP2B4). Divergent residues are shown in ball and stick, labeling being based on CYP81AA1 numbering. Standard 
positions for major regioselectivity-determining residues are put in brackets. 
Serine 375 (standard position 328) occupies position 5 behind the EXXR motif, its side chain 
pointing toward the heme group in the majority of CYPs structurally studied. The position is a 
mutation hotspot (Seifert and Pleiss, 2009; Gricman et al., 2015) and is preferentially occupied by 
a hydrophobic amino acid (Seifert and Pleiss, 2009). In CYP81AA2, however, there is a polar 
serine residue, which may be required for interaction with the polyhydroxylated substrates. In a 
number of CYPs, mutations at this standard position 328 resulted in dramatic changes in the regio- 
and stereoselectivities (Born et al., 1995; Schalk and Croteau, 2000; Kerdpin et al., 2004; Lentz et 
al., 2006). The point mutation F363I completely switched the regiospecificity of spearmint 
limonene 6-hydroxylase to that of peppermint limonene 3-hydroxylase (Schalk and Croteau, 
2000). In CYP81AA2, however, the point mutation S375A caused only a partial change (~20 %) 
toward 1,3,7-triHX formation.  
In addition to standard position 328, a second protruding residue in SRS-5 is expected to occupy 
either position 8 or 9 after the EXXR motif (corresponding to standard positions 331 or 332, 
respectively) (Seifert and Pleiss, 2009). Although L378 residue occupies position 8 behind the 
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EXXR motif, it was assigned the standard position 330.1 for which surprisingly no mutations have 
been reported. In contrast, multiple substitutions were carried out at the neighboring positions 330 
and 331 (Gricman et al., 2015). It may contribute to the orientation of the substrate within the 
active site and/or shift the position of the whole loop by interaction with the heme group, affecting 
the size of the active site cavity.  
SRS-6 is formed by the turn in β-sheet 4 between β4-1 and β4-2 toward the C-terminus. A483 
(standard position 437) is located at the tip of this turn, its side chain protruding into the active site 
(Figure V-14). Mutations at this position affected the regiospecificities of multiple CYPs 
(Gricman et al., 2015), such as CYP94A2, in which the F494L substitution shifted the 
regioselectivity of fatty acid hydroxylation from ω to ω-1 (Kahn et al., 2001). In CYP81AA2, 
L378S and A483T exhibited less than 8% change each but induced around 20 and 29% shifts, 
respectively, in combination with S375A, indicating synergistic interaction in controlling the 
regioselectivity. The triple mutant S375A/L378S/A483T caused 80.7% of the total product to be 
released as 1,3,7-triHX and another 10.4% shift was contributed by the triple mutation 
M486L/K488R/N489K in SRS-6. However, no combination of mutations was capable of 
achieving the absolute regiospecificity of CYP81AA1. In case of the sextuple mutant 
S375A/L378S/A483T/M486L/K488R/N489K, a portion of 6.9% of the total product was still 
1,3,5-triHX (beside 2% unidentified product). To summarize, S375A is the most influential 
mutation, however it cannot cause alone a complete shift in regioselectivity. There must be some 
“helper” mutations to achieve this. L378S and A483T are almost useless on their own or even in 
combination, but when added to S375A the effect is dramatic. 
Reciprocal site-directed mutagenesis was also applied to CYP81AA1 (1,3,7-TXS). However, the 
maximum shift in the regioselectivity achieved was 6.8 %, indicating that subtle changes in the 
backbone rather than substitutions in the SRSs are needed to convert 1,3,7-TXS to 1,3,5-TXS. 
Similarly, the I364F modification in the peppermint limonene 3-hydroxylase, the reciprocal 
mutation to the above-mentioned substitution, did not achieve the regiospecificity of the spearmint 
limonene 6-hydroxylase, quite the contrary, it afforded an inactive, although properly folded, 
enzyme (Schalk and Croteau, 2000). Notably, none of the enzyme mutants generated exhibited 
uncoupling of the consecutive hydroxylation and coupling reactions. 
CYPs are probably nature’s most versatile enzymes in terms of substrate range and reaction type 
(Munro et al., 2013). This vast repertoire is here extended by the properties of CYP81AA1 and 
CYP81AA2, whose study provides further insight into CYP-catalyzed oxidative phenol coupling 
reactions. However, further work is needed to better understand the selectivity determinants, as 
indicated by the challenge to convert 1,3,7- to 1,3,5-TXS. As ring closure catalysts, the enzymes 
may be attractive for engineering efforts and biotechnological applications.  
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8. Perspectives 
The identification of TXSs and studying their properties on the molecular level complete the 
cascade of enzymes required for the biosynthesis of xanthones in plants starting from malonyl- 
and benzoyl-CoA building blocks. This allows future engineering of the whole pathway in other 
hosts for the heterologous production of xanthones and their derivatives in microbes as well as for 
improving the desired values of other plants. Identification of the yet uncharacterized upstream 
steps for the biosynthesis of benzoyl-CoA from cinnamic acid would even allow the de novo 
biosynthesis of those products. 
Another interesting aspect will be the identification of more TXS homologs from other xanthone-
producing plants. Our phylogenetic analysis based on the currently available trascriptomic data 
revealed that members of the Malpighiales indeed express related genes. These genes should be 
isolated and functionally characterized to confirm the function of their protein products. On the 
other hand, no TXS homologs were identified in xanthone-producing plants from transcriptomes 
of the Gentianales. Although whole transcriptome data represent valuable sources of information, 
they cannot be relied on as the sole basis for the identification of new functional CYPs because of 
the large number of CYP superfamily members in plants and the absence of sequence to function 
correlations. Therefore, a strategy similar to that described in this work could be followed by using 
one or more members of the Gentianales to establish an analogous system to H. calycinum cell 
cultures that produces xanthones exclusively upon elicitation. Analysis of the gene expression data 
from this system together with the current knowledge gained in the present study about the 
composition of residues within the active site of TXSs would facilitate the identification of 
candidate genes encoding functional species-specific TXSs from the Gentianales. 
Control of the hydroxylation pattern of the produced xanthones in the producing plants may be 
accomplished by manipulating the expression levels of the TXS enzymes. This might be beneficial 
in cases where one form, either 1,3,5- or 1,3,7-triHX derivatives, is desired because of its 
pharmacological activity. When both enzymes are equally expressed, they would compete for the 
benzophenone substrate and produce a mixture of both 1,3,7- and 1,3,5- derivatives, which would 
subsequently compete for the next enzyme in the pathway, producing less amounts of the desired 
product. Moreover, knocking out/down all TXSs in a xanthone-producing plant may increase the 
benzophenone pool available for the biosynthesis of bioactive and structurally intriguing 
prenylated benzophenone derivatives, such as sampsoniones (Hu and Sim, 1999; Hu and Sim, 
2000).  
The trihydroxyxanthones produced can be further hydroxylated, methoxylated and prenylated at 
different positions to produce more complex structures. The enzymes catalyzing those steps are 
interesting targets for future research (Schmidt et al., 2000; Fiesel et al., 2015). Studying whether 
or not those enzymes are associated in gene clusters would reveal valuable information about the 
evolution of this metabolic pathway and its regulation. It would also facilitate the identification of 
further genes involved in upstream and downstream steps of the pathway. However, this requires 
whole genome sequencing data with annotation of the genes to the different chromosomes, which 
is to date not available for xanthone-producing species. 
  Discussion 
111 
 
It has been reported that many sequential enzymes involved in certain biosynthetic pathways are 
structured in groups, referred to as metabolons. They are clusters of proteins which are associated 
together through non-covalent interaction and often interact with cellular membranes. This 
structuring facilitates rapid and localized channeling of intermediates between consecutive 
enzymes in biosynthetic pathways. It has been proposed that in many cases CYPs act as nuclei on 
which the other proteins associate to establish metabolons (Ralston and Yu, 2006). Therefore, it is 
interesting to examine if the TXSs can act as cores, upon which other enzymes of the xanthone 
biosynthetic pathway can form metabolons. 
Although homology modeling was useful in the identification of regioselectivity determinants in 
CYP81AA2, manipulating the regiospecificity of CYP81AA1 remains challenging. 
Crystallization of the membrane anchor-freed TXSs is necessary to gain deeper insight into the 
structural elements responsible for the regioselectivity as well as the reaction mechanisms 
underlying the observed bifunctionality. 
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VI. Summary 
 Xanthones constitute a group of natural products found in fungi, lichens and some higher 
plants. They may contribute, among other constituents such as acylphloroglucinol derivatives, 
to the overall effects of the medicinal plant H. perforatum. 
 Extracts of common St. John’s wort (H. perforatum) are among the top selling herbal products 
in the USA and Europe and are widely used in the treatment of mild to moderate depression. 
 In a number of other plants, the xanthone scaffold is the core of many complex hydroxylated, 
methoxylated, glycosylated and prenylated polycyclic compounds. Xanthones possess a wide 
array of pharmacological activities including potential anti-Alzheimer properties (Zhang, 
2005; Sethiya and Mishra, 2014).  
 A crucial branching point in plant xanthone biosynthesis is the cyclization of 2,3′,4,6-tetraHB 
via regioselective intramolecular oxidative C–O phenol couplings either para or ortho to the 
3′-hydroxyl group to yield 1,3,7- and 1,3,5-triHX, respectively (Peters et al., 1997). 
 The enzymes involved in the cyclization reactions have been biochemically identified as 
cytochrome P450 enzymes (CYPs). However, no cDNAs encoding these enzymes have been 
cloned so far. 
 CYPs constitute a superfamily of heme-thiolate enzymes which normally catalyze 
hydroxylation/monooxygenation reactions. However, some members catalyze less common 
unusual reactions, such as C–O phenol couplings. 
 Yeast extract-treated H. calycinum cell cultures produce hyperxanthone E which is a 
derivative of 1,3,7-triHX, while control (non-treated) cells fail to produce this compound 
(Gaid et al., 2012). This system was utilized to construct a suppression subtractive 
hybridization cDNA library enriched in elicitor-induced transcripts. 
 Bioinformatic analysis of the ESTs in the library followed by rapid amplification of cDNA 
ends (RACE) led to the isolation of full-length cDNAs encoding HcCYP81AA1 and HcCPR2. 
 The microsomal fraction of yeast cells expressing HcCYP81AA1 and HcCPR2 catalyzed the 
following reactions: 
- Cyclization of 2,3′,4,6-tetraHB into 1,3,7-triHX, 
- Hydroxylation of 2,4,6-triHB at the 3′ position and subsequent cyclization of the resulting 
2,3′,4,6-tetraHB into 1,3,7-triHX, 
- Hydroxylation of 2,4-diHB at the 3′ position, then further hydroxylation of the resulting 
2,3′,4-triHB para to the introduced hydroxyl group to yield 2,2′,4,5′-tetraHB, 
- Cyclization of 2,3′,4,4′,6-pentaHB into 1,3,6,7-tetraHX. 
 HcCYP81AA1 was identified as a bifunctional enzyme possessing both benzophenone 
3′- hydroxylase and 1,3,7-trihydroxyxanthone synthase activities. 
 Gene expression analysis by real-time qRT-PCR revealed coordinated expression of the 
HcBPS, HcCYP81AA1 and HcCPR2 genes. The expression profiles came in accordance with 
the published accumulation pattern of hyperxanthone E (Gaid et al., 2012). 
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 The sequence of HcCYP81AA1 was used to query the public H. perforatum transcriptome in 
the Medicinal Plant Genomics Resource (MPGR), leading to the identification of three 
homologous sequences, namely HpCYP81AA1, HpCYP81AA2 and HpCYP81AA3. 
 Microsomes of yeast cells expressing HpCYP81AA1 with HcCPR2 showed an activity profile 
identical to that of HcCYP81AA1. 
 The microsomal fraction of yeast cells expressing HcCYP81AA2 and HcCPR2 catalyzed the 
following reactions: 
- Cyclization of 2,3′,4,6-tetraHB into 1,3,5-triHX, 
- Hydroxylation of 2,4,6-triHB at the 3′ position and subsequent cyclization of the resulting 
2,3′,4,6-tetraHB into 1,3,5-triHX, 
- Hydroxylation of 2,4-diHB at the 3′ position, then further hydroxylation of the resulting 
2,3′,4-triHB ortho to the introduced hydroxyl group to yield 2,2′,3,4′-tetraHB, 
- Cyclization of 2,3′,4,4′,6-pentaHB into 1,3,6,7-tetraHX. 
 HpCYP81AA2 was identified as a bifunctional enzyme possessing both benzophenone 
3′- hydroxylase and 1,3,5-trihydroxyxanthone synthase activities. 
 Microsomes of yeast cells expressing HpCYP81AA3 and HcCPR2 could only catalyze the 
cyclization of 2,3′,4,4′,6-pentaHB into 1,3,6,7-tetraHX. 
 A mechanism was suggested to explain the hydroxylation and the alternative phenol coupling 
reaction steps. 
 Phylogenetic analysis of putative TXS sequences from the transcriptomes of other xanthone-
producing plants, the isolated CYP81AAs and representative members of CYP81 subfamilies 
showed that all putative TXSs cluster together with the identified CYP81AAs in one clade, 
indicating their evolution from a common ancestor. 
 Reciprocal site-directed mutagenesis based on sequence comparisons, analysis of the 
substrate recognition sites (SRSs) and homology models built for both enzymes led to the 
identification of three residues (Ser 375, Leu 378 in SRS-5 and Ala 483 in SRS-6), which 
mainly control the regioselectivity of CYP81AA2 (1,3,5-TXS). This enzyme was almost 
completely converted to 1,3,7-TXS by a sextuple mutation. 
 The regiospecificity of CYP81AA1 was not significantly affected by mutations performed on 
the corresponding residues or any other mutation attempted in the assigned SRSs, indicating 
the involvement of further elements outside the known CYP SRSs in controlling the 
regioselectivety of CYP81AA1. 
 The efforts reported herein will enable better understanding of the selectivity determinants in 
CYP-catalyzed reactions, give a deeper insight into the mechanism of phenol couplings 
catalyzed by CYPs and allow for future generation of transgenic xanthone-producing plants 
with customized products. Moreover, the characterized CYPs have the potential to be utilized 
as ring closure catalysts in the biotechnological production of xanthones and xanthone-related 
natural and unnatural products. 
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VIII. Appendix 
1. Sequences 
1.1. Assembled contigs from H. calycinum subtractive library encoding CYPs 
 
>Contig21 
CGATTAGCGTGGTCGCGGCCGAGGTACTTCGAGAGCGTCTCCAAGAAACTTGGCCCGGTC 
TTGCTCTTCTGGATGGGCAAGGTCCCCGGCCGCATGGCGGCCGCGGGAATCGATTAGCGT 
GGTCGCGGCCGAGGTACAAGGGGATCGAGAAGAGCATGATCCAGCTGGCCGAGAAGAGGG 
AGGTCTTCCTTAACGCCCTGGTCGCCGAGGTCAGAGCCAGGAGGGCCGCCGGCGGGAAGA 
CGACAGTTGGCGAGAACGGCGAAGGGGTCTCTGTGATCGATATCATCCTCAACTTGCAGG 
AGACAGACCCCGAGTTTTACACCGATGCCATCGTCAAGGGTATTGTTATGATGATGTTTA 
TCGCCGGGACCGAGACGTCGACCGCCACGTTGGAGTGGGGGTTCACTCTCCTAATGCAAC 
ACCCAGAGAAGATGCGCAAACTACAAGCCGAGATCGACAGCGTCGTAGGAGACAGCCGCT 
TCGTGAGCGAAGCCGACTTCGCCAATCTTCCCTACCTAAGGGCCGTCGTGAAGGAGACAC 
TAAGGCTGTACCTCGCCCGGGCCCACGCTAGAACTCCCCCACTTCTCTAACCAAGCCTGC 
ACCGTCGGAGGCTACGACATTCCCAATGGAACCATGCTCTTCGCCAACTTGTGGGCAATG 
CAGAGAGACCCTAAAGTATGGGACGAGCCAGACGCATTCAAGCCCGAGAGGTTCGAGGAA 
TACGACCGCGAAGGCGGGTACCGGTCTTTTTCGCCAGACAGGCAAGAGCGCTTCGTCAAC 
AGATGGATTAGCTCGCTATCCGACCCCCGTGTCACCCATGAAATCAGAGCCATCTGGGTC 
ACCTACTGGTATCAGGCTGACAAATCTCTTGGTCAGAAGCTCGCATCTCGTCTCAATGTG 
AGGCCAAACATGTGAATTTGATGCCGGCCGGGCACTTTCTGCTGCCGAGACATGAGAGAA 
AACGTTGGAAGGGGCTGTTATATGCAATGAATCTACATCAGAGAATAACATCTAAATGTG 
TGTGTGTTCTGTGTTGTAATACTGAAGCATAGTTTCGTGTGTTGCTCCCCCTAATTAAAC 
ATTCTTATCTAATAAACGGGTTTGTACCTGCCCGGGCGGCCGCTCGACCTTTGAGGAGTG 
CTTCA 
 
 
>Contig41 
GCATGGCGGCCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACACCACCGATCCTGC 
GAAGGCGGCAGCAGCAGCTGCCAGCAGTATGAAAGGTGGTGCCTCGCCTTATGTCCAGTT 
TGCTGCTGCTCAGTCATCTGGAAAGCCGCATCAGCTTGTAACCGCAGGGTTTCCCTATGT 
TCCGGCGGCTGTTCAAGTGAAACAAGCTGATCAGAAGCAACCCGCTGGTGAGTAGAAGTT 
CTCCGTAGCGCTTACATGTTGAACCCCATGGCGGCGCGGGAATCGAGGTCGAGCGGCCGC 
CCGGGCAGGTACTTCCGCAGGCGGCCGGCGAGGTGCCGGATCTCCTCCTCCCGGATGAAG 
GCCGACCTCTGGAGGGCCTTGATGGAGAAGATCTCCGAGAAGGTGAGCCGACGGAGGCTC 
TTCCAGATGGGGCCGTGGGGGGCCCACACGAGGAAGGTGTAGTCATAGGTGAGATGCTCG 
CCGGACATGGACTTGGGGCGGTCGGCAAAGACGACGTCGTTCTTGGTGAAGCACTCCTCA 
AAGGTCGAGCGGCCGCCCGGGCAGGTACGACCGGGCGTGAGAGGCACTCGGTCCTCCGGA 
TTTTCAAGGGCCGCCGGGGGCGCACCGGACACCACGCGACGTGCGGTGCTCTTCCAGCCG 
CTGGACCCTACCTCCGACTGAGTCGTTTCCAGGGTGGGCAGGCTGTTAAACAGAAAAGAT 
AACTCTTCCCGAGGCCCCCGCCGACGTCTCCGGACTCCCTAACGTTGCCGTCAGCCGCCA 
CGTCCCGGTTCAGGAATTTAACCCGATTCCCTTTCGAAGTACCTCGGCCGCGACCACGCT 
AATCGATTCCCGCGCCG 
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>Contig50 
GGCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACTTCGAGAGCGTCTCCAAGAAAC 
TTGGCCCGGTCTTGCTCTTCTGGATGGGCAAGGTCCCCGTCCTCGTTGTCTCCTCCCCGG 
AGGTCGAGCGGCCGCCCGGGCAGGTACTTAAACAAATCACTGCCTCTCTATATCTTCAAC 
TCGAGCTCCCTCACCAGAGCTTCGAGACCTGGTTACAAAATTCCTGAAGGAGCCCAGCCT 
TGAGCCCGACCCATCAACCTTCTCCAATTGGGCCGTATTGGGCCCGTTATTATCCTCCGG 
GGCTGAAGGTTGGACCCTAGGCCCATTATGGCTTCCTTGTTGGGCCTTCGGCTCTGCCTC 
GGTTCGACATATCGGGCACGTCGAGTGCGAGCCCAACCACATGTCCACGCACTCGACGTG 
AAACATATGGTTACAATTTGGCAAAACTCTTACCACTTCCTCGTCCTCTATTCCCATTAA 
GCAAACCGAGCACTCCACTTGGTCGCCCCGGCCGTACCTCGGCCGCGGCGATTCGAGCGG 
CCGCCCGGGCAGGTACTTCCGCAGGCGGCCGGCGAGGTGGCGGATCTCCTCCTCCCGGAT 
GAAGGCCGACCTCTGGAGGGCCTTGATGGAGAAGATCTCAGAGAAGGTGAGACGACGGAG 
GCTCTTCCAGATGGGGCCGTGGGGGGCCCACACGAGGAAGGTGTAGTCATAGGTGAGGTG 
CTCGCCGGACATGGACTTGGGGCGGTCGGCGAAGACGACGTCGTTCTTGGTGAAGCACTC 
CTCGAAGGCCTCCGGAGAGGAGACAACGAGGACGGGGACCTTGCCCATCCAGAAGAGCAA 
GACCGGGCCAAGCTTCTTGGAGACGCTCTCGAAGTACCTCGGCCGCGACCACGCTAATCG 
ATTCCCGCGGCCGCCATGCGGCCGGAGC 
 
 
>Contig56 
TCGATTGGTACCTCAGTATGGTCGTAAGAGAAACTTTCAGACTCCATCCACCAGTGCCAT 
TGCTACTCCCCCACGCTGCAAGAGAAGAATGTGACATCAATGGCTTTTACATTCCGAAGA 
ATTCGCATGTTATCTTCAACGCATGGGCGATCGGCCGCGACCCTGGCGCTTGGGTCGACC 
CGGAGAAGTTTTGGCCGGAGAGATTCAGAGGAAGTGAGGTGGACGTCCGTGGACGTGATT 
TCCAGCCGATCCCATTTGGCTCTGGACGTAGAGGGTGTCCTGGGATGCAATTAGCCCTCG 
TATTTGTGCACTTGGTTTTGGCCAATTTGGTGCATTCGTTTGAGTGGGAGCTGCCGGGTG 
GGATGTTGCCTCATGAATTGGATATGACAGAGGAGTACCTCGGCCGCGACCACGCTA 
 
 
>Contig59 
TCCGGCCGCATGGCGGCCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACTTCGAGA 
GCGTCTCCAAGAAACTTGGCCCGGTCTTGCTCTTCTGGATGGGCAAGGTCCCCGTCCTCG 
TTGTCTCCTCCCCGGAGGCCTTTGAGGAGTGCTTCACCAAGAACGACGTCGTCTTTGCCG 
ACCGCCCCAAGTCCATGTCCGGCGAGCATCTCACCTATGACTACACCTTCCTCGTGTGGG 
CCCCCCACGGCCCCATCTGGAAGAGCCTCCGTCGGCTCACCTTCTCGGAGATCTTCTCCA 
TCAAGGCCCTCCAGAGGTCGGCCTTCATCCGGGAGGAGGAGATCCGGCACCTCGCCGGCC 
GCCTGCGGAAGTACCTGCCCGGGCGGCCGCTCGAATCGATTCCCGCGGCCGCCATGCGGC 
CGTTTGAGGGCCAAGTTTGGGTTCTTTTGCTACTTCACGGCGGTGGCCATCCCGTTCTTG 
AGCAGCCTGGCCGGTCTCATCGGAGGAATTGCGTTGCCGGTGACGTTCGCTTACCCGTGC 
TTCATGTGGCTCAGGATCAAGAAGCCCAAGGTTTACGGCCCAATGTGGTTCCTCAATTGG 
ACTCTTGGGCTCTCCGGTTTGGGCCTGAGTGGGGCCGCCATTGCAGCTAGCATTTATGTC 
ATAATTGACACCGGAATTAACTTTAGCTTTT 
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>Contig62 
GGCCGCATGGCGGCCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACTCGACTGTCT 
GATTTGAACGAGAAGTTTCGCTAGTTCTTTGATAAGATCAAATATTCTTTTGCCTTCCTC 
GTAACTGCTTCCAAATGCTGTTCTAGAGATTACATCGCAGGTTAGTTCTTAAAGATGCGG 
CCAAACATCTACCTCGCATGATCCTTCCTCGGAGGCCGATCGCTCCCATTTACCGATCAT 
GTCACTACAACATCGACTAAATACGGGCATCATTACCTTCAATTTTTCAACATGAAATGC 
TGGATTGATGATCCTTCGGTGCTTGGCCCATTTTTCCCCTTCATAGCTCGCGAGGTAATC 
GATTAGCGGCCGCCCGGCCGAGGTACGGACAAGGGGAATCCGACTGTTTAATTAAAACAA 
AGCATTGCGATGGTCCCTGCGGATGTTAACGCAATGTGATTTCTGCCCAGTGCTCTGAAT 
GTCAAAGTGAAGAAATTCAACCAAGCGCGGGTAAACGGCGGGAGTAACTATGACTCTCTT 
AAGGTAGCCAAATGCCTCGTCATCTAATTAGTGACGCGCATGAATGGATTAACGAGATTC 
CCACTGTCCCTGTCTACTATCCAGCGAAACCACAGCCAAGGGAACGGGCTTGGCAGAATC 
AGCGGGGAAAGAAGACCCTGTTGAGCTTGACTCTAGTCCGACTTTGTGAAATGACTTGAG 
AGGTGTAGGATAAGTGGGAGCCGGAAACGGCGAAGGTGAAATACCACTACTTTTAACGTT 
ATTTTACTTATTCCGTGAATCGGAGGCGGGGCATCGCCCCTTCTTTTGGACCTAAGGTCG 
CTTCGGCGGCTGATCCGGGCGGAAGACATTGTCAGGTGGGGAGTTTGGCTGGGGCGGCAC 
ATCTGTTAAAAGATAACGCAGGTGTCCTAAGATGAGCTCAACGAGAACAGAAATCTCGTG 
TGGAACAAAAGGGTAAAAGCTCGTTTGATTCTGATTTCCAGTACCTGCCCGGGCGGCCGC 
TCGAACTCCGGGGAGGAGACAACGAGGACGGGGACCTTGCCCATCCAGAAGAGCAAGACC 
GGGCCAAGTTTCTTGGAGACGCTCTCGAAGTACCTCGGCCGCGACCACGCTAATCGATTC 
CCGCGGCCGCCATGCG 
 
 
>Contig86 
CATGCTCCGGCGCATGGCGGCCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACTTC 
GAGAGCGTCTCCAAGAAGCTTGGCCCGGTCTTGCTCTTCTGGATGGGCAAGGTCCCCGTC 
CTCGTTGTCTCCTCTCCGGAGGTCGAGCGGCCGCCCGGGCAGGTACGGCCCGGTGATCTC 
CTTCAAGTTCGGGGCCCACCCGGCCGTGATCGTCTCGTCCCTCCCTGCGGCAGAGGAATG 
CTTCACGAAGAACGACGTCGTCCCGGCCAACCGGCCCGTGTTCATGACCCTCTTCAGGCA 
CCTAAACTACAACTACAGCACCATCTCCGCCGCACCCTATGGCGACCACTGGCGGAACCT 
TCGTCGCATCAGCGCTACAGACATATTCTCCCCCCACCGCCTCAGCGTATTCCTCAGCAC 
CCGACAGGAAGAGGTCCTGCGCATGCTGAAGAAATTGGAATGGCAATGGACAGAATCCGG 
TTCAGACTCCGCCAAGGTCAACATCAAACCGTTGCTCTCGGACCTGACGTTCAACGTGAT 
CATGAGAATGGTCGCGGGGAAGAGGTACCTCGGCCGCGACCACGCTA 
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>Contig103 
GCATGGCGGCCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACCACCGGCCCCACTC 
TCCCTCCCCCACTTCTCTAACCAAGCCTGCACCGTCGGAGGCTACGACATTCCCAATGGA 
ACCATGCTCTTCGCCAACTTGTGGGCAATGCAGAGAGACCCTAAAGTATGGGACGAGCCA 
GACGCATTCAAGCCCGAGAGGTTCGAGGAATACGACCGCGAAGGCGCGTACCTGCCCGGG 
CGGCCGCTCGACCTTTGAGGAGTGCTTCACCAAGAACGACGTCGTCTTTGCCGACCGCCC 
CAAGTCCATGTCCGGCGAGCATCTCACCTATGACTACACCTTCCTCGTGTGGGCCCCCCA 
CGGCCCCATCTGGAAGAGCCTCCGTCGGCTCACCTTCTCGGAGATCTTCTCCATCAAGGC 
CCTCCAGAGGTCGGCCTTCATCCGGGAGGAGGAGATCCGGCACCTCGCCGGCCGCCTGCG 
GAAGTACCTGCCCGGGCGGCCGCTCCCTGGCCGCTGCTGGTGTTGCCGGATATGCCATTT 
ACAAATACAGAATCAGGACATACATGGACTCGGAGATACGCGCTATAATGGCACGGTACC 
TCGGCCGCGACCACGCTAATCGATTCCCGCGCCGGCCATGCGGCCGGAGCATG 
 
 
>Contig110 
GCCATGGCGGCCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACCCGTTCTGAGTTG 
ACTGTTCGACGCCCGGGGGAAGGACCCCGAAGGGACCATTCCCAGTCCGTCCCCCGGCCG 
GCACGCGACGACCCGCTCTCGCCGCGGAAGCAGCTCGAGCAGTCCACCGACAGCCGACGG 
GTTCGGGACTGGGACCCCCGGACCCAGCCCTCAGAGCCAATCCTTTTCCCGAGGTTACGG 
ATCCATTTTGCCGACTTCCCTTGCCTACATTGTTCCATTGGCCAGAGGCTGTTCACCTTG 
GAGACCTGATGCGGTTATGAGTACGACCGGGCGTGAGAGGCACTCGGTACCTGCCCGGGC 
GGCCGCTCGACCTTCGAGGAGTGCTTCACCAAGAACGACGTCGTCTTCGCCGACCGCCCC 
AAGTCCATGTCCGGCGAGCACCTCACCTATGACTACACCTTCCTCGTGTGGGCCCCCCAC 
GGCCCCATCTGGAAGAGCCTCCGTCGTCTCACCTTCTCTGAGATCTTCTCCATCAAGGCC 
CTCCAGAGGTCGGCCTTCATCCGGGAGGAGGATATCCGCCACCTCG 
 
 
>Contig158 
CAGCTCCTCTTGGACTTTGGTTAGGACTCTTGGGGTGTTGATGACCTCTGCCATGGCTAA 
CTCGATTATGTTCGTGGACGTGTCTGTTCCACCCACGATCATGTCCATAAGCAATGCCTT 
GACCTGGATCAAGGAGAGCTTGGCCTTGCCGACAACCTCTTCATCCTCCAAGTTCAACAA 
AAACTGCAAAAAGTCTGTATTCTCCTCCCCCTTCCCGATCGGCGTCCATCCTCCGGCGCC 
GATCGATCATCCTCTCAAACATTGCGTCCATCTTCCCGGTGATCCTTAACATCCTCCGGT 
GGAGTCCCTGGGGGTCAAACCGCACCATCCACGGGAAAAAGTCCGCCAAATTCGGCTTCA 
CCATCAGCGCCGTCATTTCCACGACCGCCGCCCGGAACTCCCTCCCGACGCTCTCTCTCT 
CCTCGTCGCCATGCACCGTCCCGGCCCAAAGCATGCTCGTGATCATGTTTATTATCGTCA 
CCTG 
 
 
>Contig181 
ATGCTCCGGCCGCATGGCGGCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACGTGG 
GAGGCTATACCATCCCGAAGGGCACGAGGGTCCTCGTCAATGCGTGGGCCATCCACAGGG 
ACCCGTCAATATGGGATGACCCTCTGGAGTTTAGGCCCGAGAGGATGATGGATGGAAAGT 
GGGACTACAACGGGAAGGACTTGAGCTATATCCCATTCGGGTCCGGGAGGAGGAGCTGTG 
TCGGTGTCGCCATGGCCGAGAGGATGTTTATGTACCTCGGCCGCGACCACGCTA 
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>Contig199 
CGATTAGCGTGGTCGCGGCCGAGGTGTCCCCGTCCTCGTTGTCTCCTCCCCGGAGGTCGA 
GCGGCCGCCCGGGCAGGTACGCCCCCTGAGGTGGGCGAGCAGTGGTAAGTTCGAGAAGAG 
AGTGAAGTCGCTTGGCGAGAGGACCGACAAGTTCTTGCAAGGGTTAGTTGACGAGCACCG 
GAACAAGGAGAAGAGTCAAGAGGATGCGACCAACGTTACGATGATTGACCACTTGCTTTC 
TTTGCAAGAGACTCAACCACAGGATTACTCTGATGTCACCATCAAAGGGCTTGTCCTGAT 
AATGTTGCTGGCGGGAACTGATACATCAGCAGTGACGTTAGAGTGGGCTATGTCCAATCT 
GGTTAACCACCCGAATGTCTTGGACAAGGCAAGGAAAGAACTGGACGCTCGAATCGGACA 
AGATCGGCTCATCGAAGAAGACGATCTTCCTCATCTTTCTTACCTCCATAACATTATATC 
AGAGACACTACGACTGTACCTCGCCCGCGACCACGCTAAACCATGACCGAGGCCGCCATG 
CTATCGTTCCCACTTCATTCGAAGCTCTCGAGGGAGCAATCAAGGAAACATTTGATAAGC 
TGGTTGAAGCGGGAAATATTACCCCCATAAAGGAGATCACACCTCCCCCTATTCCTGAGG 
ACCTCAACAGTGCAATTAAGAGTGGCAAAGTCCGGGCTCCTACTCATATCATCTCT 
 
 
>Contig219 
GGCGCCATGGCGGCCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACCTCGAGAGCG 
TCTCCAAGAAACTTGGCCCGGTCTTGCTCTTCTGGATGGGCAAGGTCCCCGTCCTCGTTG 
TCTCCTCCCCGGAGGCCTTTGAGGAGTGCTTCACCAAGAACGACGTCGTCTTTGCCGACC 
GCCCCAAGTCCATGTCCGGCGAGCATCTCACCTATGACTACACCTTCCTCGTGTGGGCCC 
CCCACGGCCCCATCTGGAAGAGCCTCCGTCGGCTCACCTTCTCGGAGATCTTCTCCATCA 
AGGCCCTCCAGAGGTCGGCCTTCATCCGGGAGGAGGAGATCCGGCACCTCGCCGGCCGCC 
TGCGGAAGTACCTGCCCGGGCGGCCGCTCGACCTTCTCCCCTCTTGGTGTCTCCGACTGG 
AACTCCCTCTTCTACTCCATCCACCCCGGCGGCCGTGGCATCATCGACGGCGTTGCCGGC 
AACCTAGGGATCAAGGACGAGAACCTTGTGGCCACCAGGCACGTCCTCGGCGAGTACCTC 
GGCCGCGACCACGCTA 
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1.2. Core fragments (ESTs) encoding CPR 
 
>zwsca0_0001_G06.ab1  CHROMAT_FILE: zwsca0_0001_G06.ab1 PHD_FILE: 
zwsca0_0001_G06.ab1.phd.1 CHEM: term DYE: big TIME: Tue Jun 29 11:23:24 
2010 
GAGAAGGCGATAACCAGCTCCGAAAGTGCGCCACATTCAAGGAAATTGTT 
TAGTTCATCTTCGTAGATGAAATCCATCCTGCGATTTCTGCAGCCGAAAA 
ACAAAACGGCTGGTCCCAGTTCTGCTCCGGATTCTTTCAGGGCTAACCTT 
TCCTGCAGGAAACCCCTGAATGGAGCCAAGCCAGTACCTGCCCGGGCGGC 
CGCTCGAA 
 
 
>zwsca0_0015_G08.ab1  CHROMAT_FILE: zwsca0_0015_G08.ab1 PHD_FILE: 
zwsca0_0015_G08.ab1.phd.1 CHEM: term DYE: big TIME: Tue Jun 29 11:24:24 
2010 
GCCATGGCGGCCGCGGGAATCGATTAGCGTGGTCGCGGCCGAGGTACTGG 
CTTGGCTCCATTCAGGGGTTTCCTGCAGGAAAGGTTAGCCCTGAAAGAAT 
CCGGAGCAGAGCTGGGACCAGCCGTTTTGTTTTTCGGCTGCAGAAATCGC 
AGGATGGATCTCATCTACGAAGATGAACTAAACAATCGAGCGGCCGCCCG 
GGCAGGTACCTGAGTCTCCATTTTGCCGGAACTAATTGCTATAAAGATGT 
ATAACTTGGCTAGTTCGGGCATTCAACTTGGCAATTATAGTTGTCTTCAT 
CAAGGAGGGAGCTAAGTCTCAACTCATAGTTGAGGTGGAGCGAAATCTCT 
CGACCTTCTGCCAATGTAGGGAGATGCACACCCTGATAATATGGAGTGTG 
GTCTCTTCGCGAATGGATGGTCTAGGAGCTGAGCAGCAGTGGGACGAGCA 
CTGGGATCAACTTTCAGGCATTGCAGGATAAAATCCCTTGCATCAGTTGA 
AAGAGATTCAGGAACAGATGGTGGTATGCCTTTGCCAATTCTGTATATAG 
CCTGAAAAGAATCTAATTCCGAATAGGGAATCTGACTTGTTAACATCTCT 
AACACAGTGCATCCAAGGCTCCATATATCTGCAGGAAGCCCATACCCTTG 
GTTCTTTCGGTTCACAACCTCAGGAGCCATCCAGCATGCAGTACCTCGGC 
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1.3. Sequences from the H. perforatum transcriptome (MPGR) 
1.3.1. Locus 416 
>hpa_locus_416_iso_3_len_1885_ver_2 
CACGACGCTCTTCCGATCTGTGAATTATGAGCACACTGAACGTCGGTACACAGCTCCATA 
AATTTTTTTCGACAAGTACACATTATTATATATGTAAAAAAAGTATCCAGTTTCAAGGGA 
TTGAAGTTTGGACCACATCTCAACTTACAGATCCCAAAATTAAGGAAGCATTATTGGATA 
TTGCGTAGAAAGAAAAAATAAAATTAAACAAATATGCCAGCGCGAGAGAGGTTTAGAGCT 
GGGAGAGGAGGCCAGCCATCTTGGTGCGAGGCGTGAAGTCAGCCTCCAGTGGCTTCTTCC 
TTGACAGACTCGCGGTACCACGCGCGTGGCTCATGTCCTCGTCCATGCCGAGGTGGCCCC 
AGTCGAAGCACTGCATAAGAATTCCAATCCCCAGGGACGAAATGTGGGTCCCCATCCCTC 
CGCCGGGGCAAGACCTCCTCCCGACACCGAACGGCGCGTACTGGTACCCTCCTTCGCGGT 
CGTACTCCTCGAACCTCTCGGGCTTGAACGCGTCGGGCTCGTCCCATACTTTGGGGTCTC 
TCTGCATTGTCCACAGGTTGGCGAAGAGCATGGTTCCCTTGGGAATGTCGTAGCCTCCGA 
CGGTGCAGGCTTGGTTGGAGAAGTGGGGGAGGGAGAGTGGGGCCGGCGGGTACATCCTGA 
GCGTCTCCTTCACGACCGCCCTTAGGTAGGGAAGGTTGGCGAAGTCGGATTCGCACACGA 
AGCGGCTGTCTCCGACGACGCTGTCGATCTCGGCTTGTAGTTTCCGCATCTTCTCAGGGT 
GTTGCATCAGCAGTGTGAACGCCCACTCCAACGTGGCGGTCGACGTCTCGGTCCCGGCAA 
TAAACATCATCATAACAATTCCCTTGACGATGTCATCCGTGTAAAACTCAGGGTCTGTCT 
CTTGCAAGTTGAGGATGATATCGATAACGGAGACCCCTTCGCCGTTCTCGCCAACAGTGG 
TCTTCCCGGCGGCCGCCCTCCTGGCTCTGACCTCGGCGACAAGGCCGTTGAGGAAGACCT 
CCCTCTTCTCGGCCAGCTGGATCATGCTCTTCTCGATCCCCTTGTAACCGATCAGCCTCA 
TCACCGGGATGAAGTCGCATATGGTCATGGAGACGATAGGAAAGAAGAGATCCTTGAACT 
GCTGGAGCAGCCGCTTCTCCTCCTTGGTGTCCTCGTCGACGACCGGCACGTGCCTCTTCC 
CGGCCGCCACCCGCATGATCACGCTTGACGTCAGCAGGGCGAACATGTGCTTCATGTCCA 
CCTTGGAGTTGTTCCCTTTGACGGAGTACTTGAGAAGGCGGCCGGCCAGGTGGCGGATCT 
CCTCCTCCCGGATGTAGGCGGACCTCTGGAGGGCCTTGATGGAGAAGATCTCGGAGAAGG 
TGAGACGTCGGAGGCTCTTCCAGATGGGGCCGTGCGGGGCCCACACGAGGAAGGTGTAGT 
CGTAGGTGAGGTGCTCACCTGACATGGACTTCGGGCGGTCGGCGAAGACGACGTCGTTCT 
TTGTGAAGCACTCCTCGAAGGCCTCCGGGGAGGAGACGACGAGGACGGGGACCTTGCCCA 
TCCAGAAGAGAAGGACTGGGCCGAGCTTCTTGGAGACGCTCTCGAAGTACTGGTAGAGCG 
GGGGCTTGAGGACGGGGAGGTGTCCAACGATGGGATATGACCGTGGGCCCGGCGGGTAGT 
TGAGCTTCTTACCGAAGAGAACCTTGTAGCCGATGATGACGGAGACAAGAACGGCGACGT 
ACAGATACAAGTCCTCCATTTTATTTTTTTTTTCTTAAAGGAGTTGCTCTCTCTTCTCTA 
TTTCACAAGACGACGACGACGACTTCTTTTTTTTCTGATATGTATTTTGAGGGTTGTGGA 
ATAGAGAAGAGAGAGCAACTCCTTT 
 
 
>hpa_locus_416_iso_3_len_1885_ver_2 
MEDLYLYVAVLVSVIIGYKVLFGKKLNYPPGPRSYPIVGHLPVLKPPLYQYFESVSKKLG 
PVLLFWMGKVPVLVVSSPEAFEECFTKNDVVFADRPKSMSGEHLTYDYTFLVWAPHGPIW 
KSLRRLTFSEIFSIKALQRSAYIREEEIRHLAGRLLKYSVKGNNSKVDMKHMFALLTSSV 
IMRVAAGKRHVPVVDEDTKEEKRLLQQFKDLFFPIVSMTICDFIPVMRLIGYKGIEKSMI 
QLAEKREVFLNGLVAEVRARRAAAGKTTVGENGEGVSVIDIILNLQETDPEFYTDDIVKG 
IVMMMFIAGTETSTATLEWAFTLLMQHPEKMRKLQAEIDSVVGDSRFVCESDFANLPYLR 
AVVKETLRMYPPAPLSLPHFSNQACTVGGYDIPKGTMLFANLWTMQRDPKVWDEPDAFKP 
ERFEEYDREGGYQYAPFGVGRRSCPGGGMGTHISSLGIGILMQCFDWGHLGMDEDMSHAR 
GTASLSRKKPLEADFTPRTKMAGLLSQL 
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1.3.2. Locus 928 
>hpa_locus_928_iso_9_len_1841_ver_2 
AATGGAAGAGAGCACGTAGTAGCTAGTCGCTAGTGGTTCTCTCTCCTGAGTGAAGCACGA 
GTGATCTAGCTACTACGTGCTCTCTTCCATTTGCTTTTCTCAAAATGGACGGTTTATACT 
TAAAACTAGCCCTAACCCTTCTCCTCTCCATTTTTATCGCCTACAAGTTTTTCTTGCGTA 
AGAAGCACAACTATCCACCAGGCCCACGTGCCCTCCCCATCATAGGCAACCTCCACCTCA 
TCAAGCCCGGCCCACTCTATTTGTACTACGAAACGGTATCGAAGCGCCTCGGCCCGATCA 
TTCTCTTCTGGATGGGCAAGGTCCCGGTTATGGTCATCTCCTCCCCGGAGGCCTTTGAGG 
AGTGCTTCACCAAGAACGACCTCATCTTCGCGGACCGGCCGAAGACCGTGTCCGGCGACC 
ACTTGACCTACAACTACACCTTCATAGTCTTCGCTCCTCACGGCCCCATCTGGAAGAGCC 
TCCGCCGGCTTACCTTCTCCGAGATCTTCTCCCAGAAGGCCCTCCAGCGGTCTGCCTTCG 
TCCGCGAGGAGGAGGCTCGCCACTTCGTCGGCCGGCTTCTGAAGTGCACCGCCGGCGGGA 
ACAAACCCAAGCTAGACATGAAGTACATGCTCTCCCTGCTGACGTCCAGCGTGATCATGA 
GGGTGGCAGCTGGAAAACGGCACGTGGCGGTCTCCGACGAGGACACCGAGGAGGAGAAGC 
GGCTGATGCAAGAGTTCAAGGACCTCTTCTTCCTTATCGTCTCCATGACGCCTTGTGACT 
TCATCCCGGTGCTGAGAATGATCGGTTTCAAGGGCATCGAGAAGAGCATAATCCAGTTGG 
GAAAGAAAAGGGAGGTATTCTTGAACAAGTTGCTCGTCGAAGTTAGGGCGCGGAGAAGGG 
CGGATGCCGAGAAGCGGTTGAACGGCGAGAAGCGGAACGCGGTTGTCGATACCTTGCTCA 
ACTTGCAGGAGACCGATCCTGAGTTTTACACCGATGACATTATCAAGGGAATTATCACGA 
TGATGTTTATAGCCGGGACCGAAACGTCAACTGCCACGTTGGAGTGGGCGTTGACCCTCC 
TCTTGCAGCACCCAGAGAAGATGGAAAAGCTGCGGGCCGAGATCGACGGGGTCGTGGGAG 
ACACTCGGCTCGTGAACGAGTCCGACTTCTCAAAACTTCCGTACCTCAAGGCCGTCGTGA 
AGGAGACGATGAGGCTGTTTCCTCCGTCCCCGCTCTTGCTACCTCGTTACTCGAGCGAGG 
CTTGCACTATCGGNNNNNNNNNNGCTACTACGTCCCCAAGGGAACCATGCTCCTGGTCAA 
CGTATGGACCATGCACAGGGACCCAAAGCTATGGGACGAACCGAACGAGTTCAAGCCCGA 
GAGGTTCGTGGCAGGTGACCTTGACGGGTACCTGTACCAGCCGTTTGGCCATGGGAGGAG 
GATCTGCCCAGGGGCCGGAATGGGAACCCATATCGTGTGCGAGACATTGGGAATGCTCGT 
GCAGNNNNNNNNNNTTTGATTGGGACCAGATCGGTATGGACGAGGACATGACCCACCAAG 
CCGGTGCGGCTAGTATGTCCAAGAACAAGCCATTGGAGGCAAGCTTCGCTCCTCGATCCG 
AGATGGCCAAGCTCCTTTCCCAACTCTAGCTAGACGAGCCGCGGATCAATTATATGTTTC 
TATGTATAAAACTTTGTAATAATGGCATGACTCTCGGACGTGCATGTGTTCTAGTTTGTG 
TATTGTGTTTGATGAGGCTATCCCATGTTGATTTAGCTAGATGTGTTCAGTATTTCTGTT 
AATTTTGTGTTCATCTTTTCCGCGTTGGAATAATATATTCT 
 
>hpa_locus_928_iso_9_len_1841_ver_2 
MDGLYLKLALTLLLSIFIAYKFFLRKKHNYPPGPRALPIIGNLHLIKPGPLYLYYETVSK 
RLGPIILFWMGKVPVMVISSPEAFEECFTKNDLIFADRPKTVSGDHLTYNYTFIVFAPHG 
PIWKSLRRLTFSEIFSQKALQRSAFVREEEARHFVGRLLKCTAGGNKPKLDMKYMLSLLT 
SSVIMRVAAGKRHVAVSDEDTEEEKRLMQEFKDLFFLIVSMTPCDFIPVLRMIGFKGIEK 
SIIQLGKKREVFLNKLLVEVRARRRADAEKRLNGEKRNAVVDTLLNLQETDPEFYTDDII 
KGIITMMFIAGTETSTATLEWALTLLLQHPEKMEKLRAEIDGVVGDTRLVNESDFSKLPY 
LKAVVKETMRLFPPSPLLLPRYSSEACTIGXXXATTSPREPCSWSTYGPCTGTQSYGTNR 
TSSSPRGSWQVTLTGTCTSRLAMGGGSAQGPEWEPISCARHWECSCXXXXFDWDQIGMDE 
DMTHQAGAASMSKNKPLEASFAPRSEMAKLLSQL 
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1.3.3. Locus 8128 
>hpa_locus_8128_iso_3_len_1785_ver_2 
GTCCACACCAACGCATCATAGTTCTTACACTATCCATAACATCGATGGAATTGTATTTGT 
ATCTAGCCGCCTTCTTCTTGGCTTTTTCCGCTTTCAAAATCTTGTCTCGAAAAAAGCACA 
ATTTTCCGCCTGGCCCACGGACTCTCCCTGTCGTCGGTAATCTCCACCTCATCAAACCAC 
CGCTCTACCGTTTTTTCCAGACAGCTTCTGGCAGATTCGGCCCAATCATGTTATTTTGGA 
TGGGCCGGACCCCGTTCTTGGTCGTCTCCTCCCCGGCCGCCGTCGAGGAGTGCTTCACTA 
AGAACGACATCATCTTCGCCGACCGGCCCAACTCCATGTCCGGCGACCACCTCACTTACA 
ACTACNNNNNNNNNNNNTTACAACTACCAGTTCCTCGTCTGGGCCCACCACGGCCCGCTT 
TGGAAGAACCTCCGCCGCCTCACCTACACCGAGATCTTCTCCCTCAAAGCCCTCCAGAGG 
TCCGCCTTCGTCAGGGAGGAGGAGACCAGCCACTTCGCCGGAAGACTGCTCCGGTACTGC 
TCCTCCGGCAAGACGAAGCTGAACATGAAGTACATGTTCTCCCTGCTGGCGTCCAGCGTG 
ATCATGAGGGTGGCGGCCGGGAAGCGGCACGTGGCAGTCCACGACGAGGACACGGAGGAA 
GAGAGGCGGCGGATCAAGGAGTTCAAGGAGCTGTTCTTCCCCGTCGTGACGCCGGCGGTG 
GGAGATTATATTCCGGTGCTGAGGACGATCGGGTACAAGGGGGTCGAGAAGGGGATGATC 
CGGCTGGCCCAGAAGAGGGACGTGTACTTGAACAACTTGGTCGCGGAGGTTAGGGCAAAG 
AGGGCGGCTTCCGGCAAGAGGTCAAGCGGCGAGGACGGAGACAAGCTCAGCTCCGTCGCT 
GACACCGTTCTCAACTTGCAGGAGACCCAACCTGAGGTTTACACCGATGACATCGTCAAG 
AGTTTGATCATGATGATGTTTATCGCCGGAACCGAAACGTCAACGACCGTGCTGGAGTGG 
TCGTTGACCCTCCTCCTGCAACACCCAAATAAGATGCAAAAGTTACAAGCCGAGATCGAC 
GGCATCACCGGAGAGAGCCGCCTGATGAACGAATCCGACCTCCCCAACCTCCCCTACCTC 
CGGGCCGTCGTCAAGGAGGCGTTAAGGTTGTTCCCTCCGGTCCCACTCTTGCTGCCTCAC 
TTCTCGACCGATGCATGCACCGTTGGAGGCTACGACATCCCCAAAGGAACCATGCTCTTG 
GTCAACGTGTGGGCCATGCACAGGGACCCGAAGCTGTGGGACGAACCCACCGAGTTCAGG 
CCCGAGAGGTTCGTCGAAACGAACCTCGACACGTACCTGCTCGTGCCGTTTGGTGTTGGG 
AGGAGGGCATGTGCTGGAAACACGATGGGAACCCACATGGTGTGCGTGGCGTTGGGCGTG 
CTCATGCAGTGCTTCGACTGGGACCAGCTCGGCATGGACGAGGACATGAGCCACGCCGTT 
GGCGCGGGTACCTTGTCCAAGGGCAAGCCATTGGAGGCGAGCTTCGCACCTCGGCCCAAG 
ATGACCAACCTCCTCAGTTCTCTACTCTCTTAGTCCCAAAGATTGTGTTCGGACCTATTT 
TATAAGTTTCTCTTTCAATAAAGCGTCTTTTGTGCGCCTAATAAAAATTTTAATGCTCGG 
ATTTGTGTACCGAGTTTAAGTTGCGTGCTTGTACCATTAAATGTAACATTTCGGATAAAA 
TCAAATATTTATGTTAGTTAATTATTATCAATAATGCTATTCCCG 
 
>hpa_locus_8128_iso_3_len_1785_ver_2 
XPHQRIIVLTLSITSMELYLYLAAFFLAFSAFKILSRKKHNFPPGPRTLPVVGNLHLIKP 
PLYRFFQTASGRFGPIMLFWMGRTPFLVVSSPAAVEECFTKNDIIFADRPNSMSGDHLTY 
NYXXXXLQLPVPRLGPPRPALEEPPPPHLHRDLLPQSPPEVRLRQGGGDQPLRRKTAPVL 
LLRQDEAEHEVHVLPAGVQRDHEGGGREAARGSPRRGHGGREAADQGVQGAVLPRRDAGG 
GRLYSGAEDDRVQGGREGDDPAGPEEGRVLEQLGAEVRAKRAASGKRSSGEDGDKLSSVA 
DTVLNLQETQPEVYTDDIVKSLIMMMFIAGTETSTTVLEWSLTLLLQHPNKMQKLQAEID 
GITGESRLMNESDLPNLPYLRAVVKEALRLFPPVPLLLPHFSTDACTVGGYDIPKGTMLL 
VNVWAMHRDPKLWDEPTEFRPERFVETNLDTYLLVPFGVGRRACAGNTMGTHMVCVALGV 
LMQCFDWDQLGMDEDMSHAVGAGTLSKGKPLEASFAPRPKMTNLLSSLLS 
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1.3.4. Locus 51544 
>hpa_locus_51544_iso_1_len_1149_ver_2 
TTTCTTTCTTAATTCCCATTAGCTCTTCACAAAATGGAGGACTTGTACTTCTACCTCGCC 
GTTATTCTATCAGCTTTTGTCGCTTACAAGGTGTTGTCCAGAAAGAAACATAACTACCCT 
CCAAGCCCAAGGGCGCTCCCCATCTTTGGCCACCTCCACCTCGTCAAATACCCTCTCTAT 
ATGTACTTCCAAACCGTCTCCAACCTCCTCGGCCCGATCCTGCTCTTCTGGATGGGCAAG 
GTCCCGGTCCTGGTCATCTCCTCTCCCGCGGCCTTCGAGGAGTGCTTCACCACGAACGAC 
GTTGTATTCGCCGACAGGCCTAAGTCCATCACCACTGACCACCTAACCTACGACTACACC 
TTCATGGTCTGGGCCCCACATGGCCAGCTCTGGAAAAGCCTCCGCCGCCTCACATTCTCC 
GAGATCTTCTCCCAGAGAGCCCTCCAGAGAACCGCCATCGTTAGGGAAGAGGAGATCCGC 
CACTTTGTCGGCCGGCTCCTTCAATACACTGTAGGCGGGGGCAAGCCCAAGGTTGACATG 
CAGCGCATGTTGTCTCTGTTAGCGTCCAACGTGATCATGAAAGTTGCGGCAGGGAAGAGA 
CACGTGCCGATCAGTGACGAGGACACCGACGAGGAGGAGCGGCTGCTCCAGCAGTTCAAG 
GACCTCTTCTTTGCTATTGTGGCGATGACGCCATGCGACTTCATCCCATTTCTGAGGTTT 
ATCGGGTACAAGGGGACAGAGAAGAGAATCATCCGACTGGGGGAGAAGAGGGATGTCTTC 
CTTAACGGCTTACTTGCCAATATTAGGGCAAAGAGGGCGGCTGCTCGGAAGGGGACAAAT 
AATAAGGAGGGCGACAAGCTTAGCTCAGTGGTGGATACCATCCTTGACTTGCAGGAGACA 
GACCCTCTGTTCTTTACCGACGAAATCGTCAAGGGCATTACAATGATGATGTTCAAGATC 
GGAAGAGCGGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN 
NNNNTCCTTATGCAGCACCCGGAGAAGATCCAAAAATTACAGGCCGAAATTGACAACGTC 
GTAGGAGATAGAAGATTCCTCAATGAATATGACTTGGCCAACCTTCCTTACCTTAGAGCA 
GTCGTGAAG 
 
 
>hpa_locus_51544_iso_1_len_1149_ver_2 
MEDLYFYLAVILSAFVAYKVLSRKKHNYPPSPRALPIFGHLHLVKYPLYMYFQTVSNLLG 
PILLFWMGKVPVLVISSPAAFEECFTTNDVVFADRPKSITTDHLTYDYTFMVWAPHGQLW 
KSLRRLTFSEIFSQRALQRTAIVREEEIRHFVGRLLQYTVGGGKPKVDMQRMLSLLASNV 
IMKVAAGKRHVPISDEDTDEEERLLQQFKDLFFAIVAMTPCDFIPFLRFIGYKGTEKRII 
RLGEKRDVFLNGLLANIRAKRAAARKGTNNKEGDKLSSVVDTILDLQETDPLFFTDEIVK 
GITMMMFKIGRAXXXXXXXXXXXXXXXXXXXLMQHPEKIQKLQAEIDNVVGDRRFLNEYD 
LANLPYLRAVVK 
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1.4. Sequences of the cloned genes 
1.4.1. HcCYP81AA1 (B3′H/1,3,7-TXS); NCBI accession number: KT716863 
 
>HcCYP81AA1 
GACAGCCCACAACTCTCAAAATACACATCACATAAAAATAAGTCGTCGTCTTGTAAAACAGAAGAGAGAG 
ATCAACTCCTTTTAAAAAAATGGAGGACTTGTACTTGTACCTCGCCGTTCTCGTCTCCGTCGTCGTCGGC 
TACAAGGTTCTCTTCGGTAAGAAGCTCAAATACCCGCCGGGCCCACGTGCACTTCCCATCGTCGGTCACC 
TCCCCGTCCTCAAGCCCCCGCTCTACCAGTACTTCGAGAGCGTCTCCAAGAAACTTGGCCCGGTCTTGCT 
CTTCTGGATGGGCAAGGTCCCCGTCCTCGTTGTCTCCTCCCCGGAGGCCTTTGAGGAGTGCTTCACCAAG 
AACGACGTCGTCTTTGCCGACCGCCCCAAGTCCATGTCCGGCGAGCATCTCACCTATGACTACACCTTCC 
TCGTGTGGGCCCCCCACGGCCCCATCTGGAAGAGCCTCCGTCGGCTCACCTTCTCGGAGATCTTCTCCAT 
CAAGGCCCTCCAGAGGTCGGCCTTCATCCGGGAGGAGGAGATCCGGCACCTCGCCGGCCGCCTGCGGAAG 
TACACCGTCAACGGGAACAACTCCAAGGTGGACATGAAGCACTTGTTCGCCCTGCTGACGTCGAGCGTGA 
TCATGCGGGTGGCGGCCGGGAAGAGGCACGTGCCGGTCGCCGACGAGGACACCAAGGAGGAGAAGCGGCT 
GCTCCAGCAGTTCAAGGACCTCTTCTTCCCTATCGTCTCGATGACCGTATGTGACTTCATCCCGGTGATG 
AGGCTGATCGGGTACAAGGGGATCGAGAAGAGCATGATCCAGCTGGCCGAGAAGAGGGAGGTCTTCCTTA 
ACGCCCTGGTCGCCGAGGTCAGAGCCAGGAGGGCCGCCGGCGGGAAGACGACAGTTGGCGAGAACGGCGA 
AGGGGTCTCTGTGATCGATATCATCCTCAACTTGCAGGAGACAGACCCCGAGTTTTACACCGATGCCATC 
GTCAAGGGTATTGTTATGATGATGTTTATCGCCGGGACCGAGACGTCGACCGCCACGTTGGAGTGGGGGT 
TCACTCTCCTAATGCAACACCCAGAGAAGATGCGCAAACTACAAGCCGAGATCGACAGCGTCGTAGGAGA 
CAGCCGCTTCGTGAGCGAAGCCGACTTCGCCAATCTTCCCTACCTAAGGGCCGTCGTGAAGGAGACACTA 
AGGCTGTACCCGCCGGCCCCACTCTCCCTCCCCCACTTCTCTAACCAAGCCTGCACCGTCGGAGGCTACG 
ACATTCCCAATGGAACCATGCTCTTCGCCAACTTGTGGGCAATGCAGAGAGACCCTAAAGTATGGGACGA 
GCCTGACGCGTTCAAGCCCGAGAGGTTCGAGGAATACGACCGTGAAGGCGGGTACCAGTACGCGCCGTTT 
GGTGTCGGGAGGAGGTCGTGCCCCGGCGGAGGGATGGGGACCCACATTTCGTGCCTGGGGATTGGAATCC 
TGATGCAGTGCTTCGACTGGGGCCAGCTCGGTATGGACGAGGACATGAGCCACGCGCGTGGTACCGCAAG 
TTTGTCGAGGAAGAAGCCGTTGGAGGCTGACTTCACGCCTCGCACCAAGATGGCCGGTCTCCTTTCCCAG 
CTCTAAACCTCTCTCGCGCCGGCTTATTTGTTCAATTTTATTTTTACTTTTTCTGAAACTATTGAATAAT 
GCTGATATGTACCTCGAGACGTGGTTCAAACTTCAAATCTTTTGGACTGTATACTTTTTTTTTATATAAA 
TGTGTACTTGTTGGAAAAATAATTGTAGACCTGTGTACCGAATTTTAGTATAAAAAAAAAAAAAAAAAAA 
AAAAAAAAAA 
 
 
>HcCYP81AA1 
MEDLYLYLAVLVSVVVGYKVLFGKKLKYPPGPRALPIVGHLPVLKPPLYQYFESVSKKLGPVLLFWMGKV 
PVLVVSSPEAFEECFTKNDVVFADRPKSMSGEHLTYDYTFLVWAPHGPIWKSLRRLTFSEIFSIKALQRS 
AFIREEEIRHLAGRLRKYTVNGNNSKVDMKHLFALLTSSVIMRVAAGKRHVPVADEDTKEEKRLLQQFKD 
LFFPIVSMTVCDFIPVMRLIGYKGIEKSMIQLAEKREVFLNALVAEVRARRAAGGKTTVGENGEGVSVID 
IILNLQETDPEFYTDAIVKGIVMMMFIAGTETSTATLEWGFTLLMQHPEKMRKLQAEIDSVVGDSRFVSE 
ADFANLPYLRAVVKETLRLYPPAPLSLPHFSNQACTVGGYDIPNGTMLFANLWAMQRDPKVWDEPDAFKP 
ERFEEYDREGGYQYAPFGVGRRSCPGGGMGTHISCLGIGILMQCFDWGQLGMDEDMSHARGTASLSRKKP 
LEADFTPRTKMAGLLSQL 
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1.4.2. HcCPR2 (NADPH-dependent cytochrome P450 oxidoreductase); NCBI accession 
number: KT777456 
>HcCPR2 
GGCCAAAAAAAAAAACAAAACTCTCTTCTCCCTCCCACCAACCAGCCTCGAAACGCACCGTTTTAGAGAG 
AGAAAGAGAGGGAGAAACAGAACTCGCGCGAAGTAACCGCTAAACTAATGGAACCGACGGGGAGCTCGAC 
GGCGATGAAGGTGTCGCCGCTTGATCTAATGGCTGCGATTTTAAAGGGCGGCCGTGTGGACCCCGCGAAC 
GCCTCGTCCGCCGGTCCCGAGGTGGTTTCGATGATACTGGGGAACAGGGAGACGGTTGTTATGGTCGTGG 
CCACCTCCATCGCCGTGATCATCGGATGCGCGGTCTTCCTCTTCTGGCGGCGGTCGTCGTCGTCCCGGGT 
TAAGCCGAAGCCCCACCCGCTCCGGCCGATCGCTATGAGAGATCTCGACCTCGACGAGGCCGTCGACGGG 
AAGAAGAAGGTCACTATCTTGTTCGGCACCCAAACCGGAACCGCCGAAGGCTTTGCTAAGGCTTTGGCCG 
AGGAAGCAAAGGCGCGGTATGACAAGGCGGTCTTCAAAGTTGTTGACTTGGATGACTATGCTGCGGATGA 
TGAAGAGTATGAGGAGAAGTTGAAGAAGGAAGATTTGGTTGTCCTCTTCTTGGCCACGTACGGAGACGGT 
GAGCCGACAGATAATGCTGCTAGGTTTTATAAATGGCTTACCGAGGGGAATGAGAGAAGTGAGTGGCTGA 
AACACCTCCAGTTTGCAGTGTTTGGCTTAGGGAACAGGCAGTATGAGCACTTTAACAAGGTTGCAATTGT 
GGTGGATGAGATTCTTGCCAAAGAAGGTGCAAAGCGCCTTGCTCCAGTCGGTCTCGGAGATGATGATCAA 
TGCATCGAAGATGATTTCAATGCATGGCGAGAGGCATTGTGGCCCGAAATGGATCAGTTGCTCCACGATG 
AAGATGATGTGACAACTGTTGCTACTCCATACACTGCTGCAGTTCCTGAATATCGTGTAGTGTTTAATGA 
CTCTGTTGATCCAAATGTTGAGGATAAAAACTGGAGCAATGCAAATGGCCATGCTGTTTATGATGCTCAA 
CATCCATGCCGGGCAAATGTTGCAGTCAGGAAGGAGCTTCATTCTCCTGCATCTGATCGTTCTTGCACCC 
ATCTAGAGTTTGACATAGCTGGCACTGGACTTTCTTATGAAACCGGGGACCATGTTGGTGTTTATTGCGA 
GAACTTAGAGGAAACAGTGGAAGAAGCCTTGCAATTATTGGGCTTGTCGCCAGATACTTACTTTTCTCTT 
CATAGCAATAAAGAGGACGGGACACCCCTTGGAGGTTCTCTGTCACCTCCTTTCCCACCTTGCACGTTAA 
GAACAGCTCTGGCTAGATATGCTGACCTTTTGAGTTCTCCCAAAAAGTCTGCACTGCTGGCTTTAGCTGC 
ACATGCCACTGATCCAACTGAAGTTGATCGACTGAGGCATCTTGCATCCCTGGCGGGAAAGGATGATTAT 
GCACAATGGATGGTTGCCAATCAAAGAAGCCTCCTTGAGGTCATGGCTGAATTTCCTTCTGCCAAGCCCC 
CTCTTGGTGTCTTTTTTGCTGCAGTTGCCCCACGCTTACAGCCAAGATACTATTCTATCTCGTCATCACC 
CAAGATTGCACCAACTAGGATTCATGTGACCTGTGCCCTAGTTCTCGAGAAGACACCAACCGGTCGGATT 
CATAAGGGAATTTGCTCAACTTGGATGAAGAATGCCATCCCCATGGAGAAAAGCAATGATTGCAGCTGGG 
CTCCAGTTTTTGTTAGACAATCAAACTTTAAACTTCCAGCAGATCCTAAGGTCCCTGTTATAATGATTGG 
TCCTGGTACTGGCTTGGCTCCATTCAGGGGTTTCCTGCAGGAAAGGTTAGCCCTGAAAGAATCCGGAGCA 
GAACTGGGACCAGCCGTTTTGTTTTTCGGCTGCAGAAATCGCAGGATGGATTTCATCTACGAAGATGAAC 
TAAACAATTTCCTTGAATGTGGCGCACTTTCGGAGCTGGTTATCGCCTTCTCCCGTGAAGGACCCACCAA 
GGAGTACGTGCAACATAAAATGGCCGAGAAGGCCTCGGATATTTGGAACATGATTTCTCAAGGAGGTTAT 
CTTTACGTTTGTGGGGATGCCAAAGGAATGGCAAAAGATGTGCACAGAACTCTCCACACCATTGTCCAAG 
AACAGGGATCACTTGATAGCTCAAAAACAGAGAGCATGGTCAAGAATTTACAAATGAATGGGCGGTACCT 
TCGCGACGTATGGTGATGAGTTAAAAGAGCCAAATTCCTACATTTACATGTAGTGGGACCACCCCAACCG 
TTGGATGATGCTGCGAAATTAATTTCGGAAAGGCTACCGCTACATTTTTCTTCTATGGTTGCTTTATTCT 
TTTTCTTCTTATTTGGAAGATAAAATTATTCCTGTAATCTATAAATGACTCACAATAGCGCCATAAATGG 
TATTAGGTGTCTTAGTTATTAAATATATATATCTTACTGTATTTCTATGTAAACCGAAATATTAAATATT 
ATCATGTAGTGTACTACTTCTCTATCCATTCACTCGGCGCAGTGGAAAAATAAAAAAAAAAAAAAAAAAA 
AAAAAAAAA 
 
>HcCPR2 
MEPTGSSTAMKVSPLDLMAAILKGGRVDPANASSAGPEVVSMILGNRETVVMVVATSIAVIIGCAVFLFW 
RRSSSSRVKPKPHPLRPIAMRDLDLDEAVDGKKKVTILFGTQTGTAEGFAKALAEEAKARYDKAVFKVVD 
LDDYAADDEEYEEKLKKEDLVVLFLATYGDGEPTDNAARFYKWLTEGNERSEWLKHLQFAVFGLGNRQYE 
HFNKVAIVVDEILAKEGAKRLAPVGLGDDDQCIEDDFNAWREALWPEMDQLLHDEDDVTTVATPYTAAVP 
EYRVVFNDSVDPNVEDKNWSNANGHAVYDAQHPCRANVAVRKELHSPASDRSCTHLEFDIAGTGLSYETG 
DHVGVYCENLEETVEEALQLLGLSPDTYFSLHSNKEDGTPLGGSLSPPFPPCTLRTALARYADLLSSPKK 
SALLALAAHATDPTEVDRLRHLASLAGKDDYAQWMVANQRSLLEVMAEFPSAKPPLGVFFAAVAPRLQPR 
YYSISSSPKIAPTRIHVTCALVLEKTPTGRIHKGICSTWMKNAIPMEKSNDCSWAPVFVRQSNFKLPADP 
KVPVIMIGPGTGLAPFRGFLQERLALKESGAELGPAVLFFGCRNRRMDFIYEDELNNFLECGALSELVIA 
FSREGPTKEYVQHKMAEKASDIWNMISQGGYLYVCGDAKGMAKDVHRTLHTIVQEQGSLDSSKTESMVKN 
LQMNGRYLRDVW 
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1.4.3. HpCYP81AA1 (B3′H/1,3,7-TXS); NCBI accession number: KT716864 
 
>HpCYP81AA1 
ATGGAGGACTTGTATCTGTACGTCGCCGTTCTTGTCTCCGTCATCATCGGCTACAAGGTTCTCTTCGGTA 
AGAAACTCAACTACCCGCCGGGCCCACGGGCATATCCCATCGTCGGACATCTCCCCGTCCTCAAGCCCCC 
GCTCTACCAGTACTTCGAGAGCGTCTCCAAGAAGCTCGGCCCAGTCCTTCTCTTCTGGATGGGCAAGGTC 
CCCGTCCTCGTCGTCTCCTCCCCGGAGGCCTTCGAGGAGTGCTTCACAAAGAACGACGTCGTCTTCGCCG 
ACCGCCCGAAGTCCATGTCAGGTGAGCACCTCACCTACGACTACACCTTCCTCGTGTGGGCCCCGCACGG 
CCCCATCTGGAAGAGCCTCCGACGTCTCACCTTCTCCGAGATCTTCTCCATCAAGGCCCTCCAGAGGTCC 
GCCTACATCCGGGAGGAGGAGATCCGCCACCTGGCCGGCCGCCTTCTCAAGTACTCCGTCAAAGGGAACA 
ACTCCAAGGTGGACATGAAGCACATGTTCGCCCTGCTGACGTCAAGCGTGATCATGCGGGTGGCGGCCGG 
GAAGAGGCACGTGCCGGTCGTCGACGAGGACACCAAGGAGGAGAAGCGGCTGCTCCAGCAGTTCAAGGAT 
CTCTTCTTTCCTATCGTCTCCATGACCATATGCGACTTCATCCCGGTGATGAGGCTGATCGGTTACAAGG 
GGATCGAGAAGAGCATGATCCAGCTGGCCGAGAAGAGGGAGGTCTTCCTCAACGGCCTTGTCGCCGAGGT 
CAGAGCCAGGAGGGCGGCCGCCGGGAAGACCACTGTTGGCGAGAACGGCGAAGGGGTCTCCGTTATCGAT 
ATCATCCTCAACTTGCAAGAGACAGACCCTGAGTTTTACACGGATGACATCGTCAAGGGAATTGTTATGA 
TGATGTTTATTGCCGGGACCGAGACGTCGACCGCCACGTTGGAGTGGGCGTTCACACTGCTGATGCAACA 
CCCTGAGAAGATGCGGAAACTACAAGCCGAGATCGACAGCGTCGTCGGAGACAGCCGCTTCGTGTGCGAA 
TCCGACTTCGCCAACCTTCCCTACCTACGGGCGGTCGTGAAGGAGACGCTCAGGATGTACCCGCCGGCCC 
CACTCTCCCTCCCCCACTTCTCCAACCAAGCCTGCACCGTCGGAGGCTACGACATTCCCAAGGGAACCAT 
GCTCTTCGCCAACCTGTGGACAATGCAGAGAGACCCCAAAGTATGGGACGAGCCCGACGCGTTCAAGCCC 
GAGAGGTTCGAGGAGTACGACCGCGAAGGAGGGTACCAGTACGCGCCGTTCGGTGTCGGGAGGAGGTCTT 
GCCCCGGCGGAGGGATGGGGACCCACATTTCGTCCCTGGGGATTGGAATTCTTATGCAGTGCTTCGACTG 
GGGCCACCTCGGCATGGACGAGGACATGAGCCACGCGCGTGGTACCGCGAGTCTGTCAAGGAAGAAGCCA 
TTGGAGGCGGACTTCACGCCTCGCACCAAGATGGCCGGTCTCCTCTCCCAGCTCTAA 
 
 
>HpCYP81AA1 
MEDLYLYVAVLVSVIIGYKVLFGKKLNYPPGPRAYPIVGHLPVLKPPLYQYFESVSKKLGPVLLFWMGKV 
PVLVVSSPEAFEECFTKNDVVFADRPKSMSGEHLTYDYTFLVWAPHGPIWKSLRRLTFSEIFSIKALQRS 
AYIREEEIRHLAGRLLKYSVKGNNSKVDMKHMFALLTSSVIMRVAAGKRHVPVVDEDTKEEKRLLQQFKD 
LFFPIVSMTICDFIPVMRLIGYKGIEKSMIQLAEKREVFLNGLVAEVRARRAAAGKTTVGENGEGVSVID 
IILNLQETDPEFYTDDIVKGIVMMMFIAGTETSTATLEWAFTLLMQHPEKMRKLQAEIDSVVGDSRFVCE 
SDFANLPYLRAVVKETLRMYPPAPLSLPHFSNQACTVGGYDIPKGTMLFANLWTMQRDPKVWDEPDAFKP 
ERFEEYDREGGYQYAPFGVGRRSCPGGGMGTHISSLGIGILMQCFDWGHLGMDEDMSHARGTASLSRKKP 
LEADFTPRTKMAGLLSQL 
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1.4.4. HpCYP81AA2 (B3′H/1,3,5-TXS); NCBI accession number: KT716865 
 
>HpCYP81AA2 
ATGGACGGTTTATACTTAAAACTAGCCCTAACCCTTCTCCTCTCCATTTTTATCGCCTACAAGTTTTTCT 
TGCGTAAGAAGCACAACTATCCACCAGGCCCACGTGCCCTCCCCATCATAGGCAACCTCCACCTCATCAA 
GCCCGGCCCACTCTATTTGTACTACGAAACGGTATCGAAGCGCCTCGGCCCGATCATTCTCTTCTGGATG 
GGCAAGGTCCCGGTTATGGTCATCTCCTCCCCGGAGGCCTTTGAGGAGTGCTTCACCAAGAACGACCTCA 
TCTTCGCGGACCGGCCGAAGACCGTGTCCGGCGACCACTTGACCTACAACTACACCTTCATAGTCTTCGC 
TCCTCACGGCCCCATCTGGAAGAGCCTCCGCCGGCTTACCTTCTCCGAGATCTTCTCCCAGAAGGCCCTC 
CAGCGGTCCGCCTTCGTCCGCGAGGAGGAGGCTCGCCACTTCGTCGGCCGGCTTCTGAAGTGCACCGCCG 
GCGGGAACAAACCCAAGCTAGACATGAAGTACATGCTCTCCCTGCTGACGTCCAGCGTGATCATGAGGGT 
GGCAGCTGGAAAACGGCACGTGGCGGTCTCCGATGAGGACACCGAGGAGGAGAAGCGGCTGATGCAAGAG 
TTCAAGGACCTCTTCTTCCCTATCGTCTCGATGACGCCGTGTGACTTCATCCCGGTGCTGAGGATGATCG 
GGTTCAAGGGCATCGAGAAGAGCATAATCCAGTTGGGAAAGAAGAGAGAGGTATTCTTGAACAAGTTGCT 
CGTCGAAGTTAGGGCGAGGAGAGGGGCGGATGCCGAGAAGCGGTTGAACGGCGAGAAGCCGAACGCGGTG 
GTCGATACCTTGCTCAACTTGCAGGAGACCGATCCTGAGTTTTACACCGATGACATTATCAAGGGAATTA 
TCACGATGATGTTCATAGCCGGGACCGAAACGTCAACTGCCACGTTGGAGTGGGCGTTGACCCTCCTCTT 
GCAGCACCCAAAGAAGATGGAAAAGCTGCGGGCCGAGATCGACGGGGTCGTGGGAGACACTCGGCTCGTG 
AACGAGTCCGACTTCTCAAAACTTCCGTACCTCAAGGCCGTCGTGAAGGAGACGATGAGGCTGTATCCTC 
CGTCCCCGCTCTTGCTACCTCGTTATTCGAGCGAGGCTTGCACTATCGGAGGCTACTACGTCCCCAAGGG 
AACCATGCTCCTGGTCAACGTATGGACCATGCACAGGGACCCAAAACTATGGGACGAACCGAACGAGTTC 
AAGCCCGAGAGGTTCGTGGAAGGCGACCTTGAGGGGTACCTGTACCAGCCGTTTGGCCACGGGAGGAGGA 
TCTGCCCAGGAGCCGGAATGGGAACCCATATCGTCTGCGAGACATTGGGAATGCTCGTGCAGTGCTTTGA 
CTGGGACCAGATCGGTATGGACGAGGACATGACCCACCAAGCCGGTGCGGCTAGTATGTCCAAGAACAAG 
CCATTGGAGGCAAGCTTCGCACCTCGATCCGAGATGGCCAAGCTCCTTTCCCAACTCTAG 
 
 
>HpCYP81AA2 
MDGLYLKLALTLLLSIFIAYKFFLRKKHNYPPGPRALPIIGNLHLIKPGPLYLYYETVSKRLGPIILFWM 
GKVPVMVISSPEAFEECFTKNDLIFADRPKTVSGDHLTYNYTFIVFAPHGPIWKSLRRLTFSEIFSQKAL 
QRSAFVREEEARHFVGRLLKCTAGGNKPKLDMKYMLSLLTSSVIMRVAAGKRHVAVSDEDTEEEKRLMQE 
FKDLFFPIVSMTPCDFIPVLRMIGFKGIEKSIIQLGKKREVFLNKLLVEVRARRGADAEKRLNGEKPNAV 
VDTLLNLQETDPEFYTDDIIKGIITMMFIAGTETSTATLEWALTLLLQHPKKMEKLRAEIDGVVGDTRLV 
NESDFSKLPYLKAVVKETMRLYPPSPLLLPRYSSEACTIGGYYVPKGTMLLVNVWTMHRDPKLWDEPNEF 
KPERFVEGDLEGYLYQPFGHGRRICPGAGMGTHIVCETLGMLVQCFDWDQIGMDEDMTHQAGAASMSKNK 
PLEASFAPRSEMAKLLSQL 
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1.4.5. HpCYP81AA3; NCBI accession number: KT716866 
 
>HpCYP81AA3 
ATGGAATTGTATTTGTATCTAGCCGCCTTCTTCTTGGCTTTTTCCGCTTTCAAACTCTTGTCTCGAAAGA 
AGCACAATTATCCACCTGGCCCACGGGCTCTCCCGGTCGTCGGTAATCTCCACCTTATCAAACCACCGCT 
CTACCGTTTTTTCCAGACAGCTTCTGGCAGATTCGGCCCAATCATGTTATTTTGGATGGGCCGGACCCCG 
TTCTTGGTCGTCTCCTCCCCGGACGCCGTCGAGGAGTGCTTCACTAAGAACGACATCATCTTCGCCGACC 
GGCCCAACTCCATGTCCGGCGACCACCTCACTTACAACTACCAGTTCCTCGTCTGGGCCCACCACGGCCC 
GCTTTGGAAGAACCTCCGCCGCCTCACCTACACCGAGATCTTCTCCCTCAAAGCCCTCCAGAGGTCTGCC 
TTCGTCAGGGAGGAGGAGACCAGCCACTTCGCCGGAAGACTGCTCCGGTACTGCTCCTCCGGCAAGACGA 
AGCTGAACATGAAGTACATGTTCTCCCTGCTGGCTTCCAGCGTGATCATGAGGGTGGCGGCCGGGAAGCG 
GCACGTGGCAGTCCACGACGAGGACACGGAGGAAGAGAGGCGGCGGATCAAGGAGTTCAAGGAGCTGTTC 
TTCCCCGTCGTGACGCCGGCGGTGGGAGATTATATTCCGGTGCTGAGGACGATCGGGTACAAGGGGGTCG 
AGAAGGGGATGATCCGGCTGGCCCAGAAGAGGGACGTGTACTTGAACAACTTGGTCGCGGAGGTTAGAGC 
AAAGAGGAAGGCTTCCGGCAAGAGGTCAAGCGGCGAGGACGGAGACAAGCTCAGCTCCGTCGCTGATACC 
GTTCTCAACTTGCAGGAGACCCAACCTGAGCTTTACACCGATGACATCGTCAAGAGTTTGGTCATGATGA 
TGTTTATCGCCGGAACCGAAACGTCAACGACCGTGCTGGAGTGGTCGTTGACCCTCCTCTTGCAACACCC 
AAATAAGATGCAAAAGTTACAAGCCGAGATCGACGGCATCACCGGAGAGAGCCGCCTCATGAACGAATCC 
GACCTCCCCAACCTCCCCTACCTCCGGGCCGTCGTCAAGGAGGCGTTAAGGTTGTTCCCTCCGGTCCCAC 
TCTTGCTGCCTCACTTCTCGACCGATGCCTGCACCGTTGGAGGCTACGACATTCCCAAAGGAACCATGCT 
CTTGGTCAACGTGTGGGCCATGCACAGGGACCCGAAGCTGTGGGACGAACCCACCGAGTTCAGGCCCGAG 
AGGTTCGTCGAAACGAACCTCGACACGTACCTGCTCGTGCCGTTTGGTGTTGGGAGGAGGGCATGTGCTG 
GAAACACGATGGGAACCCACATGGTGTGCGTGGCGTTGGGCGTGCTCATGCAGTGCTTCGACTGGGATCA 
GCTCGGCATGGACGAGGACATGAGCCACGCGGTTGGCGCGGGTACCTTGTCCAAGGGCAAGCCATTGGAG 
GCGAGCTTCGCACCTCGGCCCAAGATGACCAACATCCTCAGTTCTCTACTCTCTTAG 
 
 
>HpCYP81AA3 
MELYLYLAAFFLAFSAFKLLSRKKHNYPPGPRALPVVGNLHLIKPPLYRFFQTASGRFGPIMLFWMGRTP 
FLVVSSPDAVEECFTKNDIIFADRPNSMSGDHLTYNYQFLVWAHHGPLWKNLRRLTYTEIFSLKALQRSA 
FVREEETSHFAGRLLRYCSSGKTKLNMKYMFSLLASSVIMRVAAGKRHVAVHDEDTEEERRRIKEFKELF 
FPVVTPAVGDYIPVLRTIGYKGVEKGMIRLAQKRDVYLNNLVAEVRAKRKASGKRSSGEDGDKLSSVADT 
VLNLQETQPELYTDDIVKSLVMMMFIAGTETSTTVLEWSLTLLLQHPNKMQKLQAEIDGITGESRLMNES 
DLPNLPYLRAVVKEALRLFPPVPLLLPHFSTDACTVGGYDIPKGTMLLVNVWAMHRDPKLWDEPTEFRPE 
RFVETNLDTYLLVPFGVGRRACAGNTMGTHMVCVALGVLMQCFDWDQLGMDEDMSHAVGAGTLSKGKPLE 
ASFAPRPKMTNILSSLLS 
 
 
 
 
 
 
 
 
 
